var title_f5_7_5232="Parasternal long axis echo aortic valve vegetations";
var content_f5_7_5232=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F62352&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F62352&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Parasternal long axis echocardiogram showing aortic valve vegetations",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 372px; height: 277px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The parasternal long axis view shows a bulky vegetation (veg) arising from the aortic (Ao) valve; the vegetation is large enough to prolapse into the left ventricular (LV) outflow tract. There is also a left atrial (LA) vegetation (arrows). Both the Ao and LA masses were shown to be bacterial vegetations.",
"    <div class=\"footnotes\">",
"     RVOT: right ventricular outflow tract; MV: mitral valve.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_7_5232=[""].join("\n");
var outline_f5_7_5232=null;
var title_f5_7_5233="Hair tourniquet syndrome";
var content_f5_7_5233=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F50150&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F50150&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Hair tourniquet syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 358px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Infant brought in by mother who noticed toe was red and swollen while bathing child. Hair touniquet removed using forceps with good results.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: William E Franklin, DO, FACEP. Copyright &copy;2003 William E Franklin, DO, FACEP.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_7_5233=[""].join("\n");
var outline_f5_7_5233=null;
var title_f5_7_5234="Grade II liver hematoma CT scan";
var content_f5_7_5234=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RADIOL%2F86844&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RADIOL%2F86844&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 494px\">",
"   <div class=\"ttl\">",
"    Grade II liver hematoma CT scan",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 474px; height: 329px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The CT scan shows a lenticular-shaped high density collection (yellow arrow) in segment IV of the liver consistent with a grade II acute hematoma. A small collection of fluid is noted in the left anterior pararenal space (yellow arrowhead) that could represent acute pancreatic injury.",
"    <div class=\"footnotes\">",
"     CT: computed tomography.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_7_5234=[""].join("\n");
var outline_f5_7_5234=null;
var title_f5_7_5235="RA RV pressure junct rhythm";
var content_f5_7_5235=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F82603&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F82603&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 506px\">",
"   <div class=\"ttl\">",
"    Pressure waveform changes with a junctional rhythm",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 486px; height: 206px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The initial rhythm in panel A is junctional and the P waves are superimposed on the QRS complex, resulting in simultaneous atrial and ventricular contraction and giant \"v\" waves on the right atrial (RA) pressure tracing due to atrial contraction against the closed tricuspid valve. With resumption of sinus rhythm, the RA pressure becomes normal with an \"a\" wave that is taller than the \"v\" wave. There is also a change in the right ventricular pressure waveform. The initial rhythm in panel B is junctional and the RV pressure is 38 mmHg. With resumption of sinus rhythm (end of panel B) and the restoration of atrial contribution to RV filling, the RV pressure increases to 50 mmHg.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Morton Kern, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_7_5235=[""].join("\n");
var outline_f5_7_5235=null;
var title_f5_7_5236="Alvimopan: Drug information";
var content_f5_7_5236=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Alvimopan: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?43/22/44387?source=see_link\">",
"    see \"Alvimopan: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F6102383\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F6091258\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Entereg&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F6102389\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Gastrointestinal Agent, Miscellaneous;",
"     </li>",
"     <li>",
"      Opioid Antagonist, Peripherally-Acting",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F6102422\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     For hospital use only.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Management of postoperative ileus:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Initial: 12 mg administered 30 minutes to 5 hours prior to surgery",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Maintenance: 12 mg twice daily beginning the day after surgery for a maximum of 7 days or until discharged from hospital (maximum total treatment: 15 doses)",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F6102423\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F6102424\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mild-to-severe impairment: No adjustment needed; use caution.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ESRD: Use not recommended.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F6102425\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mild-to-moderate impairment (Child-Pugh class A or B): No adjustment needed; use caution.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Severe impairment (Child-Pugh class C): Use not recommended.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F6102429\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Entereg&reg;: 12 mg",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F6102387\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block accres drugH1Div\" id=\"F11216856\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Prescribing and Access Restrictions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     As a requirement of the REMS program, access to this medication is restricted. Only hospitals enrolled in the ENTEREG Access Support and Education (E.A.S.E.&trade;) Program may administer this medication. Hospital staff must be educated on the need to limit to short-term (no more than 15 doses) and inpatient use. Hospitals may contact the E.A.S.E.&trade; program at 1-866-423-6567 (1-866-4ADOLOR).",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F6102427\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Patient must be hospitalized. Initial dose should be administered 30 minutes to 5 hours prior to surgery. May be administered with or without food.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F6102390\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Accelerate the time to upper and lower GI recovery following partial large or small bowel resection surgery with primary anastomosis",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F6102384\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Alvimopan may be confused with almotriptan",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F6102400\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     1% to 10%:",
"     <b>",
"      Note:",
"     </b>",
"     Incidence reported limited to bowel resection patients only.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Endocrine &amp; metabolic: Hypokalemia (10%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gastrointestinal: Dyspepsia (7%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Genitourinary: Urinary retention (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hematologic: Anemia (5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular &amp; skeletal: Back pain (3%)",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F6102395\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Patients who have taken therapeutic doses of opioids for more than 7 consecutive days immediately prior to alvimopan",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F6102396\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:0em;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Cardiovascular effects: A trend towards an increased incidence of MI was observed in alvimopan (low dose) treated patients compared to placebo in a 12-month study in patients treated with opioids for chronic pain. MI was generally observed more frequently in the initial 1-4 months of treatment. Other studies have not observed this trend and a causal relationship has not been found.",
"    </p>",
"    <p style=\"text-indent:0em;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Complete bowel obstruction: Use not recommended in patients undergoing surgery for complete bowel obstruction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Hepatic impairment: Use with caution in patients with mild-to-moderate hepatic impairment (Child-Pugh classes A and B); use not recommended with severe impairment (Child-Pugh class C).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment; use not recommended in patients with ESRD.",
"    </p>",
"    <p style=\"text-indent:0em;\">",
"     <b>",
"      <i>",
"       Concurrent drug therapy issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Opioids: Use with caution in patients recently exposed to opioids; may be more sensitive to gastrointestinal adverse effects (eg, abdominal pain, diarrhea, nausea and vomiting). Contraindicated in patients who have received therapeutic opioids for &gt;7 consecutive days immediately prior to use.",
"    </p>",
"    <p style=\"text-indent:0em;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Japanese patients: Patients of Japanese descent should be monitored closely for gastrointestinal side effects (eg, abdominal pain, cramping, diarrhea) due to possibility of greater drug exposure; discontinue use if side effects occur.",
"    </p>",
"    <p style=\"text-indent:0em;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Appropriate use:",
"     <b>",
"      [U.S. Boxed Warning]: For short-term (&le;15 doses) hospital use only. Only hospitals that have registered through the ENTEREG Access Support and Education (E.A.S.E.&trade;) Program and met all requirements may use.",
"     </b>",
"     It will not be dispensed to patients who have been discharged from the hospital.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F6102404\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F6102403\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Analgesics (Opioid): May enhance the adverse/toxic effect of Alvimopan. This is most notable for patients receiving long-term (i.e., more than 7 days) opiates prior to alvimopan initiation. Management: Alvimopan is contraindicated in patients receiving therapeutic doses of opioids for more than 7 consecutive days immediately prior to alvimopan initiation.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F6102407\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Food: When administered with a high-fat meal, extent and rate of absorption may be reduced (C",
"     <sub>",
"      max",
"     </sub>",
"     and AUC decreased by ~38% and 21%, respectively).",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F6102391\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F6102392\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal studies have not shown teratogenic effects to the fetus. However, there are no adequate and well-controlled studies in pregnant women; use during pregnancy only if clearly needed.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F6102394\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F6102426\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Take with or without food; high-fat meals may decrease the rate and extent of absorption",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F16570423\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Entereg Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     12 mg (30): $3389.60",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F6102410\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An opioid receptor antagonist which blocks opioid binding at the mu receptor; alvimopan has restricted ability to cross the blood-brain barrier at therapeutic doses. It selectively and competitively binds to the GI tract mu opioid receptors and antagonizes the peripheral effects of opioids on gastrointestinal motility and secretion. Does not affect opioid analgesic effects or induce opioid withdrawal symptoms.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F6102412\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 20-40 L",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Protein binding: Parent drug: 80%; metabolite: 94% (both primarily to albumin)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metabolism: Hydrolyzed to an amide hydrolysis compound (active metabolite) by gut microflora; further metabolism of active metabolite to glucuronide conjugates and other minor metabolites.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bioavailability: ~6% (range: 1% to 19%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Half-life elimination: 10-17 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Time to peak, plasma: Parent drug: ~2 hours; Metabolite: 36 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Excretion: Urine (~35% as unchanged drug and metabolites); feces (via biliary excretion)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Leslie JB, &ldquo;Alvimopan for the Management of Postoperative Ileus,&rdquo;",
"      <i>",
"       Ann Pharmacother",
"      </i>",
"      , 2005, 39(9):1502-10.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/7/5236/abstract-text/16076918/pubmed\" id=\"16076918\" target=\"_blank\">",
"        16076918",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Taguchi A, Sharma N, Saleem RN, et al, &ldquo;Selective Postoperative Inhibition of Gastrointestinal Opioid Receptors,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 2001, 345(13):935-40.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/7/5236/abstract-text/11575284/pubmed\" id=\"11575284\" target=\"_blank\">",
"        11575284",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 9057 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-210.101.131.232-0D05C0E861-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_7_5236=[""].join("\n");
var outline_f5_7_5236=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6102383\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6091258\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6102389\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6102422\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6102423\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6102424\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6102425\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6102429\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6102387\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11216856\">",
"      Prescribing and Access Restrictions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6102427\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6102390\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6102384\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6102400\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6102395\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6102396\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6102404\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6102403\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6102407\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6102391\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6102392\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6102394\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6102426\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F16570423\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6102410\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6102412\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9057\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/9057|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?43/22/44387?source=related_link\">",
"      Alvimopan: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_7_5237="Methenamine, phenyl salicylate, methylene blue, benzoic acid, and hyoscyamine: Patient drug information";
var content_f5_7_5237=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Methenamine, phenyl salicylate, methylene blue, benzoic acid, and hyoscyamine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/0/15366?source=see_link\">",
"     see \"Methenamine, phenyl salicylate, methylene blue, benzoic acid, and hyoscyamine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F6789429\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Hyophen&trade;;",
"     </li>",
"     <li>",
"      Prosed&reg;/DS",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10018310\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691668",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat a bladder infection.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease pain from a bladder infection.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691975",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat muscle spasms of the urinary system.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10018309\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702492",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to methenamine, phenyl salicylate, methylene blue, benzoic acid, hyoscyamine, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10018314\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697225",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have glaucoma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697164",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a bowel block, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697312",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have myasthenia gravis, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697349",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have trouble passing urine, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696851",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take aspirin, antacids, or drugs that raise the pH of the urine while on this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698573",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may need to check the acid content (pH) of your urine using a dipstick test.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696643",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid citrus fruits, dairy products, and some veggies while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696713",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Some types of water pills may lower the effects of this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10018315\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697952",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in color of urine or stool to blue or green.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10018317\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699018",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea), even after drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699058",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in thinking clearly and with logic.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699087",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10018312\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696130",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       To gain the most benefit, do not miss doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695899",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with a full glass of water.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10018313\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10018318\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10018319\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12184 Version 32.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-08BE826B45-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_7_5237=[""].join("\n");
var outline_f5_7_5237=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6789429\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018310\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018309\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018314\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018315\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018317\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018312\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018313\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018318\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10018319\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?15/0/15366?source=related_link\">",
"      Methenamine, phenyl salicylate, methylene blue, benzoic acid, and hyoscyamine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_7_5238="Bullous pemphigoid tense bullae 2 PI";
var content_f5_7_5238=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F87308&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F87308&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 596px\">",
"   <div class=\"ttl\">",
"    Bullous pemphigoid",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 576px; height: 432px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGwAkADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD1RVGM1KgGKRFqUL+dUSOVcningUicGpF5pXEKnT2FSAAsMDpSKOop+3IyTg0rgGPpzUgHftSAADrmlUc0XAUDpgnHpS4wOc4pQM8UY5+lIAXjJpD654NLgc80EcYoAbjv3ozjvgU7OBzSfWmAmOOOtNIOO2acTjoKZ1ORT6AJRnt0B70bsijqeelAC5HqeKTqO2D60nQig9aAGnjqeBTWII4z+dKxyRimkYNMBD+I/GhRnI6H1p23J9akC+opiGKmSM4J96eIxggcGnqMYNPA/GgCEx+goCHtVgjmkVc59aTGMVcCpAuMcZpyqPQU9Vx0ODSAbgbc9qVQD0pwGcgninYFADeOlGM9akxkY4FJgA4JoAQAc44FH0HFOIwOKUAn2z2oAbj2penYUYxzig9s0AHYZ6UH3oByMCkPJoAX8aOM8E5pCRQpwPWgBSR/9eg9MimgAg4NOzQA4dgTTv8AgVIMEUpPHQZ9apIBeOvOKOpoGepHBrH8Qa5a6RaPJM4DAcA00Frj9e1eDSLMyzyDIHrXz1438Wza3eOkbEQBj3603xt4quNeu2CuVgB6etcuFwB61hUq9EdNOl1ALuOacVx17UqKR9KlKkoADzXK2dUYkUQBk54pzsN3zdKkKk9uKQwq4AYcCobuapCrErrwenf1p8ceCGHQVJgEKgXAFTBY4xkHcffpSNEQSbmyeMe3FNXt2FK0i7yAu7PTJ4pxDFct9w9KRYqTA52cUh5Y7uBSBS2VQhUHU9KMFec5x60DGuSzDavHqe1LtwSAfxpxAJyqs57+lN7/ADKMfWkNCcF2Cgk9mPNLgh+MkjuTTxJIy5XCIO9JuA5DA49TkmgYoZtm3qR6CozMzPszj8KV5QB98j2xil2lhnB44G0UDsNUsnO7P+71qNjvJw+Aeoz1qwIDtG44QntxUDwKpyhwB1JFA0hSnIXBYY6dKYyEZC4Wp8LgcgntnpTAR5bAqQw9DgUhlWQBV559qgbbgD5h9Kt8HG1Tx6c1E65fB/AY60AfToVc1IFBxRH0xj3qUJ8ua9W582NC9z1qVRx9aADnFPUYOMVIhoGMZ7U8DqaUAHoOaeMZHBoATGB0p6jg80d+OKBjHTrQAuMAUbj0NHGMAc0dT70gEOOuTRnK8UuOORSED0p2ATrikfJ4p3Awaaw5pgMwcH0pnPansRjApNoI9MUxEfcDpQCdxFKR2FKAOhGDSGByOetGMnk804dB6d6QY6Kef5UwGkZOMYpQvTOePanqOfWnADHSmK40KAfrTgOTmlAHUU5Rii4gCAjIBp6AU4DkZoPUYoHcQjIyKUDrjrSgGpEXgYBzUjGlByR60oHPTNSHkYoA+UigBvfpSleacFwQDTguM9aAGBRt96cFAAxTsA80EelADMc0Enr0Ap+Pm46UmPpzQAw89O1IcbqeAcYxijHbHNAEQ4NLyQcfnUgXnkUFcHPb0pgQ8HpRjsKlKjPTBpNuDQA3A/hHFOUcmnBfSnYxnpinYBvNKB0p/AUk9u9cZ448YW2i2sixuGlPAGaoEm3oXfFviiz0S1YvIPMx0zXz74r8S3OuXLvI7LETwoqnrus3Ws3by3Dlhnhc8Cs0JluQfWuapVvojrp0kgA3DgU5F+bHepEU9cU+JGJO1evU+lc7Z0qIqxkJknmnxZwTjNNAIzk5qSM/LnByKi5qkIcE9xSxJtfPX0qRmG0lgMnoKUMwXLDA9e9I0SDG3LNyT39KjUoCRncSe/SjdGzZLN/jQzIBkJz6CkUkDhS244B6cU1pNhXYMj+8aCSy7Bj1phUliSeB39KB2EZ2IPPXqBTFIzwxOOgPWnBUGcAsP7xpyrkjbgD2FItRGLIxXgMn41EwHIZznuByavmONBkZd/71V2h3c8BvbrQUlYZFsx6f73NGADkMpPuKBEy5HX0FC5ywbqOw5pXHYljZmIyvHsODT8jHVj3I6VWdwoxg49zUKTh8ncQfSi4rF/eCMbMe5al+bKjzAWHoO1V4cPzlmx+FTglCfnwfpRcAYxkENuJ7kikQq7hWJyBwCOKV1DYZgck4470fJnAbJ/u0AQyDecJlT6DgUmwj5gpb61IUY5PQZ4BpGyFGHAI7CgD6aCnt6VKox1NCkYGT1p+M816h80KF5zTlA3ZNC4Bp4OTz1pANA+b3707v0o78cUuQSMGgAwCM9qXqaQk5xxS44PrQAnueB60dsik56ZzSZIXjFMBwII560hOee1NBOcAYprnFAhxb1xSZPpxSflRnGT6daYXEweoHtS7TSg9etJu9OtACEfiaAMgeopf0pM85HpSAMY46UAe+Kdj1oAyPQ0wBVyeOKeqkcHGaVQP4s0oOT2oEAU+gp+OAPSlA4HFPACnnigBgU49qcFzz6U7A7U5F7UihFTIz608AAkAc0uMfTrTu3SgBhBpVAA55NKSATmlwMDmkA4DI6mkJHbr3pRwOMk4oxxnjPWmAH0oUjFA6560Fuo6EUABXg03HHNSDjB/Gkbr/ACoAaoOOeaXv0x707IyeKT0oAaQR70FeM4pzdMfmaOOnegBCDjJxTdpPepBnGDzS4HbBpgMA9CKc3ygljgCh2SJdz8AV5l8RPH8VjA9rYnfO3oelO6W40ubRF/x744ttJt3igcPNjGAea8E1bUbnVbpprlmbJyAegqveXE17ctPcyM7scnJzSBgMDrXNUqt6LY7KdOwsce0HAzTkjy3NMVyTwAB61KrAv3JrBs6IofsVWww4p6EIAucA9abyXHc1KqKRuY0jVISTDJ0Ax+tQeccFeiinH5+AcDPJqOby0XbgnP5mpLsKHLENzx7UrSM4Iz07mmZwo25+hpwi3nJ+XikWokRO44zmpAzMAI+AOpHGaVIOM469vWiRCMAsFX0FJmiiP25ADEfh/jTZAduBwB6U7acAnIX3pRkDI6Dj2FAyNGDY3Bsjt/jU6t6njH8IqLcAv3fl6n1ak81ScEHaf4RQUixgdYyiAdTnmhQzHcFyOhI71GoAKlgMeh4p6jjduzg9c8fhQAjNHvKbSBnnHSq8rFOIwAO5FWJUU/eyx75OKibBj2ljt7BRSGVpNjgZzvPemrbZPUBh1zVxYY8n5WfHYtilZRwSmCPu59KTAjjTYASSQfQVKTu+XjHbdR5m5NoBHoT2pUCOuGxuzkAHtQQNUhFJ5JHQ0oZdx80KpI4O2nsY9w+Rtvs3NQyshfhWIHdjQBOxUcZyMdcdKrO4QcEHB6+tNDcE/wAOaR49/wBxQT2ouI+pdvGacq8Z6UAZHvmnYAr07nzYoGRzgU/GO9NFKOvrTAFyT7UoGQaOvPeg8HnrQAAc0hBAA7ZzQTjgU0njg0ABOTTcgD3pGJHSmg5470wF4PfApM8fSkPtSdV49aBMccetA5OOwo20o6+9MQoxjvnPel4z2oxntkilx370ANAJ6g4oxg9c+lPAzz0pcUAIRuPIFOCgj0xSgYIxTlBznAoGGM9eacF4x0pQPSnE0AIAOOTUgHOfT1pAMn608ZJHqP1pDBAMCn9/TFGOnFOHYmgBCOw5p/B45xSD5TSnrnNACECkI2k46Up96QfpQALxSnHJ70nUn0oBJOKQAB+FB564OKU5xgCkx/kUAABx1zTs9aQrggnpRnnJ6UwHfQA/WkOce470hIzg07qCaAAnnrQqjJPrSDGR6mnZA+g607AHAOCRmq99eQWcTPO4QDrnvWJ4o8V2Oi27GSVTIOgrw7xf41vtaldY5GSAnoDjNJyUdy4Qcjq/H/xEMjPa6a5yeNwPAryWad55Wklcs56setNYtIeuTTguVwOtc06jZ2QpqKECAjcWpyx5OQKXYTgEcVMse0fewazbubxiQeSxPI4qdUVcEDFKMjjk07Pzrv8AwFQ2aJCoeSAo2jvSn5vmIBp4bnAXAHX3pm3zeAOB0qbmiQ0Erzhceh7VAWZju28+vrVh4iSAcADrk0bGZht6D8hRc0USuy85Jx61LANo4Vue57U+RdvCkOM4GaYxZWP8S5+6TikWSy42knCp355NQ78crgE8ZxwP/r1IdqODNgnsKgneWSN9pw38A7A0wGO6xsFncA9cE5NOD/uzs3FSefTFYsFpceb5k4GQc8nk1rrL5iHcGCKPvDjmgVweKeVysfyp6imi3Nucu5bJxhaZPLM0G23cqOi4HX1rH8y9W6RJnbAP3WphdnQBssc4PGAD2p6klM4xxVBiTbHyiVIPzAdanhLKVy/AHQnHNSy0WUWMhmk3Kp6ZGSxp5bYuIwFJ6jv+NLiNSmyQvnkkDgfnT18llJKuT3560ikVdxbAbP0zTwxYgZyMdugqUxgyA+WVB/vGkYAfN5g5HYdaTHYhZSW5bafVulMXcVLMRj2qV4iw4OfcionG1Tk7R9KQrDlYMD8pAH93tTifMBz89NVQRuUnJHY9abJuLli2x+nAoJsPSJslSAvGee9AyCp5GOvFHmfLhueM5PY0oUtHuVu/IPagk+pOlOHSkH+c0vA7V6h80Lz7fjR260gXjOeKCaYCig84pCcCmE4pWAcSSe1MJ6+tI544P196RuTjH4+lUA3NIWwOMAUbuoA9uaTAB96YCc9O1OU5PSlAPU/lSigQ4fepcDn3oBA6U8AHGeKQhAvuaNo6Zp+OlGM0XGHXilCgHIGKUJg8dqUdyfxoABjrT1AKgimjHpUijP1oATGDTwDk+1LtwOvNPA+boKAGAdjUgFBXBpQCOnfjFIYgHOKdijHNKRgc9e1ABjHOKUngA9PWkGcjNKOgoACASOvTrRxkHoaVhuAHakUDPzEUAHGSec0KBjP5U9RgUdeKLAMPT3oGQPWnnk5oOcUwGqM5pCMH1p/0pcdsE+tMCMAA89KcPbpS9snAHvXNeJPFdjocLmSQF8dAe9OwJX2Nu8u4bSJpJ3AAGeteWeM/iSsPmW+nYZ8YzXC+LfG17rczLC7RQk469a5DBJLMeT61lOolojohS7lzUdSudRnaa8kZjngE8VUb5sYpSC+M0qoQDgfSuZyvudUYWAIF+6eTUsIwOcVGsbcMaHOGHy/rUN6mqiWPvKcDj1pqkZwT9CabGxb74Cr6Cp44yzZIGzpUmqQ/a2zcoH51AhJbJ61aVEXKHJJ61A37rhDhjxzSLQqR53eY5VfX1pysUyI1AxTUxtAxwO5qWPaVbjA7mk2aJEQ4yzEc+vWkEhbOcLHnp61JII8D5jn+760x1DdFJb+8e3sKDRbDV2M2GQrk9BzmkuImCszY46DvSqwXO3CuOlRT3IJXcQTngEc00SV0D7CSCpIwARk0olCkADLdCT0FPlOXUFyMfw+tVpMFiQCWz09KYEnBOXJ2j9PaoZJzI5iRcK3PualO88MM9zjtTZBuwFGIu7d2oJIlmkWNkiwVPGMU1LF7q5Vg+3GAcnOKsi3PmYHTtg8AVJgZdLclQFy7Y+9QgGNMYWMUas/+1jpRCEJBcktjuKsBNyL8vzsBhTxTgv2d8grvB6AZpSRaHQgHKhl9znj6VL9/aC+1B+ApkSb1+WM8ngHjJqWRo1wJTlgMccgVJQoYbR8wweMY61Gw27t6EnsF6CplVJF3MxiCr8o25/DNRJk4Azkfwk4z9aLFIUKsihQzBj0UDvUcqGNBkE565qcqyuVTgHk46ihlUs7H7h4BPNIZSCBnAUlQB0zTg65y/Ldz/wDWodDHuEa8jkk1GQ6tuxj+8PekJkjRnooGDz7UiOWJIyAO44pQDuJUggE5FErbyyRMQOCT6UEuJ9SjnoKU57dO9MB570pbB716h8uO+nFITxTSfekzTAUsPX/61NJ9BkUhbnBNN3Ad+fWmAucc5pOpHP1pPc9PSlXtQIRh7ZpUXHUZNLnHWnY5HUUAIATz3p+AMenpQvU805c5pgAGOaUDnFKeRx27+tGKQxQKeoyaQfNT+B/jQAg4BFGOnr7U4D5c4604ZJGBxQAgA4qQLkehoC5p4FACbTjNPC80HBHFKKQB16UpBpcYP60YOOtACbQOvODmgZxzz/SnY96MAc+tMBpFOAxmlH6UoHHU+1ADccUoxnpmnDNKOlADAT6Uo707AzQQQOlADSOeDR0yTx9adjHTrSMAQQQGx69KYCHPp2qG6uI7WFpZnCqPU1n6zrNnosLyTTqoC/dJrw/xx4+uNWd7eycpD3YHrTbUVdlRg5HWeN/iUlvvtdOO+Tpkdq8c1XU7vUrhpbyUux/SoM5JLHJPUmkbHUda55VXI64U0thit+VOX5gQRQpOCMDFOVcAY6msbm8Yj06YFSBht7cVGSqn5utACnJ5z7VDNVEfkk4HFKIUL/Mc03AXb83XrU3y7cjrUXNFEmjijVegye/pTmCptCncc9BUJ3yIAoK9s4p8KELnGD04oNLCIz7j3A705gjMp6H1qZgpUBiy56AU1oyR8gwP51I7ETsD8qfdHUn1oDA4ByB6CnCJ8EEBF7bv4qR18sgLg9s5oZqlYRQpYkpnjg55FKSxwiudo6BR0pqIxZhkl84AzTokkVt0Yw4+8xoGMky6BXCqo5+v1qu0casJOrjv/hVlk3kvKCcDIPY/WkKc5ZlbHUf4UxMoyCVpQAOTwMClaARownyJRyorTsZjFuaFR5j9eM/zqnJE0haaQ54/HFMkgWL5DhR6kf3j6VFG0jZE4wi9PT6VaYFyhlYRrxkDsB/WorwP5TmJcRryiMP1NF7iGbpJOUfLgcdsU1Bj/WKxc9un51DFdXTlvOVQpGAyjGTVqyt5HRi0iq38TP0AoAlt8qC90+9gO38NSW4R33sCqjnAPao1/egOv3F7/wB6mNLHHncS7NwcDgUFErsWXcGYxA4BHekVGaYggFByAvU0hfyl3FDh/ur1BFSjzFjBTjOSQP4aQCs52x/LnH8LHoKUSK1yDIeD8o/2acpWRTIOR09ac9oXO6QKgP3cnAPGaGikJ5RR2VzvH1xmp4hEWwyBcfcGe39arWali+7J2dM9qtBWVQ33Ag37sfNipLIp0DYO3B+6wzURjEjLHzuUEkDoalZj84BUljk57+hqFt6SFwchcEsP5UMQg/eMxUjp83bmjf5b52cEdKkTy0I4JLH8BTFKKzuRnsARk0gPp0j0pGNNbk4PBpCcjAr1T5UVjzTSSc80h4780fWmAZA68e9AGccijt/jQoHcEUAJnnpTgMU4deB0pcc47UAAAPBHNOVe+PxpQtPCjOO1ACDjPFKFHrmjsacgAAFAAo9DTscUAc0uMDP50AKo5HrRgZ6c0/jHFKB2oAMdqdgdzzSYwPenelACgfNycCnAUo/WnAce9IBAe1FOxj60AY5J/CgAIwR+lKwwaU498+tBHb9aYAeOlJzSngmgD3oAUDij+H6UfjSjk0gF7ep/lSjg0mOaU9KYB60dTzSgdcVn6tqtrpcDS3LqAOeT0ppCLkkiRKWkYKo7k1wHjT4hWmko0UDK8x7CuM8c/EWW8aS3018IeN4ry25leaUvK5dickk5qJVFHY6IUbq7NTxBr9/rtwz3MrBM8JnisVcA7Rz60jsex/KnoNvJrnlK+50xhbYczZ9qb1pyqG49aeIyBxziobN4wY2M5zmpXkyAuKRY85HQVYjtwwJXGRUNm8YFQx5cYJPtip0RdueamSMDOM7venRnbHt24yeTiouaKNiMQj7ygfjTwoXB/vU9h8vAyT7Um0sFPAHpSuVYbHLtyFJPpmp1lHIUDI4xUbRcDaBSHAIH3c8GgfKSSSqRtOd2OuOlN3YPzEAAdjTJIXDBsbV7Z709EGVDt6mgdhJmC7VUYPXJPanbRIgAIG0cU5YgXLZ3HtSnYFYFhkdP9o0FogIYADbwemOMfjSM5Ee0LkDrj+VTYJZThiO4BpFBYlR8m7sOePekMjiwxJ9uB606MrCCZApzwF68+tP8s+gDN1Y8cVG3lhcFuh+XHf3p3EyLdliCMkd/aiSWVlVBxGvT1puWluDHsO0fxkckU+JEbKhi3BPJ60ybDMq3+r5kJ+XJ7etOugVjj3xgsBjr973p/kII0kOcsdqL/WkSItkK23BxuPp3oCxRCl5uc+WnYevpSPucZYAqP4QeM1pOWWJVRFyUK7h3HqagtYJI2MYCsRyARwaBNWIQ2ECx/wAPX0FKgE8RTiPJ+v606TYWygVX/u9d2Ov402VMjBYKj+nU/SmIYrh2Bb5tnyAZ61Yj6YR9hfqzfwDpzUKpvlxEpwgzj1NW2gWBI0LLIGcAqD0PvQUxY4DbXCxo6zrnkgYBq5qd2JEYLEVJwApH3Tj+GoZ08ovC7KZC3mEqeiinyCR9kzLkyjCjsAOtJuwWIoLYrHhmbzCdzr6CpXbfMSikq4IGT0HvUjS7ZUmXBAXAUd8VESxiAizu4aTI4HtSLRHeAeWqKAuBuBHUmmYaScR4CxgZxn2q0BHBOCG8zenOR39KjtyAtxMdu/dgA84+lSFyIo0iMqI528tgdBVeQBgrKSF6/iOorUuN2QschSWUhPwPWqd980RMKbIlbCr1z2PNMVz6UJyc5pDxTc85pTgkV6p8sDdqXHqRSAYPPNP74NACbSMZApwBFN6seM5p69+e9FwADHbrTlGefSgA5p4B55oAM8dcZpRjPvSfXrTz1yOlACgDv0pQMHFGOOtKKAFAC9adgYOOnrSelKcEdSRQAgGee1OHK0nIx6U8DnigBevGacOOCO9IBnPr3p4HOfWgByjK0pHy/jRwRzwRSjpxQAcD/wCvQM54pe3tRyV68UAHI69SaXqPpSUuM9TQAHnrR1Io96On1oAXHUZ5o9aF9D1p3HTvTSAOo4ppYKmXIAHeqWpara6dEXmlUY968l8afEot5lvp2D23A0Oy1ZUYuR23i7x1Y6NE6RzK03TA614f4p8V32uTMZJGWEnIUGsK7uprydprli7k5yaru2fpWM6t9EdVOkkIT1waYVJxipI0yetS7Qo96wbOiMCvHHtPHJpWYd8Z9Ke74HFRIhZwSOO9Ju5vGBOhwnH51NECRimW8eSR0A71YTZnA61mzZRsCqMZJx7U9Aecn5fSmcqcjmnkjBJHzZqTSw8R8jg5HQdqlXai56k+tRICR0OM+tJudpF/iUAj6CgqxMrBQSww3qKU7PLO1cMe/pTUCEkbyKbh+dx69vapCwBhkDDAdyO9IVDNx25wBzUkahAZANvpmhOWO0Hnrj1oHYFRgC0rZx2NMCB5N+No7CpnwF+bj09TTd/ygYz2oAGfjahHIwT05qORMgZIz0+XoKkKbmxuwM44pxUqoVVKg9CT2oGhiqx6NgjgcdaXlEcJGDn+P2/xpxO75SfkHBb0pW8yPMiqcEYUA8H3oGVsseWbPr/9ah0VlYldpJ4XH3RT1KCFt5G/rkdzUiuNiBxu2dSvDY9TQBWYPHIFwVc8jPpUwiUJyoKdTx3pSzy3e8g5ABOR3NOZmJw2UyNoGOPrTAgcuLfJC7ccZ/z1phChVALEqMuccCpGV2iKRHgHof50x4/3KKg3Ow3MQe3emTYYxZ0fIzIwzzxlfakeG4LRM2VXOQOPxqYCN7dlVcshPPII44qzBbfaYI0Ub53IYBm2+WvdqaJZmI2Z5Sf3e4nBUdqhjyIyVUHaen96r4iEl/OkfzLHx8wyMZpl3FGMPARkAjOcY96EgYzMcVviF2N3nkAd+/1FSTlYdPX5V+cj5l5Ln+lQ2MYCm4JbHKg+3rT9OKXDTxscrjIJ4wO5FAIc+QI94zJMQWz1Rf61ayfKkRZc5c8DjA/+vUMUkayM4Bkcjy0B9PWnqCtvGOG3q2T3BBqWWiRhvltkQZXGDtGOKQ4jDlXyx5we496JJzDaQYTZLuPTvkYqMoIm+c7twJbHc+lIZHcS7Q6pyWwF/wDrVZgjWJIZJXVQV3Kp6kisuOXdK8q5IiXC+5NXIlUq0t07KsCqowOrUhMseWWuYJ5WXzZAz8n7gHr71TkO6IoOIlOc+tTtuffcTIyLIMxj/Z9aqo6tC8kuSQ4AXHGPSmI+l847UoGBx3oGTjJNI3y9enavVPlx1OJH40i+ppSKQDQctgcVKOSKjUYepl68856UAKMinA80gFC8CmA7GeaByMdqQHHSnKPTmkA4cjH86dxj6UlOXp70WAB0z3p1GBgDPJ6UY5+tMB3B6DmnYwCM9aFGMdsU/bx/OgBAMgU7HTjihR0z0py/lzxQAEdsUdelKRS4IxQAgODxyaUkg80g68U/tzQAlBGBRjsKHIUZbge5ppXEAyM8cUrMEGWwBnqTXP654osNLRjLKAwHr0ryrxR8T5JmaKwzjoDRolqUotnsOpa7Z2C5llUH61wPiX4n21vG6Wh3P0GK8a1LXb7UZCbmdz7A1ml/72fxqXV7G0aKW5v634kvtZmZ5pXCHooNYxPoMmoVkLcL0qQIduSea55Sb3OmFNCqhbk0bcHilBOB3px2gZJIJqLnTGFhi9aeQpXAP1zSRpnJByKmVFxyM1BrGJDwRtqTagGBx70pZegH5UQqXfAI+pPFJotWGHI4HT19adGTnacipnSCBSTIJHxwB0piFH6kg9qlotEiRlmB7dsVJjG3I+uaaiYAGfzpJWOcg9O1IpExZO2cAcH3qBSW4/LFPjAbHPPpUpgO3qOfTqKRYLzBx8uDyT60ZI+XgMe+etJKNq4JJHoBSYZgp3DgdP6UmMVm5zjGOnvS7sFSoPPOR1pqkMxxlynQD1qRV2gP/Ge4/lQArPuIKkE9WBobd5hdiee46CglRIqKME8sMdPanvhsIjHb/D/WkFhI2V2G/jjOMY4pUkI4UZPZT2FSR7yM4ByMsW9B0xRgrIzMu4Z+6OKBkcjFtoCBV6kgc0BTIwAwQ3AU+lKVdBJwWbjI7U6L5VDkhgOmRn5vSgCOSFEQFAzhTkr6HtmmsXaYdSx5c+pqzs5CjBJO58U2JBJK77gsYBwcUXAax/eEvuVU7Z5prjbGZScqThRnkU6TLhNwyTgAHtTpVWciHJ3ITnccfhQA1MGHJ+U4+8BzmoH/ANYAyooCZbB4b2qVNy7tx5Q4C9uajKZREJChvm/D1p3E0NJTdIctuJyOepxU1op+zQsoKvkgberfWmGTdGybAWkIAGOQB3FO4SFJIAcqDjn+LPIFMlojljMMmYwd+PnwevqaR4ESwLK5kZ8sxxj/ACKsRkPKTtVnk2gqOPqM1HclN00ARIzv+Zs9FpoCGN/s+mtGULGQcZ7VAiSWkMDOAxDnj6/zqS4laU2yrkcj5WHTH86UCOV5PN5EQPlr0LHNK/cLD7OF7Yodm6Z26nsO9MUjAIIGC23B6c8mpQ6LE8pJy64znv6VVjd0iEZBwThj7elDGW3mVyZpUbyol2pzyGPeqt1MwjQLjefmJPcmoprnEZEY+U/KPQf/AF6hXLybn+4vTnvSAeYmhjMT5Dj5mwe/YVP94lrhsRx/MY+7HHeqkzyTzs2cE4Bz2qWcMSqxksuRknvikK5fF090ZJbgFsYAxwAB2HtVS5b7QI+QplY7U7L70wfPkCTESgu2TjJ7CmscwjOI1xwT1x7Uxn0+o5ye3SkkAABxkU8A9elMZevNeofLArehpRnv+dQAEN1/CpgeFFIbQ8DLD26VIOg56U0cGnLwD60xDuh6UpA5NIOacMnr+NMBFB71IB0xTRzzTgadgDkGnrzntTQMjIp6+lIBQo9KkC9DTACM1IGHOc4oAVFPbr3p+BTFz3qQA84oADyOgOPWgZwPSjknOacPSgBOe1AzjGaUDmjHcd6BCgDHoKUDJ9sflUc0qRKTIwCiuF8Y+P7PTY5I4HDy4wADVebGk3sdfqWqW2nQmSeVAFHc15R4y+Jy/PFp5DHpkV534i8VX2szHzJGWPJ+UGufIycj8aylVWyOiNHqy5qeq3upTs9zMz7uxNUtvel6jignA9aybb3NUrC5AGSKYu52/wBk1JsyQW6VOqr17DpU3saxhcZFDjJ6AUpxux1px3ZyeF61JDA8h+QDHqelS9ToVkRn5RgcUbS/3QTU0iwxOAzea4688Cmm4ZmxG4jX3Hb0qdC0rjSNnGefSly6gggAnjmpAyJgqAXHTB6/Wo5JyG+Xlwcn2NJtFJMRldVLEhQBn5qasUzjjG3sT0przBmDyAvg5+bvSG5dmyTkdcVPOjRQbJHt3GNzrnr8v9ai2ShuQvtimNMSSc8dcU3zGz975j6dh7VDmjTkJQ9wHKgbgOc+lRyXL7sbcZ5oWYhCBkEmk3ZHTNTzD5bGhbXAfbu/iqwzDbhWHrjPasLDKCUPzHmrlnN5sgVzhwelO4Gmz7lUYYsePwpxw4ITG1RxnqTTVPznapBHBY9PepFKjAb7oHbrQyh6Bo0QMoKgknAxk0dCHHA/PFNxlsZ3An5ttPl+YDy+pHJPbFIATaQSMAt3NIoZmKKBtUbSw7U1IwI1Y87s8g9KVl+ULGSo6n/aoGTxosinLBQgyG9apqDI7dR364wKstIFjHB2E4UDuaUpFK0iqQNiZJJxu9qBoaglS1A3Aq/JB6/nUuVMZkQFMgKB15qN2Z2B2cnhVB+7TioUNEuGjXByeuaBD5YikLOuWYgYI7Zp8cZmeOFVxt69smoVlwCMkBjg47VbRxG7hFL5O5j6igCC5ZRbhX2llbJIHVs+tVwplmUAjLMWwOoqbcspcbMJGcj8fWoCpWWTaMyZwARxj1oGJgG5YLxuUkKfUdaWLa6K0gOc5AX09KVU2RvIcBgMcmmLuiihLj5dgOe4oEIxcXZcEg/d+gpgHkITj59xEeTxQpOzzSeWfgHuO9PdZ1QzCMtEhKIx9TTAkEbQW8jbvmkXcHU8Y71SjYSRz3HllY2YKRnPygVPK5S2MQbcrAc+oPb86Ta6WnlkKh2ksCeoPSqRJHdTyyzRySOPtIKqp9FHShjI091IoXKjJOeRk9aowuHmiTJwDnJ6irN4yxTuFI+ZMHJ6+lSAsUm5H3KePur7+v1qssuI3Lkh+eB1+tO34VVOPMxyT2FQSNumLchM4X0PFINhshLrGWYjB3BfWp7aMtG8zlVQHkn+lV0YSSJv5O0nAqafe8iRpx/Ew7GmRcT5fJk2ggu2AT1xUjhgqInLY5OelVGcycdAxzgfwirYLgx21mju8jYCquWY0gHAoCkcXGSOvtTJ2ElwzFSFU8KOcn0qbTY9t680ljJcwWvM8QzgDOMMR05qG3USs1wwMUW87QD0GeAPpVFJn1Icnlee1Mcdj1qUcE9h6VG4r1D5dEIUbqlU8dBx+tMxg+1SpzgYpIbFHXpTwPl9aTGR70/HHT8quxIv8JpcHGM04cn2oC80AxACRilUfpTnKKPm49zWZqOuWNkp8yVePU0WGjUHUAA0pYAjLAV5xq/xEtIGZYpAx9q5HU/iTctuEGQOxzUtrqV7OTPdPtMSnmRfzpPt1vnHmCvmufx7qUhz5pH41VbxrqRbJuTSc4lqkz6jSeNyNjg1YHXrmvmXT/H2owuGaXcPTNeheEviNHdOsV02CfU01JPYTpNbHrXegVBY3kN7ErxMCpHHNSSzxwIWldVA96aVzPbQkxxz0rK1rXbTSbdnmkUEDpmuO8a/EW00xHitXDzY6A14nr3iK+1qZmnlYR5yFzRKSiaRpOW52XjX4jz6gzQWLFI8/ezXm1xdM8heVyzHnJNQyOOmKgA3t83TtXPObkdMYpEiyF2I/WrUafLlqgVQCMAVKrEjBqC0rjj6A1LFA0rBUUs1RxgtKFUZb+VaAlaKIxRnAP3j3NFzSMR3lRIAkh3yjtnAFNcjcAihscDaOBUPBJx8tSRyhFyeg6D0pXNFEtKkaKGmAdh97NULi7MjMQQB2A4AqK4mLnGcentUG0jkjj+dQ5WNowBmwc96lQ7F6Zz1zUSqD0GKlAwADWVzVIAep7+tNAPr1p3Sm8k+9S2aRQnXvSgd6ci5Jx09acAN3Iz61JaIgoPWjy8n5eg61NsxjHI9aUc9OBU2LRAVwRxSEY4qcj6U3B6gYA7UDaIiM+1QzKVIkUkOv6irDA56daa4yRk9KZLRoWEwnjUBvkHJ55BqydrPhSSevNYNnK0N00YUbH+b06VuAs0TFcB2PTuBWhnsN83HO3px1xUsUwdTuxnIwfStW20pI7CSe8byyFyo65rNEAb5sAIeaHHuNSTBtyDCAhupY9x9KlgkfzJAjFSQRgdBVdo2jlZXJXAxz1qaGVQohC5I/iPHX1pFkimVFWRVGVOFyOM1FKQCcHCnOTjvUks4cou0+VHwqg5wPemSqu9ljYOWAHB/OkA5cpBHKmSR93P86nVH+0BiQDHxv7A1Eys65RsSsNoxwMe9OYq1vECoLA7mIP3j6UwCVkMcuSd5b7w6MfXFWrUFPvMoBPTv9KzmLBpBIpDKePYVaDBYRI33vbnNIQQKZdwUFtzE47jFOiy88k2/a4G1QB1Peh3MVsgjYglsnHXPt7UMmyO4jTJI+Zc9cGgRCCkiSBsqc8+mAKrtj7GGfBIYKy+2KssF2RgELsyT7t6VVk+fO/IAJcj37UIZJeD/AEUlkKF8FQPSm3APyICSVUMFzxio2eZ1t4ZQ22Md+3epm2G4K+W5QJuyaYiqzny4nyG2nBBHQetV5AX3tKxGQdvvU+FaKAKCoIOSfTNV5+XxF90k4GegouBFZbUaVpOTjbx3o3ZljOMbcfhUay4jlPQHocUipIm3g7mG4k+lIVwf5nDMflLHkd6ZOZJ7hY0AODwOmB61NxIAG+WMHqByfakt2wHZeC5P4Y6fhTI5hGjMZbagyMDjmnBnfe2cYG3Pv6UyOIuyLyATl8H7xp8JA3sR8iHIHbNIQeWI7dl3bckBge5re8GvKb3UFgmSG/e2aO0kc4Af2PY46VhyozBFONwO5yfX0rV0XTbe+lup9Qke1tLWEzOIxliM8Y9DTW5MttTS8MaRrljrUdzLFNaWitm7lmICOnVgefmzXM3rCa7nFsCIDMxjXoApJx+ldKs/h/YIJZtbkQ44kkDBfwPFctNtLSQWx4LMVZ+oGeP0pvYIN3uz6qIPr3prDPP51IenTApm3PGeterY+cGbeOtTIMAUgHX0p3Qc00DYqjIzjkU8YzzwKRR8px19KiubqO2j3zMB3p2FqWMVm6vrNvpkLPI6jAzya4zxN8QLey3JEwYjoM15H4o8WXWquVDkJ6ZpSmobmkaTerO38VfEolnjtDu7ZBrzfUvEN7qDlpZmx6A1hySEuSeSaQvxwa5pVZSOhQSLf2kg5LEn61A05YnJqBm5FMZ8His2y7Ezuck1GXI5zTAxPek696LjsSpKwIOTWja3piIcNhh3rIBOcd6sQQM3JPFNNg0mem+G/iFdWEQjcsyjoc0eIviFf6hH5ULmNT1Oa4FMKMCmSTDBGTxWntJWIUEi1PcNM5eVizHkkmoTKCTg1SeUsTinKpwAelQ2UTq3mcClK4bryO1OiCoDjrTgAW6cGpLirj0HAqYKAuRzUJ64HA9aejHfg5wKm5so21LUaiMtt6nAzUhHPB6cYqO3wx3sxzjPPrSNIVBJwCfWnsOKux7cjk4qCR/MwB2qMy7j0pVyenFQ2bxQexqRQAKbjvSj2qGaJDht3ZAocjPFC5zzTSBx61LKSEBp230pVj568VJ2HAHrUmi0GpxgD8akVCAARmhU3E4PPtUqg4O40WHcicEqABgfrURU554q2UxnPPvUTo3OealopOxWdsY64p2elSGLd2PFNVM8LSKvcYwO3AOc1GRVlUO304zn1qvJnJA4zQS2VgcXts2AcNiumVgY1+VdxGd3oK5ghjfWyqNx3ZArolXlQ2CTw3NaLRGV9S89yxtwu5iH+VQTkDHepIUjE0n2ngKM784yx6VSducxFQcjnH6UyF3djvYjceOh/SncLEzSNJMzgiRycZPOaglUMDltj/ddce9SQMZJX4EaDso7+tOLB2ZschfwJ9aRY2RFVCA5GB0IxgDtUkaFo2mPlhcYIJwfqKRczCVuWfblhnGKVtw8uOXaDtDj1AosNMltseQc7jsO0rxkk+lMRGit3bLrIr46fKPc+9EZG6Ro+XUhh2ye5qWEO0Z8wM6SHcQOoFAFcwRCV42nUtwM846ZPNNiGLZcbWBkPOegFOjUOmAn3yTz3FLGMRNFGoEwf64X0pDFlYFTnIw4A+lSo4kmYYOWAyWbioN+2Xaw2kNzjkYpUwtqZwoyhwR6ilYlolRB5srfKNrZLA9vaq5YOHldjukbBx0A7YpUKrbP1Oefbn1pTsjtUx2XcQfWgB0UhWdztwQvysT6VXM+yG43R7jMN3H8J7AU5yQieZzsOTx61Vkf/XuM4UgAUwGs7+TAq8qR1/pVe5bY6gHGFJPH6VbiYOVYKBGUP4e/1qowjmjm3LlRhdw65oFcZGFjtRkN/d/3snmnSu7yqqjfKzYGOwPGKAu6SHdIEwPTgYqoZCjCQEgg8EcGmSyVmzPHAB8mSpb+ZpGObgr92NuBj0HamI4jdh/EqnJIz1pd5MccmOUG4/nTM2ywsgE0pUcqAqgdBTItph2DuSSc8Uxtsdvv5ImOcfj0p7RHKrgAls7fapGtSYcxxM45ByR6+9buiTmz1CWW506+ubeWLy2VVIUg+vHIrCt5tsj7l3Ky4G4cD3rUt/EGsIWRNSuPlwowcAAdxTWmopJtWNa3j0dp283w3q6RtnO2Qk49uK5nYsM0witmTcSUDjLKM8ZrXfxJrH2jyV1S5yuNzbhjNZ0zzTylw7NI+QGz780NroEU1ufTvUYpOSRQwPQUoGeh6V7CR84KB85A5odljQlyAO+apahqdvYRs8rqGxXkfjX4hndJDaSZPI4ouo6scYOR6Prviuy02NiZF3D3rxzxn8Qpr13itHYL03Zrg9U1m6v5i00hIPaswvu681jOtfY3jSSL815LKxZ3LMeuTmmj7u4nJqOOPIHrT7j92m0Vzt3NkkV3bc3HFB3Y4zSIrOwVRya0pFjhtDu+90oRRmnJ+tSrCdo4wa3PC2if2jOWkxjrg9q0dasILFWVcEqO1Pl0uByDqVHSmquegqxIfMYgU+JPLGT0qbBcZHB0OMVZBCgcYpFwTkZpp+c9cCmtAHuS33ajO0cnmlMiqMZ4FV2kLMFXpTEDOAccipFfAGDmoTnOByantYC/OSTSZUYtkkW5uTVyNsY+XmlgiO3sPWnMgHzMeB2FQ5HRGBExy57U4EjA5AJxzSyvGijA3Gq/mtI2D0HIoSFJ2NG3wA/GcjAqncSfvCATgcVYjY4IyAVHNU5sM3y+vNEi4gjAkY5qwMnr0pkIXsOanHyjHXNRc1Qo5QY5FCg8YFOVTnOOPSpFG3mpZoMIBPTmnKufoKnSElctgjvipYYWZMKvJ6CizKuV44twyuMVPHbM4XCk56cVdt7Q5j3/ACq7Y3Y6Guq07RvtEkiDcgQY3euOSRVRp3FKdjkntwEDKjDHB+tIsBIAx1/Ku+udBjl02XyFbawDbyvPHv71gizW0vCsi7kQbSRyCccgVbp2IVS5zzQ/MV6gDPAp0lo4RiuCEwc+ua6C+05INYAhBMfleZ8x6iqNhcRxzMrAGM7ossM4B+6frmocUaKdzE8vCuMHbjOccVHHLt2sAMqemKuXTbVDKSu4/MO2ay5nJZhwD7VnKyLi7hJLljkjAJwKgc8ZzwKYQRznpUc8gSMsfSoKbJNIQy6mZRgCIYyfU1svIIASFVj/AArjrmszRomW3Vv4pDuPtmtJ41DcujMvGBWltCBDIyI3mQ4zxkfzpUdlhEoiO0EfMP5UqF4x8xJU54z0FA8xYjGh+/yR/KkUWhNuRmDgREYYDqPaq+MueAVHIx6UixYCMU+VuGPoRQqqrucjO7nJ6j2oAs5h3jf96RcADjYfWpGby4xISDICVPZiCKimiEbusnIRPNX3zSTN5zq8f+sY5P8AsrjimJEtvujhcqyjG0FSOop+8byoJ2scAqf4TyRSFjNJ5u7aAmwhVyCe4qO3iZI43jYHJb6jtSsUXYYU81Yz+7iZSAT/AAmqsYySyBRITjI6nFWHbzNNtoycyZwoz92qiqySXEeeMgEUMSExvtJPlfzXl2n06VHHgRyAnG4EYJ6elW1H3niLbDjn36VAmxoSCgMiMXLH69KQDQ2xm8wHO0fKO4qF33pHFHwxxwewzUsmx9RhaMkBhxnpVOK4CXJkclgWIHsKBNk83yyuVO4ouT71njDWzZZuGyfQ0ss775DGOG6Z6kVXSV0jaMLkOQW/CmxcxYBd1VYyd0mAQO1LFthlmDKGRSOM8Zquly0V0JY8hCecdcVAbrzJWJJJZtoyKBXJzIBFKPQ4B+vWqrcrklhsGUB+vWp08tpGilYhCCfl6kiopQGhkOcOSFGfSnYTZCxLzliMljg57elJESbVwHO+SQIR7VFO3lOVU524JOabM22OHYMNtDlfQ5p2M2zXZQ8n7zBWLCD0z2p+S05UD/VDLYqExeXbqRn5nByPXvU4R18sR4xMTuJPJ+tS0OIEhbffxuxxjtVq2bFgsUAEkrHeSF5AqvqG1ERRgk9F6YxW34bs7ZEvLq6DvHaW7TNCrbd57DPpQlcpuyuZ1nbxvMzXEphtA4SScLu2nHpT7kWuY/7OuXkj53SvHtK+/uDW/pFtaW1pothd2K3E2sMZJixO6NScLt9x/Suekh+ySXFoCHRJWXIPoSBmhqxMZczPpzHHGenesDxF4gt9Kt33SLuA9aTxbrkWkWcjF8OBXzn4q8TXGrXTku3l54969eUlBHz0IX1Njxj41uNQmdIXwmexrhJ5WlZiSSTzzUQLOeuamWFtuTXJKTZ1KJDUkcRYZxUscJY47VpwWiiEliBUFkFrGChJHPWqFy7PIfSrEtwsQZAc1nNMd2fWmM0LMojlmGTim3cod89hVLz2Xpmo/Mdm4FOwrnR6Xq81kn7o4zxwahvb6e9ctIxx/Ss2HcF+Y4qyr5G0daBXuPRcDIHNOUDHJozhCB2qJ32AkjJpDJ2kUR4HaqxlLH09qYp3DLDn0ojiYnJx9aNB2uPI3MBgn0pyRjcRjOP0qaNTgYXp0qwicEnH41LlY0jC7IIbVN/XO79KtxhYy4GAFH500yBSTjd9OlN3rj5j8pqOZm8YJE3DEeWcH1HSmSSGNvn+ZsdCajkdBHiLO40xYy74LZPGSfWqiglIZI5ZvrSxBncBfpVmVIICVdt8g5G3pn3psEiG5DsQuMnA6VSWpDtYfsePIkGJCeTUQXLHjpUjzb52Zzk5yKUA7A2PlOTUS3saQHBQoGevUU4NwBjmrN9E0bwxngiFXI9M802C3LtjHOcVDXQ1QkYYsuMkH0q9b22RHjLAnkY96uWOnb/sO8bRJIykjrgd62NIs44NVs1uVYJKrbWHUEHvVxgwcilBaIbaQlWUmTYmB0+taulaV9rnSFAVBAZjt6YNbtnp8HlalGkilFK3AVuxBIO31NZkOrmyvi3P7uWSPaegVxkVrypbmfO3sb0+ix29xA00S7IkaRjngjH+TUh1BLfQZLeQgNN5cinuOO34Vj6jrn2q3haVnjfaFG3gEdCKx9d1LdqKbGIjVRGFPYCq5ktiVFvc6+61awtLCeNDN5TW+3aexPcVzMxMFharI/7wAuVPViRisEasGXy5QSgILDPUDoBVM3zzSyM7YY9c/wAqzc7mijY2b3VozqUQYBlgXBOevH61iPdKxlHRXUMPqKoGYGcvnjkZqNpAeew9aybuaxJZbkyW/wA33yR+VVJmzI2Bg1Hu5YjODScszdgOayauaKQhbI5P1FRxRi4m8sfdX5j/AIUshCpknPsO9aOlW4TBb78gyR/9emkK9y5CmNgAG/ou3/CrJjDyLHFHgAjJ9TQ6sJDvwhUAKfSpC+2GVVG4nguPXrxVDIWCo7MOQ527BzmnyiQlZRGU8v5sdvzpyK0Ii3CMuVO09eTUCEgSCRyY1zGM/wAJ9x6UDC5unlum3SHLgAZ54qHcCjiQAFXGGXnHvio8gzI0u1QVxkdsVYjKbPNcLv5DLjg+lACKzOA5bzIy5UMOOPpT3OVkKLtZOAenFV4laELuJDP0x2NX4wwv2ikI6fM3Y8cGkFx53RuDCxQsRjoRgjvRZ3OIXtl+ZdxcMT270ltut7mFsKCibtrcg+9MHCTGLgF+ARQNMlsht2u2wkoxUH9aiTKmXcDlgSufrU7KFtnVR/qSBz1y3X8KrsWCmNeQij8DSGTTsI0VYzkLnP16mqb5jhgYk5dd+PYmpJgzXBiHOWzx9KYjNJ9lBJKA7Me3agQ25lVLqNo1yoUlQe3bmqCIdpyASfSppmLsFCgMhOeantbfzgoCHJ6U7GbZU8oFTzg0xo/WuiTS3ZC2zlRzWfcW22TEwOMYyKLMSaMmZQoJ7VRwsiER8kfpW3dWhREYDKkcH1rPkhEIOOpPNDWhKZiOxsrpSSTH19s1bafMQQAgk7qWYK4ZWXIrPmDWy5QF1U5KmkmD0Jrk5hBAOOhxUz7ftETOT5eRnHeqdtP9oGEI+8DyelXVkWQyNgGPYcLn7prRIyvqX/McID/DuyuT15rTJiNujhmd1Rg3GAuPSsmJt0vzIxjjVSpPJHNWZLkvNNGhABIUnpkHrUs0iOt5EltHnlYCZmCovt3NdFoyXsuopJpk0cEqKSwkHybP4i+eNtc8E/dTRMAPJPDe1bnhu7to2ms7vdDHewGEyZyEPUMfaktynsbYXVG8QhoNWtpbi7siYpBHhcA8JHnoevNcofMs7pkmHzLknuQfQ12jQ2EFxpl9Lqts0OnxhGSFtzSODkYx0HTrXF6jMbm8uJo3wWkZwMepzTmTBl/4p+JZL3UWt43IUeled5JFP1C6e7vHlc5LGhVyowevpXbNuTueNFWLen2bXALKOB3rRs7PzCd/GKt6HMlvbEMmSfaoLsz4kaLagY8ZOKmxoVLnyreVhnpVK61AkbEOBUV1bT7sswYn0NUnjdeoxU2KHEgnLHJprEdqjLYNPSMsc+tPlJ5gxuAxU8SAc45pIotp6datKgUc80N2BJsjUkkCraIFIz1NMXCqTxTGYswCtgVJaiTPgnC/jSOucknFIOBgHdSkbxz09qVy1AWIDBJOR9KlTBydvFRuvy4XgetHmFQdp6VLZtGBZRwBxSlmyFxkU2HlRwAKlQb+q9PTqai5tZDWXB6YqHLMxwuD0zU87lQAVAAPANRRT+XzsBJ6e1UkKWo2MrGgzuLc8YqCVtmW3EZ5ODU8jEhiwwW64NZ91Iqj5uo4xVoykJNIUwXbAPalExOCvJxTEtxcP5kuUUcgetWI7fjKr+FBNmya2LMxYseT+VaTkfZrfjH3hkfWs6Bdp9j3FX45MxoMfdrN7m0VY6DWow2q3ZUNiO3TPOcHaKfoKxTbgSRKCWUdjx3rLlvJGkumBz5y4JPcelXdCuVt7uOV1UouC+frj+VDauaW0Oms9slhZuNoENy8ZJ46rkfyput3wtbqCeNH8pXYpk/wnqM1kpdqslxGpzFJJvQE+nSqF9cvNHKJMkAjjPQ1o5WRKjqdJdarFHFbMrSAKdpHXgjnNc5dX2b65K/Mjnv7dKqrIXQDrxzzUDkrK2QMkVm5NlqCRqPeBxF8xB4DZNQXc264BckEHOaolhgAdRUUsm5sk5zS5hliWRTyM9agdsI2ODnNMIIb5unsaGXKAAnOenrS1Hewxv8AVjPXrmlAV0O/nFHWQIynGetI5AO2Mcbv0oFdCHDYA4/rSAZbAOOOtESPM5CZIHQDtU8q/u44QAFHzHHUn0osF9SGyg8+XewyinGB61tIixsBwQFPboap2UbKuwDC9WUVO7AxFdrecH3cdMYoSNErFqC6KKRJlkVSARyR9aRJTjz0ZWxyy5xuNVJ4NsjAS8SAbgOCT6U6NGEayqny/dI96Ghk4nXf+7U7SNwyfunvT4xG0V0qMcyYKqR3z0P4c1HMTv8ALKlkPIwMFain3pJFPuA3HGR0pWC5aWHy96ptePaCgfr15pnltsvB124JYjlf/rVEzPJOF+8QC3ynnAqR7rMpkBMsbAIzsMbvr9KBkd4A2WblcLhgMYOOtTHfHKwcqSUAB6g5p13k29wYwcHDbQOAB71GCMyYwEAU/SkK5akdOBH1EeG3Dp7VHZysLeVZsBXcDIHSq6PuiYseXzgjpn/9VP2tBAc55w+M8UDuSzq0ciNhiryFSPUClI8y4xDnayEEDH4CormYNJu24UvkDrwRU7YQyucKsJU+/wBKBlbzxHLLLkjaAOR3H0pJ8qLjYQQjA5B7E9qaGxbbS6Dzck57HNJDazLp28AbX5Cnq1FhNoik+VyQAc81q6RPhkjlOecAk1lQA7SZOnTkVbhMD7QG2HG7d7+lUkYtnd201qwjWFxCdvz/AC5LH0qv4hsoJ0iMMGzK8lDkE+lcnHcyxFGccMcg10Vpey3YQSEJsB4Hv1NbJpqxlJcrujmriMrGyFtwU8AVjXCnB6+1dnqNl5dsHEZGOQw/irkrtSXYAgnrWU4tGkZGXImDx9cVTcAt83C960JCDnIwR3rMmbk4rMCldWywOZLPJUEHBGMj6UWl0sgYKMM3T2OanaUhMYGM9ay5h9nu1mT7h5I7ZrSMr6MxkrO6OuiujDeF/LBEgAYAccU2zdVv442QFD+8APU47VXs7oXEZmTh1IIFNZmj1GJlO185BHNDRaZqJIJ2vHUBCwyF9Oa6LwbDa+fdXF/DDdwQWzPIjA7gcjGK5WKQDU2DAqWPIA75/rXQ+GP7RXXy2mRhrk5WSMgBCncNnjFQtGXJ3ibug3umXupPZvoVjGtw4VDHuYnrgn1HrVa+TT5tM/tGLT1t5be5a1mijf8AdnHQr6VtTWOsQFRpumaRZSvHhrmOTLKp6kAnge9chrl5O+nW9nZrGLO3Y79n/LVuhdj3zVvTRkR1ehyFvozuQ9ywjU8471exaWy4QA47mqtzdvIc56+9UJWZ2xk5rokzzoxNCbUyOIfl98VUN7k5fLn/AGqrFMck0wjmocmaWRdS+Ib7qj3xUj3Ecinftb6Cswqcdalg24IIpqQWQ6S1APmIpYelCAM2M1IsTtgISDnoKlWwnOQy7O+407tk8owbV61IoDfMx+lOawcY3zJ7UjWpGR56lh04pMvYrXB+bA4pFYbeWGR2p32CUknzVYVVuYXgbD8Ciw1qXdwVcgc1JAd7Z6AferMjl3DPOKuQuzj5Rx2A71JrEtM424ixjPWgkn5n24HHFSGFowrOvbkY4FVmIlfGdu3r6Gs3e5smkXIBkHGCB3qe3dVJLAk9hVGBiyHAwucVZBYjKDJX9KAvcf5ZmkYuwAHqelQMEJO48Acc5zUzF3BVTgN97jrUMg3kRxkDbxTTJkLxtKh8n36VTFs8s4aRB5anjPers9u3lMpyjN3FTW8ZESqDnAxk96fMJRuQujOflAPbA9KkSFljzt5PAxUpjO8cYGOamQEcZwB0pcxpGmVhbkR45zntTlyrEd6uglcEcDtimokctwIycBurHtS3G42KynIBPbirEEhSQHjjpmoJlEL4Bzn8KbHJ68expO6CLTNKSYsnRck5qN33KTnrxioY2zGRjNRtIQemKGyhwcgEZxg1HO5Dhs8YppJ5z3pHA2EnJ4pAShmYE8Dio1b8cU0NuQ4GBilSGWVXKKSF6npRuApfJA7U5GxLuO7YvGQO9XrfScxo0swwzbeO1TwW0SxIqYZmYlgfQUx8tyv9mmkZT8u1zgeqj1NMWzdHRTKhSTJJXmr8twyFpLfKGQbNpHQVKgjgsxJIx3AFY+P4u5NWiWrFWC0RJHe334HRu5x1NMFu04d9mFUZyO/vV2Ux2lp56TCTaQp2jhgetSRatamwuVlsj9okP+uBO1F9AB60No0jBvYraVF9omxLKscTHazZwDWvHp8MzXEiOrtnZEoPoMk8Vx9uxNwxWNTDjguSBWtPcW8VsAp8q4I425G32qVOxrKmy7b6XJe5hjUNIuDnOC3vVaaKWycqYn8t2KkHkEj0qOzuJo5QxuGjl6AH5Tt/wrqNN1601W3e2vYUMkabYBHj92e7e9XFxmrMzacTm4p5S6eUm4/cAx1qlMGZJztI8pgTzxmuo1i18u3t3iiVYtuxfUt3ye9cyfNiEk7IpgdthB6VM420FFpl21Vkngkjj3o8e0rn8+arpF5ltcJG4Xy3Bwzdf8aNP3+eY1JURZYA/wAvyq1FtFpd+XAkiSAFif4Oe1SUELG3tL+F5eGACr65qrtj8qQOzRsEwnH3qfelneKZk2jOzr1x60t3GfsLyJjOclT/AAD1oEWFVY47eIqCSSdy8jBH86rE/wChyeYMuD8uD26ZoaSVxazhfKDxlVZejEUkkoWIR+WQ4QjPrk8ikFyYNu+zblKvs2gAdfQ0XDllLSsC0qfN7EUx4ne1jlBbaqfKT1yDUV6V8gAYAcDHPNA2yJ/3sMCKOCNg+uavmYxpNmXDRR/Iqj71UxKUS2G3PlSHPbqO9RTu32PzWyNzHB9R6U0QyVpMoY0ORjgmowTxnBWrEsOLO3cY3NwM9x3NVrj5G8vK5HpWhi1qTy3O0Ku7Kr0WprXUHXcCcqeoPaswqSPMYYA6etCE4YjJIHNSnqM6qe987TkB3bR8qnOST6Edh71h30QjkkVXQkDll6N9Kjhusx7Ubb/ef0FQ3AW6vWWxE2zGFEgBb6nHQVTdyUUmA539RVCRckEEY56Vf1K3QTCO1d3jXAkkPIL9yPaobmJUYwKfmU4J9feo5QcjPeI+TnHHrVKdVZNu3g9Rjoa2pFLuIVA24wpH8zWXLHtlIzwp5PqaHElyIbG4+ysIGAw7ZRycY9jV6WcxtHMvJRxxWbKFcqvI5OaSzuGmVYZDhlbbn1qlqRzHROC9zJdRyruQqcdyDXS+DZ1lOq2r3C281/btHFLIcKGzkZPbNcnpb5jn3jcAhHHbHc11HgiG2keae7ha4EVu8qQA483BwR749Kn7Rrze6bnhtm1L+wrz7XFENN3294JJcZjDccfxAjj8a5a+eGGS4WFC6+Y3l88bCeOK1bfWdLiyzeGbAx5I+83GDWNqMhgfBC7JvnQAfdBOcfh0qWVHRnNqMkmjIHLdaYzFfpTfvCt7nDYsb1Zeai8vDH0p0cWcdz6VaEAkAGAMCgNimyADIwaahCt0z7VNMQinI69KprzJk9aBrUupceX82ctSvdydckmoVA4yBTyARg0nKxpGKGNO5O52JJo+0PyMnJ704ICOaYyKATzWfOa8qHpMQCvb0B61JIFuISpG1gO9QpgEg+lTRbdvOafMw5EVRCApGAOwrf0eBI/LZlBK81mOgYjHHpWxZKWt9zn5R1rSL0F7PqXteu4hpkULwqZ3YyF16gelciGUM24bSexrS1CSR3c7iQRg/T0rOjhbhtpI6c96HqIuQIy8ovBHXtVrIRDxnjntUaMWjVE4UcZ7ZqK5JjOOpPr1qbFX0HSSEEkOQfbtTrZ07jtyaqMdo+cFWPSlWBp0KK2wg/Nnpj2osJO5fWQbgVbParWfmC9OO3aq0duY1jQcDHBNW4UXaM/mOazZvFCEjaFBwM5zTSxI+707VKyJjdwoHQetVjIFJBJDZHbP15oKLFuDgM3GTwp7VRur9LK6AYb5OTgdKuRyoiMGf7udoPr3rk712kuZGB3Kc9KuKMqsrKx1Q1WyuoVBgZm+716HHb2qt5UiqDICM85NYdrC3noQrKq4xjj8a6uNd0aq5JB4G7+dVPUzpIpKT1OaC3HuT0rTjhiWBopIw7E5VulOs4ImkBeLegHQVnY6bMz1jkkJ8tCR/KrUOnyvGXckxoRv2joCa6CAwRW0sAQAscq57D0qipZEZY3YCRsMo6HFDVgSuQPYQIshyWJYCIg8H1zV17S2kNvFbyAO255MrjaR/D7/AFqt9o3pEssaEK2QehxU8TIXlljZlVlOwH1/wpJlWEhjLM+cAFiAVPT1PvTEIQzSoowo2KSKlc+VYxLwckgex71VkynkQSkhGO5vWjqMjvE/1ZX5ickEH06in6uxjsIo2VisgHlsCMZ75p0yL9sQJcCSIYI2+voB61U8Q3X2ie3sriIQjcWErZB/KtopJO5hOTukQ2V4Fik84bo1AUIvIzVqKaFLNnGzymOPJ3Y3e+evFY2oK9naRqo3xy8qcfeGfXsantlDJ5zouxc7ix5H0FYNHo00rAlzJDMoVA8R4+ZTjH09Kmiglfc9xGwuTyvGRtzwaXTZ54dXhu7HDyw8qrOMdPQ8H6Vo2M1xquuQiTcBIjKzRrtx37dfpQjSptoJdxz6rrEC3jmSQKIwWIARBwB71lNH9i1phayNtU/eTovtWhqpmtVaeE7ZQfK5/iXOM47Gohbl9Xg84FVYAOMfrWsY3icNSpaR0z6oz6bbLdOJ5YgUbI+5nv8AWsWQwrY3Kq24qwIGO+a0LyCztVSOCZjGzZbJ5z61hRuLiRtpAZnOOMZx3pyehnCXM7mu6nSp7SZZUkLqNxA4BYcg/So44Wk06eRZFQNIEAbjcBzVG+cyo2dqtuXgeuO1WB81rvXapAIx746+9Rpcu4y+Ro74xlxsXBPcBqtXMM6w3SuqCOEKxDHBwemPUVRUgG3dgXaUMjc9+1SWZzfbZN2zjchPJx2qQ3JLSPfb2MG3DM5OSe2aTWPL/tCKSNNiS8hc9O1Q7vLHmxko6swHPqadt+1XttH94FQNrHGMdcU3awupYCiPYjyblCEnJ4rJUtKY0AztOTj68VpKDJcW24jEgJbPUAGspk2fa5Af3YbaCDz1oJbEmlkKOp3BvNxgc80yWVXkjti4GWB3Dp71d8PNZf8ACTRpqUxS1IJzjq2OBTPEmkvD4nuII1VEAUqQ2RgjitFDS5k5tMls5/K1EI43FFZcZ4I+lNsfLluJYtnmOTlc+g6gVBpNqstzdvPNCskce5FckeYR12+4pbVHTUreLO1pPkDZ6Me9D0Gnc2mjSSB0CNG5wD3IrHvtsUhEZLKeueM1pNK0cadPO3srAHPPSqN1CTjAyAPzNJu4uWxTLNtAjTJPAUdTV60ZrO1nE0jAzcNFGeXHoT2FGlRl5lQlYy3Bkk/hrTk0yC3hDtM0swJMoUcL6c0Ri9yXIi1mOKDSbK3jMJMUZdimfvE5596wLmMxqrykBpOcHrit3To/tupKbvItYjvlI9KzNdYT3UjocoW4PrVNdSLkEUY+zu4YBlXt71jXMZLZ7N6dzWg11tUqFyxOCaguFC4dTwe9LcTMZ02555qrKTb3sRXgNgnitCfO92Xn096zrpzLPbgjBzzRHQiR0ekgJe3MQ+YPGeOw967P4cMwl3RIJb1IZPsgZchX46/UdM159aOsGp4cOy+UwIBweld5omg3VtaJLZ+ILC3mZQcpcFSAedppNWdzSLvGxrLrHifzJEksAWySB/Z68t2zxXF3Pn3SyyyqA0OXkB453c4HbntXc2EGrPOGl8V2ewcYW7YcnpXETfJ9tjlJkk3sBJnOTnk++etQzWFuhzpGMbuRViCDew/lT5Lf9xbuwIEmTnHau18FeGk1S4k3ypAyIDGXHDHP+FbKOpyXMGx0iaSXYpXK43Z7U27jZbgwxxkNGCj4HWu81uwi02Gdd6/a5ZAPlHBTP38+lc9qTrK16lqGeOJCfOx78k/WtHHl0J3OKuQWYjHA4qJYsq2Kutt8gEYz6VEoYP8AdI9jWLNY7EW3BHc4qQLg89aeRjJOOasPbtGEMgAZxuAPp2rNm0SHjacjtTQgIGKtLHtB3DJxwD2oVT09PSpsXYovHjnoaaG2jitAwZB3dKrSphTtoGVxMR6CraXLm3/dbjzz7VTmQgZNT2UTLErFhsxkirgQySKJpFZ3OBnH1qYKSNqp9fp/SrEblGQsucdF6j6GpsMwJwPmPJAxn2AqnIFHuMtFURGaYHylPIx156VWkuIpbh5gp2FvkHpVplT5VcsoU8//AKqqG3Z5S8ZCx4wB60KQnEiupo2LF0IVRkkd6XTQWjaV9y+gz1qM2M7TADBQtyCeK07eJQBgYVT0NKUhwjqTIrr944JGQCM0McDAB3N6d6BgMSJBkjG09aC/lpyqknsDyKzZ0IJpAqARjcwGCuOM+1Ukjl8xmkQMq9qsKXY5LYAPBNTOnZup4ouFjPnTKkhjlulc88LxShWJ3enauquBkj5Dt6nnNQm2iuFEU/yFjnze4FaRdjGpDmKenfM7FTuYDPJwD7VvMg8jfuOAMAVStrKO2YKjmTB6ha0iuIPKYYLN3/hpTZVNWWosgJhjTHzbdw9hT4wy4WPPHUZ6UELlgx+VVAJHeiIbVPlsMdSD1UVBuiYZkgfdleDjPfFNZ44LTglpSR+AqCUZUozN8zAgZzuFIMSTSZUDYhIA74oCxMuGciTCuq4GehzS3CBWiCMWzxntn2qou7DFwcDk+1TW5eTyvL/iYLhqQMndmZxHMCNxHUdB61WaZlmnnhJaOPAV27VNqihfKFvOZ8jaePuH0FS3ogW0+zlVGQHMq/xADgVaJb0HWk0VtIt7KVL4Lqf8B9axNdmOohQmZ5sF165HcjPepow5hxIMRsMAnr+Aq3ryzRz21zLIThQIcEAgY6YHSuiGsdThrNqRlSE3lkscEIwjLMrHqOzD6ZqSGR4lDKv+rPKsvyn8Kgtb6K0uVDMshXKkY4Oe9ay/YvLd5bzdOccD7pH/ANasZaOx6NGacS3o66ZFbapY31rFKt3CpidYsskg6BCOmc9ah0WO40S+R4FkiuYSQyzfOM+wp0DKl35+kyRHywMFOgb1AarUepnSrWV4IWkuZZMm7ZvmUY5X8am/c1b0fmUdZme+aRJTHHdqwI4OST3PvVSeyW0hjSeWR7pRu3B8rn1B/pVgZCjzDjK7iSPmJJ6k1LBYiW3F1Mw+zxsCw3fMx+npWkE7HFXlzOyKM1vdQIGuZg0k4wF649DWi1lHCdsRYIgXe59T1phgMrvczbvLU4Xvt9KlkdLv5ogAiJzk/epysKCaKVtBi7mLMWSMbt2PwGKmiUwu8b42EbvpxVZCUuEmDAjheKtMQbmR2k+doiQcZ5+lZGozZGmnHr5obeG984qa3IjhDHHnONzMeTUabGlt4huaIDG1m4yepqdylq9xbSkiJ0+Ug52mhbjuUgCXRQw3vJ930x3qSZW/es2d0Em0uO4NU7GRmmDK26SMbgx7471d1KRZ2SVMh7hBuzzubPJpInqV/NkWeBPLDeXHhmA7H3qhbBiJ43yEMg3e3vWjMVRrd7ZiQV+dT/Cw6imxqk1xcNGwWN4WdgT19vrTWjJZlaxLGutTbYwqbgFA7DFbkWy6vLhYHY5iHlykHIwO1ZF7Zl4baKTCt5RdJMctx0q/p88UFnCzRljF8jDJDKxPUVqmZWZlK/nNDbvGDKsm4P3q9qkaRG2kSbc4bbIuc4x70sc3l6o8ht0YdPLPUHrkU6djLauFQYEjHPr7Um9C0rF+yUxajIzYYR/NjPXjt70SHzIjsUZQZ/DNULSc4USZb51PvxUsVwClyVOCGwTnnbUJjZZtJ9lwqxsMONrFhkDn71WdWmCweRA4k3PksBgP6H3rCSTbkoTtJzVyJ4nQszneoG1P61ad9DFmigSKySOMMIcZkcnJkb29hWZdfvLQSjgE4jGOtXLiUptWNyZXXao7AHt7VQ1KURooOFKfIkY7epqiDJkzHcfvMd8ipNQhaKwR3XDzZYDuB6/jUumwrcXnmXO4wRtl8Dls9qZrdw1xcu4OB0CjsPSlFaXJZjxqeXP8IzVOaP8A0qOQuozn5e/1rYv0S2nkiG1gBnKnI6Vg2LLJemSQExn5c0IlvUvTXBXVY3IHzKR+lbTf6Hb2WWjxIu9fX6GuduiRew4Un5ioH8q9G0zXPEOpva2emw6c7opB823QCNR3YkUpK5UJNHP6esRiuQ20bwSvHcU8OfswnLZXOCAa9Nt4fEhtYFZtDWTG/fsjxt9cY6V5ZPIBdXAWRGzK+7YPlPPJHsaylHlsbxnzG09nbf2boU7EFJhLEwJyVYHg47Vb0jU4rf7MCNksUf8ACeGIPGa5eO6IRV3YCNvUZ6Gj7Sy7trfMx65rp5jjNq51qe8naSVyQTkr6DPT6U+bUBH4fv4AAJpSBuU44zk1zkZPnsSSSeuKfPIJIcHKkHJHrS5mUUI3MhGDjmrkaNPIBu+Zm2//AF6qIoBOOtWIiVlVhxg8kVmy4mjJELnW0t448RqyxYQ9ccE/WtQXdvJr019PHiK3/wBVB2JUYQH+ZrDimMV0HRiHViQw6n3pATK+1xjJzk+vrSbNEdTo2jf2hPcT38y26JiTy+rzu3IVB/P0FS2vhi9u0EscDYbOxBwWA5JHsB3rO0vUDaXdvcDdmPcExgnOMZNap8YX9s8AglIWCA28Y4IwxywoVupepmTaeIEupGw8MDiMnPcjpWPdREiR1GFXBA71e1fVZL2bfIV+/uYqMZOOtZt5cs5Z5DlmOWAqHYtXKTDzJQm0kHjA4NaVrbqoLYJ28Ae9Q2MbsC3y7243HqB7VqRgKny8tjgg8ClcEhixbVHALY5PpTioVN6kbxwF/rTiUVVA3Fj17c1C7ggnG1uhOeaY7GTdzuzsocAKeW65p/2nywqjLnA69atvbx20fzENKeikdc96pmFwrAKofOSzHt6UySzazEtgjOe46ir8bkxELhgD9OKz7S3eRlCn5unHFaDRGInBHlA9PU0mXERlBQu333GFx2NMniaAnj5vu+pyamXYJQECnYudrjofQU8NuZY3B+U4DDnFIsgeFlVQxUNjp60142CDaG59utWpsSN5a9EO7OOtW7bTHkhZxJ5SAY3YyATTirsHLlVzIRykQZWDRnAx15qYQxsrMxCuATg9D7Co54FtZFiiHmJEclycbj9Kllkjmw8agqSBjpg1TSRClfoSRIuFRiNwO4kfpVp+fnkw0xPyAenc1WmfDEkgBuVXvinxAMz+bn7uF29jUFDrSPzIySeQzMw9B2qe/K2+IUCSAoGODyCfU1GqYiUBhk8tz0qYPCZJ5rlRMAMBVOAOOM/jQaIqbds8SBWwq7xtOTk07HnXIIIjZjyDwB9aislZy4d2VyecDoKECpOGjbf8xGGHNAy1dxmCMASiQyArhT/Oq8DGK4UklVBx69qmjnS6lj3ZVEU7hjmmPG2+JHAKj5hQxDppC8sUbBMoOdgwcUyTLWzRjLqowvHzYzU9ogWe5kbDEDaCPWpRE0NxNGqK6sny47cUxEG95hEkimQIAQScY9hTryzkuzFNHbkCRSMkngj2pljI8MZcIWL5AI6r71d0+6dbV0inJUPhcjOM+1b03pZnNVj2MW68O73kSYiCWJd7sTlVJ6L9TVGfTioVYN5LYHruPqK6uOC4WGZCAZpHyzOO3asPWGmMixRIBcHPIXAB9RVtRluZqUofCUNL1S40557SMArOpjlDKCdvsT0NdN9tgQWTxLu8tQwXG4u3uDXO6RpCuZZLq6dJlUEIF3bieuT2ra0uRY4diouDwGJ5UGsnCzN1UclqWbfTzBcSSanKfNch3U/wA9Paq91D5su4FVRm2uT0A7GtZZhHLGtzItyA+PLA56evcVm6hcqb9mjRVt4wAIx0OBmnJ2WgorUcZ5DFeafbBfJEhd377QKzmlWLTkWEbpZ2PH91R7+9SmQw6JLLuG+aQfIPvH6e1XvDkdurW5nUSNNkbR0XFK12kXsjKjTZNaRZ+Zm3Hn+dTqircTpJIAUVtvH3vQUzVf3fiDMSjH8Ip96Vee4K9IxtbHfjmoasVe4y1yti7yqT5nykg/d96faypKkz3b4UIEBA5HuPWq6S7NLaAo/BUxnPAyeQav3dm0OkeYoG0YSRSeQeo4pJCZmabCkVrO5YEklQCO1Sx7rtLQJ8oj/dgnjJ9aaWFvbsqgFJjuUH171Ppjxi3UKN0iyBwnfHcijqA21kji1FhOpaAZzgfdJGMmq7BYpk8vbtlQxkk559at2jPA8sqxiRJJGDBhzxzVG3j83z+gKDIGeRk02hE14s1pJbh9xkgAb5h09vpiprZQ0kzZK+eu4KcEfSoLzdcQs0jGRwRFu3d+2PbFX2gSXQmlj3JNDJsdSR0I7UK5JU8lfJSYOWb5gQBgrjp9arBmaweQJk7yeuKu3UpTHyhY5kGMH7pqsI2jtI2ydrbiV/rTKM60JW4kf5mCryfTNQ3EbQRSSI7FiNzY461atEJaZGOC4wMDuKSFmfT7i3A3AfMw7jBpIhmwIra4sI/NAjHlphs8k1lxP5Dsu4hvUe1RaffkW50+4XeoYMg9D9aJwhdgvBJJDdQfaqfchokkulDiWSTe6rgDPU1DYq95ckPmT5STjtis24LJ8jjIHfNOinlgDSKRgcAZoTuZPQ2VlWGJ1hIDEk565rLmdmm243l8DcO9E13KyqVjUrjJbvmqkXCG8lKhASFXPJPrirJZFqkixl1C/O3ygetLZWLRRRpKnzZy2T1ptlavf3H2qRTsU7VUj9a2XQSQkscsOvbnpSBIwJYpJdSgRAcgbgT3ruPDstrLDqcFxdpZPfWv2dZHyFR+vzH0OK4x5JV1O3aIFnjHQdxXW+HLW2uJL+9uLf7bFbWrXQtT0kcHoe+B1oJXU6Pwsn9oWOhSrf2sEmjOyXnmSbS0W7jb/eBHFcZcQxzXN7cWYHkee5jU/3dxrW8JTwz6zbxy2UFzFqe2JgPvQ8n5k9MZ/KqYQWNxPBHJvVZHTeeehIzWcnojaOlzEhQuMj/wCtVlo1jlCu4OP7tZkcjBt2eAAAOxqSOYb+c5PUirbMVA0I71WQrEoUAkFscmo33NyW+Ue3WkXazbYwfcYq1HF2xn0xU8xqolVYQylmHHbFIYXjGGVgRzWksZA3MBgc7e9WmO8BpCGlOFI7KtFy+QxUbHzfgBUhJYf1rft7WF4JJpUXyYxt3HGSe1RC0tJQxVNoOOB0H0pNjUWY4k24yRSkliqxZZj2HJrbu9Ns1GUVW4yMNmnOi2rCRIkV3HBQYxx2FSWoswHV/LdmJVV7dyajgV5cZPX+LFal1GW5P3hxnFLDbrGuAP8AgXr7UilASJdqEjHHBP8AhTlliWQeZz6qKV2VCzMQ2B6dPas6VZGYnYCzc+4oG3Yuq8UzkF+M4HbJplyP41U4Bwp9arqGXG/IIHy+n41MLhXfJyMAAAdvpRsLcBcOCBJtbucj9KAqyDnI5Gc+tSGNCzsMhAOw5/8A11GIsKQHBJXJwf50XHylsBFG2PBTGM56tToHDSKsZJCcsvXJqCJWLIdgjUpgHHH1qRLfDsAORydvGPrQMngR/NZgCjMWd9w7CniBo1MjDLct6Z9KfGzq6gE4I4UnPHer00iygExgEkKrLwCO9K4FGOBJJM/dwpLEnqfanxyzLE4V3CuQMEcYA4qa3XzS7SfKpYjJGcYq49sPsaouG3sDt9Ka7jMGTKgnbgEkA54J+lWtQnjv5YFSEL5abTt4X8qZcKIpWG1WjPyjIyc+1QWaYYh2I3HnIxhadxNa3JCASsjr91gpx0q/cSiBmBRN4+bIHGKhuYkR1MWeqkio5CSxdjuycA+opFJCxsJJARyO5HX61JDA8yKsa7ixPTqaLcJEp3kFyPlGOBVm1hZbA3CO4lU5Up0AosUMRfLtnuEQ5BKNxwc0kFophUr88iYd+2M/zqf7SsNoA6iQMCRnuTTr6NQlp5MeJtoLMpzu9KYGbDAxmkKgnDHIHf2qV9j7nBbAj2jHr6Vcht3s2t3kzHJNvDKw4BqsI8HyGGyQ+vTNDVgWolqWgjQlsK5BIx6etW7mWNjcyE7ZWX5FHf3zTHBktlZVAEcZVmHr71DKBMqRE/NhQPehMW5FaStay7pI2ZgmMduahtphBPKhdgr8jAxg1bVJJZJRMgQI6xOwHGc8AntVXUrZ4LiRXhdGByCfTtT1SFZMt3Ms/wBpLyu0jAEA47Yp1wvmy2rNl1ZAAmeR7Uy3kLeTNu3M4ZSD0PFT2LhILSVyOJdpXHQqfX3qudmcooqW6eXM0zJ+5JxtJ56VJc2JuoN9rltowu0Yqe9t44LhVVmWcqzMpHQk8D3zTYomgVSGeGVskgN0H09apS7kOJmwfaEsWkLrst23LnqD0xUkqNJZoqncznzGXHTNSzREafcb2OGPmYz70LOYI4GXB3xlW/2h2qJM0itDpNC0FNW0abUGuo4zbgpDHIOCVAyPqc8VgxaZe22uPbQxOZUj8ySIdUB64qxo0sloYrZJCkpnDEg5Vgw+UY9auWt9LYeI7i8nLzPIpjYj7zc4IFaJppEpO7OW1mUvdJMFwVwEIPJ+tSSB1mihYnlQWOOTnmrlzAJ9XeQKkca/OUJ4X2NLE8Uunk5/fR5Yk9wD8oFS9WWtjPvGOHWM8eaCAfbpWxqUnnaDtijCLEMmRvvOx6j6Cs2+tTFLbpINrufMweetJNIfKnjG5lDCQA9hUrqNrYWIJcEPtGIIgMH+NqjzESkkaSRshKsCeue4pLK6eK2k2qV3NncRn6irkuobRHmJfKXLBiPvH1qlaxnLmvdGXDqm3zrWYHIJIPoTToYwLRpiSJCPlI/l+Vc7O7/2juVvmJ5/OussImm06dH+9Gu/2we1LqFzOSUrbRAYCO+TxzirECu0kgiLOpUlwDVW5kDRWyRHJIKsB29q3dFVbeZztDHy9hJPAz60bhcp3bo1jarHu3NkNk9G/wD1U18m2jRiMkYVuwOelRL+7nCOBIkTMdo70ya6jKeT90Z4J520MdytLIyW8LKQGVj0oSUSHzIgEbpIo/iHrTLuJGK+VnAGOO9RJEY489D0z3qb2IvcpTHN8XhwMHiti9lE9rAyRhUDbc9Dmstx5J3H5hnr6VaWQtp0rZ3hWyPx71SdxMp3OBMyyPwTh+PuihbNAyh2O1ssDnqM1ZuYd8Dzov38E5/pUDbY32gksgAGe+aozY8YjjjLRnZgkBWwRz0NVEWS4YIoAhV8AHnFXrp42ktULbVCDePcU61VFhkkkBLbwqgdPfmmTa4WzmNZATtx83B6k0rTBIpIl6l81BK22XodmTjPXFMLASyA4yyABu4pXuBDp6rca3EjsVXaSxHaum0vT9Q0/W3j0zUrKGeKITrM0w2FW/gJPBPqK57Q4vM135iVQDqe4rpPDVlYzavqR1eJ30+K0NxJscqwweMY6k+lUjLY6TzNbNkFtbvwxaStlTNA6qxB689vwrjDDhZEZoy4JBZTkE56g1t+G18I6pfCyGk30BmbbEXuiQzdhx0qO90/TTpYvdOjubdUuGtZYJH3mNx0IbuKzmr6mkHbRnCIeTnp2qaNCfujFSeSpc88etTwp8+0Yx0FSWolq3jIUbeSR1qcAwrlev1oiGMlccdPUmpHK4DM20kghf51JokSRHIJOD7U9gkSgkbgeSO+aarpgbAVPYdaXeUk+fa7kZOe1BoiQHauWIYnkL2WrhDFQXSNARkKPSqYj8v/AFgbJ5I/xp8ZZhkNxngHv70hokSYgkrkL03e9KZNpLMAQe4H3TUfl724bGegJ4FSwsFJAT5uhIPUUiiDBzlCcdv8TT0K5BcZAHGOx9akwrOTgux546Y9KbL843zKEPUduKYyrJySBtwOduM7vrUEsXIZxtLcnHYVoRCHheTK55zwAKjvUZn3IuFf7vHWmnYhozJ5FEIWMnLHHNNji2lWfcTnnjpWlBYo3zSdFHQdM0+C1aZwBglhvz3x9aG7jSGlVaNgpwoAzkd/U1GIgmAAH7sBxVtkxEsSkhHOXBPpT1hJQ4BIbnp09M0iyskO5cKSZCM4z92pRKF3mYj5sFl6Fz6Ch4mZpUQbj0VxUYLqx81FfoSWOCvoAaEKROh82ZFiGMjkE/nVm5BDSRgZSPjjnBrLtZlaJhFNiUtt2e1XndEhjJTawIBB6saBItWEaPEGaRlXd1I4raVoYEPluHLDbk1i2rMGQMBszwCcgGrtyMxxphQFPJU5zTTsDVyjfRpLcxKkq+X8xbH8OKjhjTzWU5IXjr0Wo0hPnM7R8KcEA9vepA3mwu0ahQgODnkigBXQvEHZm3Nu69h2qNYI5FRtwAUbdvvVtmaeNFhLBmwOTxtAqKxRTHKpGJN24Ejv6UupSHNb/wChyHcMrgYHY1oNui0tnQoVfEbKo4Un2qAS+dJ+8TbJJIG3L0IHtQZwNyod0iuWkxwDzxxVINytPuiubaAKpSHOeM5B71agjLX7CJ2MQClM/mKdBepa6gJWQPui2Y242n19zU2lyWza9KwkKWrrkc9Pr+NNaiuWdUbzbFIZCwkiXzZG65OeMf1rIsLre5luUDPNlAfTA61b1t5G81I28zzhhe5IBqWaPTZU0m0ikEBLET3D/wAIx6U5asIuyMzTyZc23meV5zblZj8pUdc1oaVahtcWV7Vrq0tY/Pmj+4HQd+apTI897BYRqCUlKhsYyvbn3rV0KUwvqQlVvLOIeTyig9PccURV3YTJtD1WbTLm7njgimsbhh5iSoG2jp0PpVfxnpE+mLbSxXEc9rf7TEF6LnovtjNa99ZQJZPcKqhXYscHA2+lYGtzP9kS1ldpIYkzECOhPStJaKzJW90ZVtC1lfTW9wMGA4IByPepbSRYSRMjPaRz/MqnB2n0pvl+UZfLXInKojtz9eaYJQt/cxyZZXBDA8DIHGDWKKepq6jJa3GqIUDJaFThn5PA4U1CLQzac1yitNg4Kg8x+hHqPeo5/La00x4lVWOVbPQmrtvey2kMsaFFyWw46cjkZ9KvS+pD02M6dBNot1JIds0BVVA43gmqceJWtYpFYoDlxjn6flV2a3eZ5fsy5JjVlRj6DnHtSozC5sLiVBhpirYxzjGQRUtXHeyNDULPyNHi1O3kt5EWbAZD8/spB9Kg1B915p7yPGdtt8vl8c9efemW09sWu4rhOG3hQeAG7HFVrcvNZ2skscaJAdjc5MnocelVfoEUQXYL2pfP7yQ8jqVApCV/s6EIm1xl2PoB2q6pMlvLcyIqpMSuAOBt6YqjMHj0whyVd2wQwwcHpU7Gg2CZ5ry3uJGPyYUMwzzTtRLLeTHcEMiNnAyrVFbwsZI4rWNpZl4WNRncfpS6tIJXHlgpImFZW4KkDmn0JY4LGbK3hIXe8bbgvUHtVCU+daojk5gONueee4rSKvOLOSJQZWIULjJJFZ98yJebXHlzeYAcdVPfimQZElji7VgRuJxj0NdE7m0UxxOrLcxKGx/D7Vj3m5tTCq3JfJNaGpyBWhDD7+CW9KEIoMnl3AOOcjPsDXSokKoUtZP9Um+QvwWPYD1rFsLdr+C9dASy8A464q7YYuRE5PJI469KewuhQu5dk8jR4Bfu3pVeKAcMx+brmtG5iEs7FQCOe1WrbSZrgoI0w8mPLHrS5W3YXMZJRtm5VOBTHQjBcbh1ArpZNNa1iZZkAZAWIPU+1YV1MpMZKjAOMClKPKNNMyZSOWKke1U3uGt45FjAEEhGQe3vVy5GXbHGT0qpON0TAqTkYqYuzImatuy/2fEMB48gk91P9RUWnwNeajLsk2lEMwfHUiquizqbEqxJeKTkHv6VatN8l5KkO4Ax4Yr29a2Rm2VbuMeamxTwuT7d81N8ws8HgsPmB7Me/wCVJMkkkvyjaETacd81LqjeWqMwG4kbsHtjFJq7Fcos7uiTHhVYL160kw3zJnCqxOSewpl1sEESqcMCWI9//wBVOkVnuoI0HylCOOeMc0ImTLOiQGbUTtwqnDAk9Fx0rQ0O9v7bxFLJp1sL3zk8mS0ZSRNGx6e2PWsu2uS2pzCMbVfEYx2GK6HwZJv1TV7aK5WC/uLJoLWR224b0B7Eiq6kN6HQGzn0O1bUNL8MGG7izh3uxceQO7BBzx79K5eTWRcaDBpcUHlbZTPNMW3NPKerH0rS8H6BrOl31rc3UM1jFbyeZczzSDYydx1+bIrmvMiu764NuAkJlZk45VcnFRIcGOijUfMATnj6mpIYlSQEqCO4PWpBjbgcn19KAFC4APPU5rI7eUijU+cWAYZ5FSeavm7du44/CmuytlFP1Oe1SQwMAqxcjsc9aQWLoQiMEDLnuBwop/lkgkcr2IHJpkbLDkEbjjAB6E+lRteDGSoLDjIPX8KLjJA4jPzs0jH+E8/SpRKz7cxbHA7HqexxVeOWQ7ViXazH55M5KipTIqM29Qzn+JWoKQRnMknmZJB+6eMmrG2QMIwFUkbjjt7ZqKAuCGZo1H95j61ajEZcruO4Dnb0akMgUSGZdg4HQelJNv3DdnPUluwqV5fkKCPYGwAc9BSPGDChZvMyeEB6AetMG7lZT52/aGy3CjHb1zT0hmDIASY1ztyc49TSOssoJQnA+RQvGAf6VZt7SQ+VHuKnJLfNwcdMUCLESJJbSeSu/amCM84zVhTAscUXlbZdu2TJwCKpxsqNIFL8cE9DjvSmfMTlmIMhGCR36UXGSxR77hT9wySdxkBBVjy98gQMFM0g6tjCj1qpI8cFyQGWQBdmV6c+9SwSW5uVVSYwI9mCc7m/iNNAJdiGC6Z7d8RxISSOnufesiKOb99eKwG5sBGGeD6VpsRdXRhihCh8LHzwAD61clsHS9SIBC6Lymd2Gz600S/MwbexS3KK64kQFiT3z0q0VIn8tsMypu571cvEQX7Gb72D8uOPYVXhjkmuLgReWGUZbeccDsKGND3LRwQ/KwweWznJ+lBZRvTeQu3hu/40kYMgQmMhTyDnr7fnTdRDiSRmiAfywCq8Dr0qbATB90JHIL8s2P8APFRyqwsZGCqd3Qn06U+BVhhmdmIGzAJ5wcdKdexiT7JEpySAznPQdqYEJlUBV5CovGTTreNnMkZLrK5+UdKZaxrPdmKRPmDEt6Y6CtkQhruO3ldfKQMBLjqO2aLFXKs0LCys7tchRlSB1xnBJ/Gqt3bmd/KgLR/LuHqfqatRRPdWi29tlZVJVhu4IHeow91Iskky+Y0H7vYTyo+taRaRMtUYi217HOphkMik4G45H51r2saLOPMADOuOPWpbOAzQO8IKRxZ3DpuPoPwqN44mDyBirnASM9gOtKdugRuty3FPAbyKZztiiXa+0YYk1Bd2qm/toSwEci5BP8P+FOtgssEYIJLybsjqPSmXKtczXJkkLNEP3eTg4qLjRE8UtndsrSkysCd4J/AmrNnfyrp5i8pWLP5jTcl898+1W49SeLRmMoBuZT5YLR/eXtz7VmQwyxQRm3djNJkFV53DvxT22GttTQlvZZYm8hmSDZhyeQM+voKzrye6ltjNKAyFdrYHPHApkcEv9nJKuUadzGvPBHcGtPXL6K50aztxb+TdRLtlXHLDswPpT1aBvWyMKVpIZYF80ujYbA9cVNZXcQ1W2aRS8Y+Zhjk4qrK/lWRmEe8LiPj+E5ptiYo75i4DL5XI988ihLqRJ20Na9KPrMsFu5+xBvNjHZScZrZurWwOnyeQXe+aQdMBOfSskwfZIbKQDNxeI25OygnC1K8i2qPAzMyMgdHxgq3pWi6tmb6WJtOiuJrx76xg8xLYgSRseQOh/CqNs0V1Les5ZQS5gO3+Lqal0nUpbOG9hibbHdKA3fPt7VTs5GgtYtrDLTsPL/u5GCah26Fxv1FhcyyD7QwAlySx+lTWSommTJcFTsBIXvx70uq2i2F9BbpKJkDfMxGOo5FV3TyxNBksrMGQ/wB4e1LYq9yWKUK9qjkrCrBznox64xUeqTvf6l5smME/MPTFROZGtRHk+Wg3xj19fxoe5gfTYUXcsxkJfjoMU1royvM0fDlzHpusifzXhmJzBLnCpx3qhIkcivdtI++ZpAxI/i7HPfNZcUssgeNwWPLZPYVdtrz5LSKQfuVYsF98cmi+lhW6k1lPJDCnBDQbghH8Jx1rLnKzXAmkUk43MT1z61qW8U0elahqLKrW0knkLu4bd1yo71iq/n280Z2qwy2SeaPUllK6diBcA5YOcn1FXdU3fYIpG43AYX2NJfCOSzgSAFXSAGTPb1P61JcTC40e3TYN1uvzN7elNEGnoLRLaLC5jXzIW/eMx4Prx3q7aRW9tHD9ibzdmDJnhskdvasS2h8y5IjUqGxgD0xW99int7lTGEBwAARxVRbsKfkU7cA3ytKpKbyGAPNdpBbR2UNte2qjarZYyAgH3/8A1VxspmS/WZwEkHPI4Nb19qc1xpkNubkfKNyR5yFz1rSLtqzNq2hR8Sait1I8i4Tdn5VrkJ25yeFI7Ve1RgZOFwSMHnv3rLjOEZX+70rCcrvU0irIhuZGaVN5XcOmO4qGdSJMAkkjFEi/vfl5AGOaa7sp56mpRM+xUt3FteAjhWzn6103hyRbNxcu6qJg6HPoRXI6gAImbGDkY9q1rGfdGqsoL8IvoB61tExb6E9vIZNSHmEiMjJz6jpTNYkV5F+TbubdgnqO1Nl8uS5QK58tThj6+tVdRbfIjdF4Cg9h2qiSvdFt+WPLZIq1kK8SnqI+x7mqcpLTKGONo6egqREaVpXHzAfLu9Kklu5PpQ23Fw7gsAcLjsagu5Cssw4JYAZ7irFqscN4Y2kKxqu5mzxuA/xrWXxJoZkfzfCllLKAN0hmbLnuTQlrcluyGeDc6hqumWd5JNPbSzqkiSSsQRn3PFUpcW+r3sUQxGs0gVT6BiAK6HRvFGiWt9HJa+FbSCaJw6OJ2yCO9cvqs27UXm6CV2cj0ySf60mhpmsXycEEKOgHrThnbuxx0+tPVOMc5pdhbL52r05PFYnokAjAPGCTzn+lSoW2lcbWPoelTCOLcHk+UDpgZyalbaJHAdSM8nHQUgKcqlcR/MW9TQikBwrFiOwGeanvTsjWIjbIBznqB2yaphSJIzGGAA4JGMe9BLZbgO2Ms6ADHKk8n61aKGMK7AY4wueM+hrHKuHKyHcAc7um6rkU6lwGYkDGQeV9qBpk1xJGn+qXc/U5Hf2qxBI+MOcI5JPHf0qlHHJI6vjchz0PUj+VW7VXEio5G1VyT1xQO5PICkbMDtbAznnA9KoLeSqWdCE2ZGO/0pb648+QkvtGPlCjPIrOEhuEhQbSRlpCe5ppCci/FcBFBmfZuznvj6Vbglebczbwdo2Z9PWsaaNpLpIycRDAYDmtW1JxIYj90YTNDQJ3L0bEQleGLEgsD271DHIyKrkfKcljjn2pkchEJ2j5tpG4dAO9JLuktjskUrwigjlvUikWV7i5MKKxTIc5+n4UkU7mUEspZvurjqKttalUV5W3sFwpB4UdqrSFCJJYlCrGdqL1JaqtZXI5i9CjiUtbglUG0YPBPc02yluUlO1yo38Nu4z71HbtILaPy3BlYHKDggd6fEuyyuX24d+Fz/Siw+YkV/Nmd5hk5/hPX0pjyL5shjO457jrW/oGlkMDcQkfLwT0Jx0B7msrVY0jllVVA2AEADBJz3ocWtWCldli3k8vVY0jRf3fzlQcDp2qvdMJr1AWbjJbPr2pgRIpGjuUZZ3UMrduehqa6WTzmdhvKlYwe1IY2bzEt4opQBl+f9qliOxZJ2ZGTGAp6mmzlZrqKNBgcu+496miQysCqZji+YrjIHtSGUTqIt7uUquWYDhas2U1zIpVQytMQCg6kVny2bzX26JQc/NtH93NdCPIljS7tQQ6FY1U9WAHzHFXFXRPM09DH02Sa3u74lzE0GQoIzuyelWIbj7NLILqJ2Mg3n5uOabNJFNqU7CPKPyCO9RajIbmeFVOXJWNVHVqC2SW8w3OcMsZOVC/3uwq21ui3cKTZSUIeF9TUOvWUmnsIpYxHNE48wg/09aknuxG6L5aRzAZMmc7wR1PvRa25KfYjspnRZg4JCnIGcHI9KliKxOkp5Y5DBh1B71TjdUs/PByd2c46/WrB8yWxllV1CxgZB65z0qWikWoP3qLZXUgSCItJyMEnHFUreWRLqA2w/eqDuRumMdR+FKk2LfPlhlfPz9SOMYqW9uYxPbXVpmN4ohFKrDn0yKaAs6A0rWl1KwDW1qxZon6HdxnFUNQlSS+SWOPy0UAFQc8CnafdGC5u3lTMTxFcryCccGq5ZGSAYIKLhsdWJ6U29LC63Ikjd7VbMry1zvY54NWDFDJdOsUThnUIvvIDk1CgeSVEJIO9sYHfFWPtCqLR43yUbJ46MTUpiZdsr+SCe2aaNXQsCxYZwB29q0NcS2mjkuIpTKV4UDgZPUfhWOSUZYJFK+XuDleThjkGugRLSOG+QbVuoo40t2Zep7n6mtYu6sZy3OfuPsz+G7WWNiLuOXy3VT1WoZlzbMUVvLDgjA4ycVFbRlNPuQciaOQrt9Dmr2mlm0u40+QhTLlkYnncO1Zl30IpZZL15kuV2yRjLORgnkdfwp7skUqpExcRgOu4c4781ViWe8tBfElpxJscZ5YAf8A1qZc3SzXMLhRHGf3YA7DvTd0LR7Drvy4mSRNwRpPMz7E9Kp3iqt44iP7vO4D2q/dAHzY5ATNCvIbpj1FQRyRXt7C8u2FDtjJVeFPSkVchlQbWkjPUfMB2FVlY77dAhbPAGOoq/expFLforlo0O1f9qq9iyGSQruEscJKEH7rUIGx+q35ksbOygx5Nvu2Be57sfesq0UCxedgPMkf5Rn+HpSl98rO7Bd42lv5mrkltmOBk2RxyMUiGfvBe/tTvdksrcW9hPKzBfO+UA9SB0pkDCXTI1G7rlge+Ktas3mRS2b7SA29X79OlVtpSwCKoPAKtjke1NslbmrZzLFd28wwwUDKkdPatzVL5b+6STeEQfKoxg8DrXOwyCO4jaQhjxuB962106W4U/YD54ALbMfMoqot9AkktWW4dVtpoVimVfPU/fA5YY5B9qt6tEkGkQiS+tpATmGKMZdVP95q5AyHzG4K5POOx9K055FFurRQ+T8mxtxLFj689KtSujO2pgXzvJOcHLs2KgY4wGxVm5bnKj2qm25i3qawk9TVldeCxGOtVrrBwaumMqKrT4ZTx7UkYyZlXoBt5AxwAMj3qeGb/QoZVGwA4znk1V1GRfs8oPYAfrToVH2eLjI4+XPNbRXumMn71jTiYIsHILNkke1Ur9y0bEc4Ofp6VYNyiwuRGCzHAPZRVC9l/dxxjqfmYkc/SqSJk9BqOS5ORgkZzzUouMARA7VLEtjjNRWo+QyEbiz4RfUjrUqKDO4OCwPShozHyYRwSeWTdz3qrbW08lwN9tcgY6iJsH07VPPKrLOzA+ZnAPYD0rpNK8camvhiS1m1C8hu7Z1+yzR8+YnQxv7DsfwqkhN6mFBbXMd9/wAe9xyP+eLHP6VFfljcxs/HX5fSt6Lxt4jM7yNrN0oUcDI61zd3MZbsSyks7lmYnuTyTSUbheyOsL7z1AXoaeHHlx+ap8k/NhRycVViKsyqOxP51NPcGCMZGO2COtc56fMWZciUtIPKKDPl/wB0eg96jSeHb8wLAtuVRwSfT6VmsXuXUsxUdSW6gd6soWKlhHtUcFgP0pC3FaVQrl2J3ckL3Poaesq3D/6TIBxwvoB6UwgqxATMY5yB1pgLBhJuUSBsbTQhlx92zzGjHzdMnJA9KJYQCTDGVXb1HOTTY4ZFGd5ATlz61YikKKNoOeo96TZSVxLHyolbAfzQOX/u+wqUKUtm4LP93A9TTgRJPsKIpdQSFOAcUs0ipLGdrFVBJHrQgK6WhaFBG/ztksAOlVUtmGERgGJwARwB6/WtUbTE0zIWBGVCHkelU4b2S3diEV2K/MzDOKq5LQltG3zHDebL93P931p4CxRFRnc/yYHFSQSKB5hjy0g2qeuBU8qRrIAAoJXdkZ4PvSZcVYjUqEJbIEYCllXjHpU9sY43IMiFZBuKkfdPpVN1Z4ThiF3D5R3q2sayPEYY23uCMdcDvSG0JMnlESyRECTnYDwB7VSsrVjMqN8mwl5GPYnp+laU/wAipEp3ZOGHoPalt0VGCXBO1juORlvpTQmjnY2aTVHRC/lRcAoOSK1nfzbaDY7+RvxtcYI71Zu7KJZ5XihxbuN0bA85piwny1LBdgQ7VY8n3q+bSxlGLvdm9pN7c2UMMhnAl5KZblQevHvWXcyJc3ySyfMWk3SOxzkdgakmgW2hgnSZXuJVI8vqVAHU1FBZSTTytA3mJbxb5OMAetS22aKxPqEkNxeRPCnl/L+APbFVp45YCjsoDs5bknB96RJgVjxIfXJp99PmZHlZZPl24xyM0rlFzT4nujdXLbAgGOBjJHoKgtHlNvJKrfOWIbHao45444pE3OqgHY23jPpmhGmht4PJB2ypsdgPvHPSkIeIzuYD/WEhc+mBUtrb4s/OwCijaw69epFM+0xRPEszCN0GSR/ESe9Rfa1zHFGcF5sjnhuauICpYifVXFkx2FB5WG5+lQXilb23Nwoj8lwJF78cn86sWtuLbUrwlwfJYD5j1J7/AJ1S1EySahC82CAd5A9M1XQOpNrdyWt0XbuMz+ZuY/Op9D+FNvo0jhySjq6ghl5MeO1Q3dyJdVt5JcyIh3HA5NSXU0TwXKzIsbT/ADpt6LzwtNK5LbRFvZ7DEZY7Rh/QirQkQsodQN+2NsdGHqPetLUlt7LSYVQKHEW3djkHHWqcKRCxhWZiJI13fL1Ddc0SiNS0G36RQMgttwhnX5AeoYHpXU+M/DFxpvhq3vbuGFXIVxNCeQG/hYVy9zeE6HHbX0SqZX8+G4UfMOf0q5c+IdR1fRLTSr6dZYxN5m5uG2qOAT6U1ZXFK7aa2MGGQq8cbOQxbDZPy89KtKypC04IKeaY8D09RVC5cF41kYRuCXLHuO1VYdXTY1upOxgWIJ43+orGw3LU6WwMElusbSbWDPIGI+8ey1TRNg8wgi3llGFHqOv86rvdGK2jSNgYwu7eRgjPUfnVl3UabbruZZFYOw/2iaryBM1NYigM8b26+UZ32eX1xgd6pws888Zj3sEw8x7jb3oneQRrPIm/yZi289z6GremLFaahfpeuAgtGaM9snBqupNjImyL+5TJMTt5mep+tS2KS3UYjBP2gvvXJ/WrkFp9o1SWOWT7Otzbj7gzyRwMe9ZsDmKcxTbxNEnloF43YPSlYOYbHIYhdR5KsTkAH+LoadchH8qFEwcAqAfbk1Je27RoHiXLBSzgjOc9qi05Emew8x2USAxq3+12FJpjuiCRi8KXHBbcEf1qc26x2rhT+9VjIR7Y4p8qPbLPaTIqyK33f5c1Vict9qExAlWPGD3qSr6DDKWuELkNuAyAOpqGCSS3S9TaCXG1j1K5PanWKw/YZWkJZ/lUZP3BnrUceDc3ZhJZFGFY96ZLYpijXTMciZpAvIGAB7/0p8cfnXvlOygeWVj9iO/4077NKdNtmGzM0wByRkEd8envRpMXnXMrTKzk5UbM/uwOd30pkkM8zTXhk2BVMJDcdccZqaRGS2iA24xt5PB+tUpmRY1jKtvMpAbPG32rVuI1aNSmG+XpTQIqwujxBFjCzLnLE/eFaWj6jLZzq0cjRkH86x3V43V4yQQNwX2pzOEfaBxjcTnNK9mU9dDRv5g97NJ8oLnccDABq3BPCYiZmLyFcDcc5rCLbzk5pDMBng+xp8xFiS4cu5UYPPYVVkAABzzUvmL5Z2j5j0NVZm2LxyKh66gJJJlcnqPWqe8FTn0pJHHTPNVrmYRRM7kbRyR604q5EjN1d+Y4geWOTVq3/cSENyY1456ntVEI8r+fIMkn5R6CrspTfG65GSFJrotZJHI3dtj7uRTHGignjH1rMlJaTOee1W7uQpdBFIJI5I7ZqsAPNfplR3qoqxEmTWoKsmPXJ+lWbcg3UzZGQCRVbH2e3H8TumfpUqgZIVQg8vH1pMSI2INpgDkktmuntfDGi/2Fb6lN4hdLaZxGcWhby367WAbj29a5NjutfQqcA10mhaDrtzo7PBLDZabeYEhu5VjWfacggHk49RVRRMmTjS/DJmx/wlUgGcn/AEFv8a5iXb58+xy0IYqjEY3Lng49+tb7+C9VCzSWb2N+i8utrcK7Ad/l6msC72Da2flXt/SqUdSHLQ2tNdnO0hgyHk5rdSBZ/wB5JuYBcgDt6mub0yWNLzyofNPzAYzxn3rokmdYm3bk8xtpPp3PFc0kelSlfQUois7KAAzZ9SB2zSwQSTyMd2ByeOv1xTPMkEeIyFhQZbj8s+9SyZZ0jQmPcgLP2C96yOmIIv71S25ABxgA8+9RtBbP83nMSo5yvelhkWcyxwqeWBAXgkCk8trqV4rYbkRfvEHgd6QxA6ucs+S2CxPA+mKtoB54y0ZVlIXyzwD2qmIgY0fe3Xn0HtUlzBnyEiIOecrx+H1oEyxLaEOcM2EA3lhjB9qnkJMhVsLuCrhTn5ajaB+k0pDsoIG7O7PQfWltYGkTcwOY1HA7HPSgCSGJ94wpAU5wD260qwo8O64BCkl2IPLD0qzM6LCSSqFx5YYHJA7mqeoTokZVd3CjkjBx2phuIbiCFv3Cszk/ePG0ew/rUkGxrWTjyZG6lz94egqlHGZV8tCA33s4yen8quQ24uVhVEeTL7SQcA8dfpSsVaxoaekYm8iRDJGOhxz04/Cl05RA80qbWZZMDJ6D6VnrIsFxOrO5RCBktzn0FWYZoZoGJ+RkyMjoxNMLjhbG5nXMqRF8/O3ADUkiec8xcgbUCfLzyOpqZklhwSV2HKbj8wTA5zUEVqUtP3IcO3RweCO9JAnYcqKxBi+4TtUk8YxSOrG6EYYldpwex+lWLaGQWwjUsrkZK4BBX19qgi2+fAFJ2LjcTznvihiGROvmztdMVAX5WIzyOi0RsJCQJyEI3yrnAY+lTam1vNqJWNwsMhDZA6VQlaOSe44wEHGB1oAakLTCZ0T5YgTx0AqURrNCGfCiVdoLcHitbTWjs/DOpiUqZJigGerDPIFMtBbpoTJIrNeOSI9wBVV9jWkYqyBsorNPHpMFkyqyXTfu2x8w55zXTeKfDSaZY2ZsXkZhGXlZzwpx2rkZpN0UEm0hrcbAf9rOelbOva3PrcQjkyqiLnHQH6U01ZpkNO6aMnw2DdvK8wwrOVOeeBTNStktdZhiBP2cncvPK+op+mu1lOxAXIwHU9G96bqbTS+VczcHcFT2FaOUXBJbkcslPyN2K9t0v7SQNHJbQvzlcFyQeffFULC7sX1Se9ngleFfkXkdeaa7XNvbYkAFkf3gDKMg/XtmqEKuLISmMvBHzKD03HpUJt7F6Lce8bLqEbEBDI4Prhc9BVjxNGW3u6+Wpw64GBn0qncb91vIhJJ2qi+/oKu6zekQtFKoDIoTB6/SqQpFHULwSwIIxiF8KATkrVjWmSHzBbfKCgHrn3rLvlZoIzEOAN7ADgYoF19qa3XeQqJudsdMUuo20kK9y6xpFIjFoxgt1xViN2tXhZ8AOnRu2ev6VmSXMswWJGRo3kxlRyxJ6VuSNFNcu0sITy4/KRM/xdzRYXPoM8VyW15eosUZEexYwM9h3rl5rNY5WdWIVfu+ua6qSH7brFvCiqrpbB/97FZ8ojnuYozGY2MmWTtgdhSloTa+pLHCJLOAFG3uOnY/hWtLax/ajCsgO6EOrkdwOhqlp0qyz2u92iSPJ3DnHPFTXz+XrAaFyzFuCe+R1qOhqg+3F9JaHZgzT8EHvx1qW62rfIkiZ8qIow3feIHFRW9vELuxaZg9vJKxZV65BxUuoL5esXEi4VBGSgYZ3DpRuIWOSS2srWSRlBdt2c84xio7qUf8JAZbT5mEQfa3POOahvAv9mWwDlwoBb1QZ6e9F4Y7aeC7hLSo/UY25GKafQlouteeaJJImBfYdwb+HisdYJfLt+MqEMqndnH+FOmBDmW3YgD5SD39abA4NvxlVLfdI6j0pvUESfaFlubaSSVRxhtw6Y7e9VZWDLcMzYZiHYDsCelPlEaXs0qqxhKYGR3qOWNZLOW6kkUXEh2Ig9AOpqLXHsLdtFAqzRrgOuHQfoaqLIjRzRLkkAOG7hqfBm8sYEdSkrMcydio71XsJIxPM/8ACF6f3qbVhM0Ekk1G6gBlQMvYnAUKKXTL+a0jea3lMfnFkkA4yPSqVqxtXCkAtKM7T29KQ3ANg8YjVWSXKEDnH1pAWHiZbGCdxt33DGMH+IAc8elTtcjYflOT6VTs3WXU7YzFvIizlM5xxS7ljLFQxUEjdnqafQFoWLWZPOmlm/1RG33z7VR80R3BEYAB+8SKtu8T6fEyr77sdCO1V1UGVfl+91J7GkURG5QyqsQbIHzVKJBJkIAcdwaoyL5czlV5789qDGVXd90HgYNBLLIckksQMGq9y5LBdwGeevWkmjVVQKcsfvZNQLAGYvncFOB/9aqSuQ3ZDp/kTPJYfwgZJqhEDcyOZ1+RMkLnvXR4itrSBGXYdu5zj71ZFo8Zinkdcl2OPYVoo2Odu5VVgqtxkhcZ9KqSMR9nRyASd5Pf8asSsEhk5+bdj8KzTzIAc9cZPWrSMZMfMpN5lTuHr60pPKxAfMW+Y+tPUqlwvGQAcA1GjAyI2Pujn61XQgsXjBzkLxjb9TTlkKAnaM7R1qCU5QMxO4t1pVffLt7E0JE3FlA+zhc8se/rXW6zp8fi17C607U7GOaK0jgexupfKaIqMHbngg1xsjnz2zjC9Oa667h8N6I1pZ6rptzqF5LAk1xdRzFPK3jIEa9DgetaRVtSGy14Z8Mnw5qsGq6pq2nW0VtIJClvP5kkuP4QB69K5G8L6jqd1MqCOKWVnVfQEkgfrXX6b4Tt7bxRo0YKX+iahKPKnHAkXujY6MPSsq5gjt766iiUKkc0iKPQBjgVcI66kTkY1lkX8ZVmABHB4rp7ON3OCGLudyLngD1rI0vT5PtQQRkuGBy3atxGy8i5Khj85B6D0rjm9D06KdxJ3D3HlB2aEHLHGNxHWnQss6SKQQ3XAP8ACKekJnmgjgTJf5SfQVFArLI6KQC74YnoBnpWNjs2L9u5tlF5AoV0Tnj7pzjFPgt5RbyXAlaOT7uV4Bz1FMuYkkuI4oZHdnbDc5D4/pVpZSIRCv8AqxLuYjJzxTGPnt0jgSMgMGXIdOgJNFyWhvo5FjRZUHlr3Vu2R71NeSNFazSQhUgwF2f3uevNM0+H7TczSzKDbwJ0J4yakCvNbypakEPgZ3nqA/pmobYbYjCjkkkF2U8YFT2yGaJsMRGhyeeMiqIZAWdztMnJA5IoBFsrHcRtKXVFRwoHcgd6qSzKsiHBlkZsg9AKSXCFPJYFMfMO9TQWTvL5cgOFQMR7k9M0LUB9mitNIpdlXGW7HHfBrWa88q6M8satBZRhIgvCsx/nSx2awXdqFCrLnZJvIA56fhWXfW0t1cXmxgLWA7m5/wBYc4JFXyktkuk6ct40s0s481nJ2k8AZqxNpsUayJbzhZUO6QHoT2FWLe4RDawS26rHbn53T7zqO3vU6alDa/bJ7QqzSthY35PTksDWiUWjO7TMqMmRSiPySF68N71upIPLgVdxyx4xjjGKwrQswEjgNb245H171PcX8scxkhJO9BGoI6+pH4VhY16F67uzMm8BYjEBHGFHXJ9arWhLzhGVQzYwRxgD+tLbBLm9tYfMVUjTfJnoMevvUVuWuHumWPcidJM4xzRbqNPoU9UkUXM7RxyKkeEXcMZqppyOYW+0JtIbluvArUuUSNEjdxiVSxzztNRWsPnwCIHaFRnlYH0pqwakkMYu0tYI23ySSY2AcqKttElvJexXhMdwrFY0C5XJrOtAwmtpWX92qZJU8jJxVpJ1k10vC0l1BCuWY9Wx/OrjG6I5ivbMRHE6DIVmZh/tClgYrNM0LbWKBnT15z+lRpta+ntQrRLv83kcgdcU+EsupxBzzIcNt6suc1LVhqVy/a7bi6vPNXLSx7/Ta3rUCJ5+izuIzII8YOfue9W9Yljhu5rxV278oIsYxx+tVYJX027QBkaN4gsoH8Sn29aez1BalFBLdyTWce+SSVVChj/ntW1aXUj6HNYuY4mi2xbCgLMSeazLCaCe7vUmDecMLAc4Kkf0xTI737FqEl1D++RPlO5fbqf1q46PQiWoa/ZSWriNJUliSRViVD0Y8nH4VQlnM98ok6IhDBupb3p1+VxayRO2S7SshPEZJ4xVzTLNLxrySbgRqAMdSfWm99BXZlQzbbV4cZdlMWPf/CoIoZDYuYSCCRGykdQO9XbT/RrmeRFEjRhgqN3NM00SG1kcvGnlEko5wX/+vSQpFPTYvMvIV8tgsOWcr2NdSxt7m3WFmjZi3yBhg49Say/D7mGSfcFZpk389Rk4FaVw8EemT3DIHkJ8uNccg+tUiTI8w2txFOjFUEu1TnnA6/hU0zp/aEblCN5L49B2qreqGiiG4tAMDPcHvWgUVbie53jasQUAjPXjFZy1ZpENJiZClwVLRb/LJ/Wi4ULfSTqpJwMEn7vPWktpWjs7cbTs37mGeGOev5VPcyxSTTyKG8p5Nhc8YGOP1qehYxQzWynC/wCjxM6gDsW7mjU7pvtgkKsITCI1J5HrUNssz2MyQsWcqIsZ7ZzUKDdYhnbcwyFDHgYPNAGprISGQIdgjmUEnH3Tj+H2rKjXdEIZGwrHKZ6MPanXzr50SwjCE4VWbO045H51TnlL+U548vPHoc0CZoC6ZJ1mmVNjJgKBwpHHT1p5JtzGAoeNhuXHY96qLGk80QmfChCdwpbyeRo4RAuCFJb6etPoIdHD9o8yWZhFCAVTrz6isuVJHUoHypzgVNJM0caQqxKEZw3GCfSn2McUjuLl5ECDCBFySakGUBIyac6gnJbaoJPA74o02JVLvLnb2wPvEdqdNb7AvmSElHKlSepqe7mZBbRuiqQC3AwST60MSIppC7TTleQPlHYdqr248z5dwUFslj0qeCNZtPlUB/NZ8bs8Ee4qOyiEdvNJuBTITDdevJFDGLbzRwNOvlh3dhh8np6D61rJAq2Z8xcOx+bP8J9KwZ2CXbNHuEW4Fc9a1l1ZBa3FsVDyyHzPMY5K+1NEtlWylCrIj8R5PWm3F1JHcMU4G7OD16UyNowQpBVivzfXPWnyz24ldtpeRTgE9Me9Fir6XKnmsWkHZvvH0o3E24DOpG7C+9NuW3L8i49TjG4euKidAHQFiNmCaLEykXLYLJJg4JJ5zReXAUbQoQ9gPWkhaNI23Agk5BFULl8k5Jz2rSOhlJ3J7qYzQkBjkjr6VUtyUQs+CqcBT61PIg2xKoJYnnPeqN78sgRSTnqfeq3ZlIrNITnLZLEkimoo5YnK7qURBUZyck80wthSF68GtIo55MCRiRyOnApVAVSoXP0pHYojrjgsM0KSG3KCDVJEcwSOHTr0PH1ogJUqp+9imBlO1SO5JqdIiUZlI6Y+pqkiGyo5+/6scV0N9q7atotpa3dnEb+3CxJejIcwjOEYdD9aylgVhGdm3HUV0lrpdrFYw3mr3T2sU+TBFCm+aRRwWA6Kvua1SM3IueD/ABJP4c2QtEl5ZbxL5MnGxx/Ep7Gsm6n8+5nlwQJZGkwTnGSTj9a0BpVlfRO2h3k8twiF/st1EEkkUdShHDY9OtYYbn2q0Q/M6KwkN3JuVnM8jYwBgAdOans4GlW7XeiLGpJJOMkHoPWqVm8kflwMAuFJbH3uvTNaMe2e7ihWNIWUgAE8D1NeZN6Hu0rE+mBYzI87Om2A+Xgf8tD0/SnWNq4gQxgF41MmT3NRRRSSQERsuQzEEt6VpQ+Xb2aeW7ecxAJA6Jj+pqDcrLbkStJu2hAsaleMMetX3uZCrW6lHLuHDqu1tqjrVKF5L6eQsApeQvgcYwOtW/NkeaDZ5RljjxkDG7nhT6mkmDI7q9Op3UTXUarMXw6IuM4GAPzot1lQtCgJ3y4MZOBn0PrQEZ7yZ5eGTczEj+KobW5Z4mj5ZVyxz1DnvUtgLdqIbNcMNxLDIOMjOOlQ2dl5gaXK5J2jeOBT70NcbCQqbgEAA4AH+NamiwbrKSZwFjRWiOeQXIPQfSqirsG7Iy76JVuIbJFSQk7t4GCfarNk8un606zxZdVztJz9KXQYQkNzqwVXEQ2rFn3qtq7SS3QupCyuX+cenHA+lVa2or62JNRuXu52aThZMYJPAAHWiaWJre3gSDY6qACP4jzyarRQNNdiPfkgZJ7DPWpnsZLe3t5SH8icuUYnqF4xSbEW9JjaSGefzUAiTK7+jH0FUb6ZYlbcm2diQ3pjPatvRobe5s7bTirx3UkpZmAyAvUcUeJrPy/EdlBdhZLZfkDRY+dR1z75q+VuNxOVmZdrEkmhyFCokzuznkeg9xUdiPOuiZJUPlDZGrdGHtXY6rPBf2cWi6Vbxx7gDKzRgNEg759TXLanbRR38MFugSJJPL3/AN9vWicLBGVytayrBNeOY87SQTnpmrdpHMIDg7N3GO7+30qrpVhPqV3JHCPMYMWKg46GrsErwTu9yrAQApu6jd2qFHS5V+hQEzSFwiFlRcHI6ZNWbbyXmmR8xkDBwcEDFRWsVz/Z4ngw32mUxlB145qO6JVby5STYySBffkYPFK1h3uaOmWlw+hy30Yj2GTyY1Y4LE96rrHdeGL9GkUFJFBDq2QPWtjQ5IUfSYriRI7dTtyxyDu6k+la/juOztPCqRBIpp5HKRSLyTXVGF43OWUrSOW8OKlxrk8tykkyPl22fewO9R39xbr4ktHsUKoGyqPwRzjJqr4dlOn3kzo5bYgBRjywP3gKs62bbUb6+vdP3LbxrGkKv1P+TWb+EtPU2/FcyvpDLCI2it3w5XktIepz6Vzv35ipBI2A4HJ/Cpbgq/nW0cbK5YHZnGMDnP40/TULaNcO8bMhfeGU/dx698VDfMzVWSMu2GxZJV53PtBzzirNnJGqy7SzwltnT9aqwOFDCThzIAR7GiBjEA0W5wXbIzg9eKcO5MtTVfSIrhZp3kIjjhypxwWHaqGg6lPbw3UMRU+awyzDJXHpThdiV5FtHmWE/wADtz71m2JMYeRcqJN23PXg1UmtGiUu5fR1fS5ZFAWWGbcCB8zDvn2pbryp0R1AIZeCF/iP+FRy4ttHt3TetySRKpHDKehpbdxBc7UcmNIsjecYc9eKQyGOBG1GYRP+7iRVMoOMVYDPELOOePdbPIZAccsB/Ss+x377lotzyFgqEdDnrmtG13fb2ilIcQxMiY5AZqEw0Ir94ZFnaDmVjgLjGPpSyoyRIGclZMbRjAyaqrCVszOrZkHyLt/vd6tEEy28KhpDGN+Pb0qJMpGrex21vcT24kBjG0McdwOv51myzY08M4AXzSQB6ioVYPMWfJXcd4x37U12VtMKSHCruc5PB9gPWkUSGcxafD5bYeT53IHTnpVWSeM3cW0usG05CnrTDJstE3HYXj5x1b2qW8kadbeR4xE8i/KoA27RxVJEXKmpXTSvGJVjUkfLsGCPTPvRlvschZhucjHocdaguYszAPlZP4vp60zUmjLRfZ3LKQF24wAabVyE7GlbzqTO6KShAC+ldF4ghgt9H0kJGBNOu6Rs+h4rk4YdkPlo+5Q2xivGD3rav7iV0ge5kDuiAQLjjHShWSY3e6M66bfPmQgxRLnOeSPSpre6a0S5CMPLkXDsVBx3wPQ1n3xaQPjaEB6dMfSl8xpRHHnEMfXA6n1rNFXGeSWvFSRSjP8AOwJzgVPI3mPPI7KQnQnqarGaQXhMhJZhgk+9RNKGWSMAYAwCPWgCeF8aaskeVJZtwpFOSkSADI5OM03CiOH5WdR9444z6VO2+1hIBXe6hieuB6fWgCNhsu2VRuKgKFK5B56GqV1HieR41CFnPyjt7VobifJfaVEp3bu5xUC7ZblpS+B13Duc1TstDMcRtaOO4B3BeWz+VVkTbJiQcA5J9annDR3A/izyT2NJlpdwkILfSixaY9GQSSSTfOhxuxx9B9KzmLb1LAbg2PaluGbdtHamFskeop2IehIS4BTG5jzx2FRDndu5weKiaeVZgUYqc5yP5UpkALEHnHIqrGcmPkfgHPIqpPl5AoOOKlyPL3McntUCk7sMfmI4qkjKTI5ciIqe4qszBcc9RzVqTBIB57VWkIE/3cAetbQWhzTeooAZQB2PNKodWwozu4pU3LLyBvzkgU4q8oG3hi3y4NWlqZuRGsZLA7ckNgVeeKNHHUFfQ00R+QN8h5FQPKWbv+PetErEN3Jmc4zXoWoia6/tW104xfaru3tWtgSAZbQJhkQnuG5IHNebb+cZNbNhrSpYpY6laRahZRsWhWRijwk9djjkA+nSmJHWaJBf2dtp1lf4S8OoxS2MLEGSJBkyscfdTHUHrXHak8b6leG24gMzmP8A3dxxVyTXIobeWHRdPSw85dks5kMszL3UMfug+wrIXqOMcUCZ/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This photo shows many blisters on the skin.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_7_5238=[""].join("\n");
var outline_f5_7_5238=null;
var title_f5_7_5239="Aprical 4 chamber contrast-enhanced left ventricle";
var content_f5_7_5239=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F55017&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F55017&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 537px\">",
"   <div class=\"ttl\">",
"    Apical 4-chamber view of an echocardiogram with and with contrast-enhanced imaging of the left ventricle",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 517px; height: 534px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The four chamber view is initially obtained by imaging at the fundamental (interrogating) frequency (panel A). The same image after administration of an echocardiographic contrast agent (panel B). Note that the endocardium is continuously seen. Harmonic imaging at 7 MHz following echocardiographic contrast administration demonstrates considerable improvement in the contrast effect; both the cavity outline and that of the myocardium are identified with greater confidence.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_7_5239=[""].join("\n");
var outline_f5_7_5239=null;
var title_f5_7_5240="Organ sharing in kidney transplantation";
var content_f5_7_5240=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Organ sharing in kidney transplantation",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/7/5240/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/7/5240/contributors\">",
"     William M Bennett, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/7/5240/contributors\">",
"     John Vella, MD, FACP, FRCP, FASN",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/7/5240/contributors\">",
"     Daniel C Brennan, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/7/5240/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/7/5240/contributors\">",
"     Barbara Murphy, MB, BAO, BCh, FRCPI",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/7/5240/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/7/5240/contributors\">",
"     Alice M Sheridan, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?5/7/5240/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The potential benefits of organ sharing to enhance long-term graft survival as well as the allocation policy of the United Network for Organ Sharing in the United",
"    <span class=\"nowrap\">",
"     States/Organ",
"    </span>",
"    Procurement Network",
"    <span class=\"nowrap\">",
"     (UNOS/OPTN)",
"    </span>",
"    are presented in this topic review. The potential problems associated with using HLA to allocate organs as well as the utility of cross reactive group (CREG) matching, and prospective crossmatching are also discussed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     BENEFITS OF ORGAN SHARING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data from the",
"    <span class=\"nowrap\">",
"     UNOS/OPTN",
"    </span>",
"    have convincingly demonstrated the value of organ sharing, as both one-year and long-term graft survival are higher with nationally shared six antigen matched deceased donor kidneys [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5240/abstract/1-6\">",
"     1-6",
"    </a>",
"    ]. As an example, among over 7600 HLA-matched and 81,000 HLA-mismatched cadaveric renal transplants performed between 1987 and 1999 in the United States, ten-year survival was markedly superior for HLA-matched kidneys (52 versus 37 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5240/abstract/5\">",
"     5",
"    </a>",
"    ]. Similar findings have been reported in subsequent years. Although the effect of matching appears to be diminishing over time, it remains significant [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5240/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/57/11159?source=see_link\">",
"     \"HLA matching and graft survival in kidney transplantation\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    One needs to consider, however, how many patients can benefit from six antigen matching, and to examine whether patients with only one or two mismatches should also be given priority. An estimate of the possible number of well-matched cases has been made by the United Kingdom Transplant Service. If ABO requirements are taken into account and the pool sizes are 10,000 donors and 5,000 recipients, 28 percent of transplants could be A,B,DR compatible, 24 percent would have only one A mismatch, and 21 percent would have only one B mismatch. Among estimates for the more genetically diverse North American Caucasian population, as many as 20 percent of transplant recipients could receive A,B,DR compatible kidneys, assuming pool sizes of 10,000 for donors and recipients [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5240/abstract/9\">",
"     9",
"    </a>",
"    ]. The total benefits of prolonging the function of first grafts for 20 to 60 percent of patients is substantial, both in economic and human terms, if this could be accomplished without cold ischemia times exceeding 24 hours.",
"   </p>",
"   <p>",
"    It is important to note that serology-based tissue typing techniques are subject to error because of the following reasons:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      A rare antigen may not be detected due to the lack of a relevant antiserum",
"     </li>",
"     <li>",
"      The reaction pattern of clusters of antisera may be misinterpreted",
"     </li>",
"     <li>",
"      There are variations in reagent lots as well as in other technical factors",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Taken together, various studies have shown that serologic class I typing can vary by as much as 15 to 30 percent. This variation with serology typing has significant implications for graft survival. Recipients of zero antigen mismatched recipients detected using genomic typing, the gold standard, enjoy superior long-term graft survival compared with patients thought to have initially received zero antigen mismatched kidneys defined serologically but who are subsequently shown to be mismatched using more accurate molecular techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5240/abstract/10\">",
"     10",
"    </a>",
"    ]. Similar observations have been made in recipients of bone marrow transplants. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/38/26218?source=see_link&amp;anchor=H13#H13\">",
"     \"Donor selection for hematopoietic cell transplantation\", section on 'Matched unrelated donors'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ALLOCATION OF DECEASED DONOR KIDNEYS",
"    </span>",
"    &nbsp;&mdash;&nbsp;National and regional kidney allocation policies exist for the purpose of the equitable and utilitarian distribution of deceased donor kidneys. Such policies have been devised and agreed upon by the transplant programs that comprise",
"    <span class=\"nowrap\">",
"     UNOS/OPTN.",
"    </span>",
"    The actual policies are available to the public at the following web site in PDF and Word formats:",
"    <a class=\"external\" href=\"file://optn.transplant.hrsa.gov/policiesAndBylaws/policies.asp\">",
"     file://optn.transplant.hrsa.gov/policiesAndBylaws/policies.asp",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    While there is a national policy, there are some regional alternatives in the policy. Such alternatives have been enacted by Alternative Local Units (Alternative Local Units or ALUs) which function as distinct areas for organ procurement and distribution. By way of example, UNOS Region I (New England) and California have regional policies that differ from the national policy. Local OPOs may also have variances.",
"   </p>",
"   <p>",
"    Organ allocation policies have engendered a degree of controversy within the transplant community both because of the scarcity of the resource and also because of the apparent conflict between utility and equity [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5240/abstract/11\">",
"     11",
"    </a>",
"    ]. As an example, a policy that emphasizes match grade at the expense of waiting time will favor long-term allograft survival. However, the same policy may disadvantage certain ethnic groups leading to a reduced transplantation rate for those affected. This observation has led to the establishment of the alternate allocation policies.",
"   </p>",
"   <p>",
"    Another issue is that, since it does not incorporate factors associated with allograft and recipient survival, the current allocation system inefficiently uses deceased donor kidneys. As a result, a kidney from a 25 year old donor that is in excellent condition may be placed in a 60 year old recipient, thereby possibly \"wasting\" many years of allograft survival due to the disparity between patient and recipient age. Attempts to address this concern include the development of alternative allocation algorithms that include recipient age, history of diabetes mellitus and angina, and time on dialysis [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5240/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     NATIONAL DECEASED DONOR KIDNEY ALLOCATION POLICY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The principals that govern allocation are as follows.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Deceased donor kidneys are allocated by blood group",
"    </span>",
"    &nbsp;&mdash;&nbsp;As an example, blood group O kidneys are only offered to blood group O recipients. This is similarly done for A, B and AB blood groups. The only exception is the case of the zero antigen mismatch patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Mandatory sharing of zero-antigen mismatched kidneys",
"    </span>",
"    &nbsp;&mdash;&nbsp;A zero-antigen mismatch is defined as occurring when a patient on the UNOS Waiting List has an ABO blood type that is compatible with that of the donor, and the patient and donor share all six of the same HLA-A, B, and DR antigens (or at least none of the antigens are different). Such kidneys are shared, as the allograft survival has been previously shown to be superior to all other match grades. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Benefits of organ sharing'",
"    </a>",
"    above.) In January 2009, only patients with calculated PRAs greater than 20 percent are allowed to be considered for the zero-antigen mismatch program.",
"   </p>",
"   <p>",
"    The Organ Procurement Organization (OPO) that accepts a zero-antigen mismatch kidney engenders a \"payback.\" In other words, the accepting OPO owes the procuring OPO a kidney in return. In the event that there is more than one potential recipient for a zero antigen mismatch kidney, the kidney is allocated according to an algorithm that takes into account PRA and geography.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Kidney payback",
"    </span>",
"    &nbsp;&mdash;&nbsp;The OPO receiving a zero-antigen mismatch kidney must offer through the UNOS Organ Center a kidney from the next suitable donor, aged between 6 and 59 years, of the same ABO blood type as the donor from whom the shared kidney was procured. No center may owe more than nine kidneys.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Geographic sequence of kidney allocation",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, kidneys are allocated locally first, then regionally and then nationally.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Expanded criteria donor and standard donor",
"    </span>",
"    &nbsp;&mdash;&nbsp;A deceased donor kidney is designated an expanded criteria donor organ if the estimated risk of allograft failure at two years post-transplant is at least 70 percent greater than that associated with an ideal reference group (as defined by nonhypertensive donors [10 to 39 years] in whom the cause of death was not cerebrovascular and the last serum creatinine level was less than 1.5",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [133",
"    <span class=\"nowrap\">",
"     &micro;mol/liter]).",
"    </span>",
"    Expanded (or extended) criteria donors (ECD) are defined by an \"X\" in the decision matrix (",
"    <a class=\"graphic graphic_table graphicRef53695 \" href=\"UTD.htm?22/32/23052\">",
"     table 1",
"    </a>",
"    ) indicating relative risk of graft failure for donors based upon the following factors: age, serum creatinine concentration, cerebrovascular accident, and hypertension. Standard donors are all other donors.",
"   </p>",
"   <p>",
"    For purposes of distinguishing expanded criteria donors from standard donors, the most recent serum creatinine concentration at the time of kidney placement is used. Patients who agree to receive expanded criteria donor kidneys are also eligible to receive standard donor kidneys. Specific informed consent is required from the recipient before an expanded criteria kidney is transplanted. A separate waiting list for extended criteria donor kidneys does not exist [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5240/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A kidney biopsy is often procured at the time of organ retrieval in order to ascertain the degree of fibrosis present. Such tissue is obtained by the operating surgeon on the \"back table\" using either a wedge or needle biopsy technique. The parameters reported generally include the percentage of glomeruli that are sclerosed, the degree of arteriolar injury, and the degree of interstitial fibrosis and tubular atrophy. Such assessments are often performed on frozen sections in view of the time sensitive nature of the allocation process. In general terms, transplant programs are reluctant to allocate an expanded criteria donor kidney if the degree of sclerosis exceeds 15 to 20 percent.",
"   </p>",
"   <p>",
"    How one should assess a \"marginal kidney\" is unknown. Studies support use of machine-perfusion measurements of flow or resistance, as those with low flow or high resistive index (RI) have inferior outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5240/abstract/14-17\">",
"     14-17",
"    </a>",
"    ]. Although there is no standardization of techniques, kidneys with flow rates less than 70",
"    <span class=\"nowrap\">",
"     mL/min",
"    </span>",
"    or RI greater than 0.5 have generally been considered unacceptable [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5240/abstract/17\">",
"     17",
"    </a>",
"    ]. Studies reporting on the use of preimplantation biopsies show that the higher the percentage of glomerulosclerosis, interstitial fibrosis, and arteriolar atherosclerosis, the worse the outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5240/abstract/18-20\">",
"     18-20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one study of",
"    <span class=\"nowrap\">",
"     UNOS/OPTN",
"    </span>",
"    registry data, for example, biopsy results from 2696 donors who had both kidneys biopsied and subsequently transplanted showed that among the groups with greater than 5 percent glomerulosclerosis, there was no statistically significant difference in graft survival rates [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5240/abstract/18\">",
"     18",
"    </a>",
"    ]. Agreement between biopsy assessments between paired kidneys from the same donor was highest for the 0 to 5 percent glomerulosclerosis groups (90.6 percent) compared to pairs with greater than 5 percent glomerulosclerosis (42.5 percent), but did not help predict graft outcomes. The authors speculated that sampling error may have contributed to the lack of differences seen among these kidneys, given the low intrapair agreement. Among those with more than 5 percent glomerulosclerosis assessed at increments of 5 to 20 percent, there was no difference in graft survival among groups, but the more than 20 percent group had the best graft survival at five years. This is surprising, because more than 20 percent glomerulosclerosis is generally accepted as the threshold for rejection of a kidney, but it may indicate a selection bias in accepting kidneys that were deemed to be acceptable, except for glomerulosclerosis. A wedge biopsy is preferred for evaluation and must contain at least 25 glomeruli.",
"   </p>",
"   <p>",
"    In general, it is felt that machine perfusion should be used on ECD and DCD kidneys. A randomized study showed that the incidence of delayed graft function among recipients of SCD, but not ECD or DCD, kidneys was less when they received kidneys that had undergone machine perfusion preservation compared to cold-storage preservation [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5240/abstract/21,22\">",
"     21,22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A significant number of recipients are receiving ECD kidneys [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5240/abstract/23-26\">",
"     23-26",
"    </a>",
"    ]. One study based upon the Scientific Registry of Transplant Recipients evaluated the characteristics of ECD kidney recipients in the period between November 1999 and October 2005 [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5240/abstract/26\">",
"     26",
"    </a>",
"    ]. Approximately 40 percent of all transplant candidates were listed for ECD kidneys, with 30 and 70 percent eventually receiving an ECD and a non-ECD kidney, respectively. The elderly, diabetics, and sensitized patients were more likely to be listed for and receive such kidneys [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5240/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. In total, ECD kidneys comprise approximately 20 percent of all donor kidneys [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5240/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Double kidney allocation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Kidneys from adult donors must be offered singly unless the donor meets at least two of the following conditions and the OPO would not otherwise use the kidneys singly:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Donor age greater than 60 years",
"     </li>",
"     <li>",
"      Estimated donor creatinine clearance less than 65",
"      <span class=\"nowrap\">",
"       mL/min",
"      </span>",
"      based upon serum creatinine concentration upon admission",
"     </li>",
"     <li>",
"      Rising serum creatinine concentration (greater than 2.5",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [221",
"      <span class=\"nowrap\">",
"       &micro;mol/L])",
"      </span>",
"      at time of retrieval",
"     </li>",
"     <li>",
"      History of medical disease in donor (defined as either longstanding hypertension or diabetes mellitus);",
"     </li>",
"     <li>",
"      Adverse donor kidney histology (defined as moderate to severe glomerulosclerosis [greater than 15 and less than 50 percent]).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     The point system for kidney allocation",
"    </span>",
"    &nbsp;&mdash;&nbsp;When information about a standard donor is entered into the UNOS Match System, all patients who have an ABO blood type that is compatible with that of the donor and who are listed as active on the UNOS Patient Waiting List are assigned points and priority as follows:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7157930\">",
"    <span class=\"h3\">",
"     Waiting time",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients may be placed on the Waiting list either upon initiation of chronic maintenance dialysis (defined as dialysis that is regularly furnished to an end-stage Renal Disease [ESRD] candidate in a hospital based, independent [non-hospital based], or home setting) or when the creatinine clearance or glomerular filtration rate (GFR) is less than approximately 20",
"    <span class=\"nowrap\">",
"     mL/min.",
"    </span>",
"   </p>",
"   <p>",
"    The &ldquo;time of waiting&rdquo; for candidates listed for an isolated kidney or combined",
"    <span class=\"nowrap\">",
"     kidney/pancreas",
"    </span>",
"    transplant who are less than 18 years old begins when the candidate is placed on the Waiting List. A prospective crossmatch or &ldquo;virtual crossmatch&rdquo; is mandatory for all candidates prior to transplantation, except where clinical circumstances support its omission. This policy was instituted to expedite placement of the organ and decrease the risk of a positive cytotoxicity cross match precluding transplantation that may extend cold ischemia time and make the potential donor kidney unacceptable.",
"   </p>",
"   <p>",
"    For a patient to be listed, each transplant center must report at the time of listing the unacceptable antigens that are defined by laboratory detection of HLA specific antibodies determined using at least one solid phase immunoassay, eg, ELISA, or Luminex using purified HLA molecules. Each center may define the criteria for unacceptable antigens that are considered as contraindications for transplantation. It is the prerogative of the transplant center to establish criteria for additional unacceptable antigens, such as repeat transplant mismatches. A calculated PRA (CPRA) will be calculated automatically when the unacceptable antigens are listed or updated on the Waiting List. The CPRA will be derived from HLA",
"    <span class=\"nowrap\">",
"     antigen/allele",
"    </span>",
"    group and haplotype frequencies for the different",
"    <span class=\"nowrap\">",
"     racial/ethnic",
"    </span>",
"    groups in proportion to their representation in the national deceased donor population. (See",
"    <a class=\"local\" href=\"#H13490292\">",
"     'Sensitized wait list candidates and panel reactive antibody (PRA)'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Once patients are wait listed, points are assigned to the patient waiting for the longest period with fractions of points being assigned proportionately to all other patients, according to their relative time of waiting. As an example, if there are 75 blood group O patients waiting for kidneys, the person waiting the longest receives one point",
"    <span class=\"nowrap\">",
"     (75/75",
"    </span>",
"    x 1 = 1). The next person in order receives a fraction of one point defined by the following equation:",
"    <span class=\"nowrap\">",
"     74/75",
"    </span>",
"    x 1 = X. For each full year of waiting time a patient accrues, an additional one point is assigned to that patient. Candidates, regardless of age, shall continue to accrue waiting time while registered on the Waiting List even if their status is changed to \"medically inactive\" (or status 7) because of an acute intercurrent medical event. This rule is a relatively recent change in policy, as patients previously did not continue to accrue waiting time points. Approximately 40 percent of those awaiting transplantation are \"inactive\" at any given point in time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Quality of antigen mismatch",
"    </span>",
"    &nbsp;&mdash;&nbsp;Points are assigned to a patient based on the number of mismatches between the patient's antigens and the donor's antigens at the DR locus. Two points are assigned for zero DR locus mismatches, and one point for one DR locus mismatch. An antigen mismatch occurs when a donor antigen would be recognized by the recipient as being different from the recipient's own antigens.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13490292\">",
"    <span class=\"h3\">",
"     Sensitized wait list candidates and panel reactive antibody (PRA)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Calculated PRA (cPRA) is the percentage of donors expected to have one or more of the unacceptable antigens indicated on the Waiting List for the candidate. Sensitized Waiting List candidates with defined unacceptable HLA antigens that yield a cPRA of 80 percent or greater will be assigned 4 points.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Medical urgency",
"    </span>",
"    &nbsp;&mdash;&nbsp;No points are assigned to patients based upon medical urgency for national allocation of kidneys. Locally, the patient's physician has the authority to use medical judgment in assignment of medical urgency points if there is only one renal transplant center. When there is more than one local renal transplant center, a cooperative medical decision is required prior to assignment of medical urgency points.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h3\">",
"     Pediatric kidney transplant candidates",
"    </span>",
"    &nbsp;&mdash;&nbsp;Kidney transplant candidates who are less than 11 years old are assigned four additional points for kidney allocation. Candidates who are 11 years or older are assigned three additional points for kidney allocation. These points are retained until the candidate reaches 18 years of age.",
"   </p>",
"   <p>",
"    Kidneys from donors aged less than 35 years (that are not shared for 0 HLA mismatching, for",
"    <span class=\"nowrap\">",
"     renal/non-renal",
"    </span>",
"    organ allocation, or locally for prior living organ donors) shall be offered first for transplant candidates who are less than 18 years of age at listing independent of the number of points assigned to the candidate relative to those 18 years old and older. An exception is candidates assigned four points for PRA levels of 80 percent or who otherwise rank higher than all other listed candidates based upon total points assigned.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Donation status",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals who have previously donated a vital organ for transplantation within the United States are assigned four points. In addition, patients assigned four points for donation status are given first priority for kidneys that are not shared mandatorily for zero antigen mismatching.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Regional policy variances",
"    </span>",
"    &nbsp;&mdash;&nbsp;As previously mentioned, some regions (ALUs) have policies concerning organ allocation that differ from the National Policy. As an example, UNOS region I (New England) has omitted HLA-DR match grade and PRA from the algorithm. In this region for the most part, kidneys are allocated based on points allocated for waiting time and geography.",
"   </p>",
"   <p>",
"    Based in part upon regional policy differences, the access to donated kidneys can vary by geographic region [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5240/abstract/28\">",
"     28",
"    </a>",
"    ]. Due in part to increasingly long periods on waiting lists in certain areas of the United States, some patients are listed on multiple waiting lists. This can result in some obvious benefits for themselves as well as for others who remain on the Waiting List once the multiple waitlist patients are transplanted.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     MINORITY GROUP ISSUES",
"    </span>",
"    &nbsp;&mdash;&nbsp;African-American patients who undergo renal transplantation have the same graft survival benefit from HLA matching as Caucasians [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5240/abstract/29\">",
"     29",
"    </a>",
"    ]. In one study, for example, total HLA mismatching in African-Americans increased the risk of graft loss [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5240/abstract/30\">",
"     30",
"    </a>",
"    ]. Another report showed that partial degrees of matching in this patient population improved survival [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5240/abstract/31\">",
"     31",
"    </a>",
"    ]. As a result, African-Americans should benefit by policies that prioritize the importance of less than perfect matches (eg, five or four antigen matches). Since most Caucasians also cannot receive a six antigen matched graft, this policy would benefit all recipients.",
"   </p>",
"   <p>",
"    Kidneys are disproportionately donated by Caucasian-Americans (compared with African-Americans) and a higher percentage of African-Americans (compared with Caucasian-Americans) suffer from end-stage renal disease. In addition, consent for a donation is greater among Caucasian-Americans than for non-Caucasian-Americans.",
"   </p>",
"   <p>",
"    The different distribution of blood group and HLA antigens among these populations may result in proportionately fewer kidneys allocated to African-Americans. Some studies have therefore found that African-Americans and other minorities may wait longer for a donated kidney than Caucasian-Americans, based in part upon this reliance on HLA matching [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5240/abstract/29,32\">",
"     29,32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A strategy based upon eliminating HLA-B matching as a priority is associated with improved minority kidney allocation in the United States. Based upon a Cox model analysis in which HLA-DR but not HLA-B matching was utilized, the number of transplants would decrease by 4.0 percent among whites but increase by 6.3 percent in nonwhites [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5240/abstract/33\">",
"     33",
"    </a>",
"    ]; this resulted in only a 2.0 percent increase in graft loss. Based upon these findings, the national allocation policy was changed to no longer give priority points for fewer HLA-B mismatches.",
"   </p>",
"   <p>",
"    However, whether this policy is equitable is a matter of controversy. One study analyzed the policy's social and financial impact using data from the United States Renal Data System (USRDS) to estimate race-specific outcomes, patient and graft survival, quality adjusted life years (QALYs), and medical cost in United States dollars to Medicare [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5240/abstract/34\">",
"     34",
"    </a>",
"    ]. The greatest benefit was expected in African-Americans, with expected savings of $7.5 million and 243 QALYs; by comparison, a loss of $7.0 million and a decrease of 967 QALYs was expected in Caucasians. Overall, this policy is expected to save $5,400 for each QALY that is lost. The same increase in minority transplantation could be expected from increasing Caucasian donation rates by 5.5 percent, or African-American donations by 29 percent, each producing large cost savings and QALY gains. The authors concluded that policies to increase minority transplants by increasing donation rates may prove more cost-effective than the elimination of HLA-B matching from deceased donor allocation.",
"   </p>",
"   <p>",
"    Another proposed solution to the perceived racial inequality concerning organ allocation in the United States was to replace or augment conventional HLA matching with cross reactive group matching (CREG). Cross reactive antigen groups are a collection of HLA molecules that share antigenic determinants. Antisera that recognize one HLA molecule of a particular group will also crossreact with other members of this group via recognition of the shared antigen (usually a specific amino acid residue at a particular position in the protein). These antigens are also referred to as \"public\" as opposed to \"private\" or conventional antigens.",
"   </p>",
"   <p>",
"    With CREG matching for recipient selection, a larger pool of recipients is eligible to receive a donated kidney. As an example, group HLA-B7 contains group members, HLA-B7, -B27, -B42, -B54, -B55, and -B56 [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5240/abstract/35\">",
"     35",
"    </a>",
"    ]. As a result, a recipient with HLA-B27 is considered \"matched\" with a donor HLA-B7 kidney, since these alleles share cross-reacting antigens.",
"   </p>",
"   <p>",
"    The immunologic relevance of CREG matching in cadaveric kidney transplantation was evaluated in a study using data from the International Collaborative Transplant Study [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5240/abstract/36\">",
"     36",
"    </a>",
"    ]. Analysis was based upon a total of nearly 92,000 patients who received kidneys from 1991 to 2002. Among the group with zero CREG mismatches, patients with zero, one, two, or three more specific HLA antigen mismatches had five year graft survival of 75, 72, 72, and 69 percent, respectively. This suggests that CREG and HLA antigen mismatches are not independent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     POSSIBLE FUTURE ALLOCATION POLICIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most allocation algorithms (including the current system that has been in place for more than 20 years) are primarily founded on waiting time and provide equal access for all waitlisted individuals. These issues make it possible for candidates with very high risks of mortality and low probabilities of long-term survival to receive kidneys from so-called \"ideal\" deceased donors.",
"   </p>",
"   <p>",
"    These problems, along with a stipulation in federal regulation that organ allocation policies strive to maximize lifetime benefit, have lead policymakers to consider other renal allocation methods [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5240/abstract/37\">",
"     37",
"    </a>",
"    ]. The",
"    <span class=\"nowrap\">",
"     OPTN/UNOS",
"    </span>",
"    Kidney Transplantation Committee has considered many concepts and approaches to allocation over the past four years (",
"    <a class=\"external\" href=\"file://optn.transplant.hrsa.gov/kars.asp\">",
"     file://optn.transplant.hrsa.gov/kars.asp",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The committee is currently considering the following three concepts, which could work together to determine a candidate Kidney Allocation Score (KAS) and has requested input from the public and the transplant community:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Life Years from Transplant (LYFT), which determines the estimated survival that a recipient of a specific donor kidney may expect to receive versus remaining on dialysis. LYFT is primarily a measure of utility.",
"     </li>",
"     <li>",
"      Dialysis Time (DT), which calculates waiting time from the date of initiation of dialysis and allows candidates to gain priority over the period they receive this treatment. This adds the essential element of justice into the allocation system.",
"     </li>",
"     <li>",
"      Donor Profile Index (DPI), which provides a continuous measure of organ quality based on clinical information. DPI increases individual autonomy by providing a better metric for deciding which organs are appropriate for which candidates.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    LYFT, DPI, and DT are incorporated so that kidneys are matched to candidates based on the expected survival of both the kidney and the recipient.",
"   </p>",
"   <p>",
"    This proposal could lead to younger recipients preferentially receiving standard criteria donor kidneys and a significant net increase in graft survival benefit for the recipient population as a whole [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5240/abstract/38\">",
"     38",
"    </a>",
"    ]. Somewhat surprisingly, modeling indicates that the revised allocation system would translate to only an 18-month overall increase in survival. A tacit inference is that a certain percentage of older recipients would never receive transplants. Needless to say, such a sweeping and controversial proposal to revise the allocation system has engendered much discussion and a final decision has yet to be made.",
"   </p>",
"   <p>",
"    Concern has been expressed that such a schema could potentially lead to a reduction in living donation consequent on reduced incentives for friends and family of patients with ESRD to donate in the setting of reduced waiting times. As the graft survival of living donor kidneys is so much greater than deceased donor kidneys, even small reductions in the rate of live donors could abrogate the survival benefits of LYFT- and DPI-based allocation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H609525632\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Data from the United Network for Organ Sharing in the United",
"      <span class=\"nowrap\">",
"       States/Organ",
"      </span>",
"      Procurement Network",
"      <span class=\"nowrap\">",
"       (UNOS/OPTN)",
"      </span>",
"      have convincingly demonstrated the value of organ sharing especially for highly sensitized patients, as both one-year and long-term graft survival are higher with nationally shared six antigen matched deceased donor kidneys. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Benefits of organ sharing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      National and regional kidney allocation policies exist for the purpose of the equitable and utilitarian distribution of deceased donor kidneys. Such policies have been devised and agreed upon by the transplant programs that comprise",
"      <span class=\"nowrap\">",
"       UNOS/OPTN.",
"      </span>",
"      While there is a national policy, there are some regional alternatives. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Allocation of deceased donor kidneys'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There a large number of principals that govern the national allocation program. These include allocation by blood group, kidney payback, geographic issues, expanded criteria and standard donors, and the point system. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'National deceased donor kidney allocation policy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A number of alternate allocation schemas have been proposed. (See",
"      <a class=\"local\" href=\"#H20\">",
"       'Possible future allocation policies'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/1\">",
"      Takemoto S, Terasaki PI, Cecka JM, et al. Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry. N Engl J Med 1992; 327:834.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/2\">",
"      Braun WE. Every kidney counts. N Engl J Med 1992; 327:883.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/3\">",
"      Stegall MD, Dean PG, McBride MA, et al. Survival of mandatorily shared cadaveric kidneys and their paybacks in the zero mismatch era. Transplantation 2002; 74:670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/4\">",
"      Norman DJ. The kidney transplant wait-list: allocation of patients to a limited supply of organs. Semin Dial 2005; 18:456.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/5\">",
"      Takemoto SK, Terasaki PI, Gjertson DW, Cecka JM. Twelve years' experience with national sharing of HLA-matched cadaveric kidneys for transplantation. N Engl J Med 2000; 343:1078.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.ustransplant.org (Accessed February, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/7\">",
"      Su X, Zenios SA, Chakkera H, et al. Diminishing significance of HLA matching in kidney transplantation. Am J Transplant 2004; 4:1501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/8\">",
"      Opelz G, D&ouml;hler B. Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades. Transplantation 2007; 84:137.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/9\">",
"      Cicciarelli J, Terasaki PI, Mickey MR. The effect of zero HLA class I and II mismatching in cyclosporine-treated kidney transplant patients. Transplantation 1987; 43:636.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/10\">",
"      Mytilineos J, Lempert M, Middleton D, et al. HLA class I DNA typing of 215 \"HLA-A, -B, -DR zero mismatched\" kidney transplants. Tissue Antigens 1997; 50:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/11\">",
"      Gaston RS, Danovitch GM, Adams PL, et al. The report of a national conference on the wait list for kidney transplantation. Am J Transplant 2003; 3:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/12\">",
"      Baskin-Bey ES, Kremers W, Nyberg SL. A recipient risk score for deceased donor renal allocation. Am J Kidney Dis 2007; 49:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/13\">",
"      Ojo AO. Expanded criteria donors: process and outcomes. Semin Dial 2005; 18:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/14\">",
"      Kozaki K, Sakurai E, Kubota K, et al. Prediction of kidney nonfunction after transplantation with machine perfusion preservation. Transplant Proc 2000; 32:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/15\">",
"      Matsuno N, Kozaki K, Degawa H, et al. A useful predictor in machine perfusion preservation for kidney transplantation from non-heart-beating donors. Transplant Proc 2000; 32:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/16\">",
"      Mozes MF, Skolek RB, Korf BC. Use of perfusion parameters in predicting outcomes of machine-preserved kidneys. Transplant Proc 2005; 37:350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/17\">",
"      Nyberg SL, Baskin-Bey ES, Kremers W, et al. Improving the prediction of donor kidney quality: deceased donor score and resistive indices. Transplantation 2005; 80:925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/18\">",
"      Bajwa M, Cho YW, Pham PT, et al. Donor biopsy and kidney transplant outcomes: an analysis using the Organ Procurement and Transplantation Network/United Network for Organ Sharing (OPTN/UNOS) database. Transplantation 2007; 84:1399.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/19\">",
"      Snoeijs MG, Buurman WA, Christiaans MH, et al. Histological assessment of preimplantation biopsies may improve selection of kidneys from old donors after cardiac death. Am J Transplant 2008; 8:1844.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/20\">",
"      Kayler LK, Mohanka R, Basu A, et al. Correlation of histologic findings on preimplant biopsy with kidney graft survival. Transpl Int 2008; 21:892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/21\">",
"      Matsuoka L, Shah T, Aswad S, et al. Pulsatile perfusion reduces the incidence of delayed graft function in expanded criteria donor kidney transplantation. Am J Transplant 2006; 6:1473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/22\">",
"      Moers C, Smits JM, Maathuis MH, et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 2009; 360:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/23\">",
"      Port FK, Dykstra DM, Merion RM, Wolfe RA. Trends and results for organ donation and transplantation in the United States, 2004. Am J Transplant 2005; 5:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/24\">",
"      Sung RS, Guidinger MK, Lake CD, et al. Impact of the expanded criteria donor allocation system on the use of expanded criteria donor kidneys. Transplantation 2005; 79:1257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/25\">",
"      Schold JD, Howard RJ, Scicchitano MJ, Meier-Kriesche HU. The expanded criteria donor policy: an evaluation of program objectives and indirect ramifications. Am J Transplant 2006; 6:1689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/26\">",
"      Sung RS, Guidinger MK, Leichtman AB, et al. Impact of the expanded criteria donor allocation system on candidates for and recipients of expanded criteria donor kidneys. Transplantation 2007; 84:1138.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/27\">",
"      Marks WH, Wagner D, Pearson TC, et al. Organ donation and utilization, 1995-2004: entering the collaborative era. Am J Transplant 2006; 6:1101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/28\">",
"      Ellison MD, Edwards LB, Edwards EB, Barker CF. Geographic differences in access to transplantation in the United States. Transplantation 2003; 76:1389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/29\">",
"      Young CJ, Gaston RS. Renal transplantation in black Americans. N Engl J Med 2000; 343:1545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/30\">",
"      Butkus DE, Meydrech EF, Raju SS. Racial differences in the survival of cadaveric renal allografts. Overriding effects of HLA matching and socioeconomic factors. N Engl J Med 1992; 327:840.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/31\">",
"      Koyama H, Cecka JM, Terasaki PI. Kidney transplants in black recipients. HLA matching and other factors affecting long-term graft survival. Transplantation 1994; 57:1064.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/32\">",
"      Ting A, Edwards LB. Human leukocyte antigen in the allocation of kidneys from cadaveric donors in the United States. Transplantation 2004; 77:610.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/33\">",
"      Roberts JP, Wolfe RA, Bragg-Gresham JL, et al. Effect of changing the priority for HLA matching on the rates and outcomes of kidney transplantation in minority groups. N Engl J Med 2004; 350:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/34\">",
"      Mutinga N, Brennan DC, Schnitzler MA. Consequences of eliminating HLA-B in deceased donor kidney allocation to increase minority transplantation. Am J Transplant 2005; 5:1090.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/35\">",
"      Schnitzler MA, Hollenbeak CS, Cohen DS, et al. The economic implications of HLA matching in cadaveric renal transplantation. N Engl J Med 1999; 341:1440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/36\">",
"      Laux G, Opelz G. Immunological relevance of CREG matching in cadaver kidney transplantation. Transplantation 2004; 78:442.",
"     </a>",
"    </li>",
"    <li>",
"     121.8 S. Federal Register, [FR Doc 98-8191] 42 CFR Part 121 1998:16296.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5240/abstract/38\">",
"      Shapiro R. Kidney allocation and the perception of fairness. Am J Transplant 2007; 7:1041.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7337 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-58.240.98.179-2FE80B8408-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_7_5240=[""].join("\n");
var outline_f5_7_5240=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H609525632\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      BENEFITS OF ORGAN SHARING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ALLOCATION OF DECEASED DONOR KIDNEYS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      NATIONAL DECEASED DONOR KIDNEY ALLOCATION POLICY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Deceased donor kidneys are allocated by blood group",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Mandatory sharing of zero-antigen mismatched kidneys",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Kidney payback",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Geographic sequence of kidney allocation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Expanded criteria donor and standard donor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Double kidney allocation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      The point system for kidney allocation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7157930\">",
"      - Waiting time",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Quality of antigen mismatch",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13490292\">",
"      - Sensitized wait list candidates and panel reactive antibody (PRA)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Medical urgency",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      - Pediatric kidney transplant candidates",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Donation status",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Regional policy variances",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      MINORITY GROUP ISSUES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      POSSIBLE FUTURE ALLOCATION POLICIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H609525632\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEPH/7337\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEPH/7337|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/32/23052\" title=\"table 1\">",
"      Expanded criteria kidney donor condition and age",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/38/26218?source=related_link\">",
"      Donor selection for hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/57/11159?source=related_link\">",
"      HLA matching and graft survival in kidney transplantation",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_7_5241="Knee ligaments";
var content_f5_7_5241=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F74251&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F74251&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 589px\">",
"   <div class=\"ttl\">",
"    Ligaments of the knee",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 569px; height: 528px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The right knee joint as seen from lateral aspect (A), the anterior aspect with the joint flexed (B), and the posterior aspect (C, D).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Snell, MD. Clinical Anatomy, Seventh Edition. Lippincott, Williams &amp; Wilkins, 2003. Copyright &copy; 2003 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_7_5241=[""].join("\n");
var outline_f5_7_5241=null;
var title_f5_7_5242="Acute appendicitis in adults: Management";
var content_f5_7_5242=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Acute appendicitis in adults: Management",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/7/5242/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/7/5242/contributors\">",
"     Douglas Smink, MD, MPH",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/7/5242/contributors\">",
"     David I Soybel, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/7/5242/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/7/5242/contributors\">",
"     Martin Weiser, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/7/5242/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/7/5242/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?5/7/5242/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 14, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goal of therapy of acute appendicitis is early diagnosis and prompt operative intervention. However, this goal is not always easily accomplished since many patients do not seek medical attention in a timely manner and the diagnosis of appendicitis can be difficult [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/1\">",
"     1",
"    </a>",
"    ]. Many surgeons use an aggressive approach, accepting a certain number of negative appendectomies, traditionally 15 percent, although the use of imaging studies appears to have reduced the negative appendectomy rate to less than 10 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The management of appendicitis in adults will be reviewed here. The diagnosis and differential diagnosis of appendicitis, appendicitis in pregnancy, and the diagnosis and differential diagnosis of abdominal pain in general are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/40/31370?source=see_link\">",
"     \"Acute appendicitis in adults: Clinical manifestations and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/34/42536?source=see_link\">",
"     \"Acute appendicitis in pregnancy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/36/19018?source=see_link\">",
"     \"Diagnostic approach to abdominal pain in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/30/16874?source=see_link\">",
"     \"Differential diagnosis of abdominal pain in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26003216\">",
"    <span class=\"h1\">",
"     OUTCOMES WITH MEDICAL THERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The great majority of patients with acute appendicitis are treated surgically and an appendectomy remains the gold standard of care. As illustrated in the following randomized trials, some patients respond to medical therapy with antibiotics alone but are at appreciable risk for recurrent disease:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A trial of 243 patients (mean age 33 years) with uncomplicated appendicitis documented by a preoperative CT scan were randomly assigned to medical therapy alone with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/10/42152?source=see_link\">",
"       amoxicillin",
"      </a>",
"      plus clavulanic acid for 8 to 15 days or appendectomy [",
"      <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/3\">",
"       3",
"      </a>",
"      ]. Among patients in the appendectomy arm, 20 percent had complicated appendicitis at the time of surgery. Thus, a preoperative CT showing uncomplicated appendicitis does not exclude complicated disease.",
"      <br/>",
"      <br/>",
"      The occurrence of postoperative peritonitis within 30 days of beginning treatment was the primary endpoint. The pertinent outcome findings included:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Postoperative peritonitis was significantly",
"      <strong>",
"       more frequent",
"      </strong>",
"      in patients treated with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?41/10/42152?source=see_link\">",
"       amoxicillin",
"      </a>",
"      plus clavulanic acid compared with appendectomy (8 versus 2 percent).",
"     </li>",
"     <li>",
"      Fourteen patients (12 percent) treated with antibiotics underwent an appendectomy within 30 days of treatment.",
"     </li>",
"     <li>",
"      An additional 30 patients underwent an appendectomy within the year following antibiotic therapy, 26 of whom had confirmed acute appendicitis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Randomized trials with alternative antibiotic regimens may identify a group of patients that may be amenable to nonoperative management.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A review of three additional randomized clinical trials comparing appendectomy to nonoperative management of acute, nonperforated appendicitis (uncomplicated appendicitis) with antibiotics identified a similar failure rate with antibiotics alone [",
"      <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/4\">",
"       4",
"      </a>",
"      ]. The following findings were noted:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Among the 350 patients treated with antibiotics alone, 112 (32 percent) failed initial medical therapy and were treated with an appendectomy.",
"     </li>",
"     <li>",
"      In the 238 patients who responded to medical therapy and did not undergo surgery during the acute episode, symptoms recurred in 38 (16 percent) within one year and underwent appendectomy. Histologic findings were available for 35 patients and included phlegmon in 25, perforation in 9, and gangrene in 1.",
"     </li>",
"     <li>",
"      Overall, 58 percent of the initial cohort treated with antibiotics remained asymptomatic at one year of follow-up.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A retrospective review included 2283 patients who underwent CT evaluation for possible appendicitis: 516 (23 percent) had evidence of probable or definite appendicitis [",
"    <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/5\">",
"     5",
"    </a>",
"    ]. Thirteen (3 percent) of these patients had improved or resolved pain and were discharged without surgery. Five of the 13 patients subsequently underwent an appendectomy for a diagnosis of appendicitis after a mean of 118 days (range, 5 to 443 days). Histologic evaluation identified acute inflammation in two specimens, chronic inflammation in one, and acute and chronic inflammation in two. Perforation was present in three of these patients.",
"   </p>",
"   <p>",
"    These studies show that there are some patients with acute appendicitis who can be treated nonoperatively and do not require surgery within one year. However, we favor surgery in almost all patients since some patients treated medically develop complicated appendicitis and there is an appreciable rate of recurrent appendicitis. In addition, nonoperative management poses risks in certain patient populations, including the elderly and immunocompromised patients. (See",
"    <a class=\"local\" href=\"#H26\">",
"     'Special considerations'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9259945\">",
"    <span class=\"h1\">",
"     SURGICAL OUTCOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <p class=\"headingAnchor\" id=\"H6573304\">",
"     <span class=\"h2\">",
"      Laparotomy versus laparoscopy",
"     </span>",
"     &nbsp;&mdash;&nbsp;An appendectomy is performed by the conventional open laparotomy approach or by laparoscopy. The laparoscopic approach is used to perform an estimated 58 percent of all appendectomies in the United States [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/6-9\">",
"      6-9",
"     </a>",
"     ]. The operative approach in patients with a suspected appendicitis depends upon the confidence in the diagnosis, history of prior surgery, the patient's age, gender, and body habitus, and the skills of the surgeon.",
"    </p>",
"    <p>",
"     Randomized trials and prospective and retrospective observational studies evaluating laparoscopic and open techniques have been performed to assess outcomes [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/8-10\">",
"      8-10",
"     </a>",
"     ]. The pertinent findings include:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       A trend analysis of prospectively collected data on 7446 patients undergoing a laparoscopic appendectomy found that complication rates have significantly decreased over a decade of observation [",
"       <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/9\">",
"        9",
"       </a>",
"       ]. For procedures performed at the end of the study period compared with procedures performed at the beginning, there were significant reductions in the following outcomes:",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     <ul class=\"hyphen-block\">",
"      <li>",
"       Conversion from a laparoscopic to an open procedure (2.2 to 1.2 percent)",
"      </li>",
"      <li>",
"       Intraoperative complications (3.1 to 0.7 percent)",
"      </li>",
"      <li>",
"       Surgical postoperative complications (6.1 to 1.9 percent)",
"      </li>",
"      <li>",
"       General postoperative complications (4.9 to 1.5 percent)",
"      </li>",
"      <li>",
"       Rate of reoperation (3.4 to 0.7 percent)",
"      </li>",
"      <li>",
"       Duration of hospital stay (4.9 to 3.5 days)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       A meta-analysis of 56 randomized trials and 11 studies compared the outcomes of approximately 6000 adults and children with suspected acute appendicitis undergoing either laparoscopic appendectomy or conventional open laparotomy [",
"       <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/10\">",
"        10",
"       </a>",
"       ]. There were both significantly better and worse outcomes for the laparoscopic approach compared with the conventional open laparotomy. There were no significant differences for adult outcomes compared with children.",
"       <br/>",
"       <br/>",
"       The significantly better outcomes with the laparoscopic approach included:",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     <ul class=\"hyphen-block\">",
"      <li>",
"       A lower rate of wound infections (odds ratio [OR] 0.43, 95% CI 0.34-0.54)",
"      </li>",
"      <li>",
"       Less pain on postoperative day 1 by the VAS pain score (8 mm, CI 5-11 mm)",
"      </li>",
"      <li>",
"       Shorter duration of hospital stay (1.1 days, CI 0.7-1.5 days)",
"      </li>",
"      <li>",
"       Shorter duration for return of bowel function (no data provided)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     The significantly worse outcomes for the laparoscopic approach included:",
"    </p>",
"    <p>",
"     <ul class=\"hyphen-block\">",
"      <li>",
"       A higher rate of an intra-abdominal abscess (OR 1.77, CI 1.14-2.76)",
"      </li>",
"      <li>",
"       A longer operative time (10 minutes, CI 6-15 minutes)",
"      </li>",
"      <li>",
"       Higher operative and in-hospital costs",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Outcome data on 235,473 patients with suspected acute appendicitis undergoing a laparoscopic or open appendectomy between 2000 and 2005 were obtained from the US Nationwide Inpatient Sample [",
"       <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/7\">",
"        7",
"       </a>",
"       ]. The frequency of laparoscopic appendectomies increased from 32 to 58 percent over the study time period. The proportion of patients with uncomplicated appendicitis was significantly higher in the laparoscopic group (76 versus 69 percent).",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     <ul class=\"hyphen-block\">",
"      <li>",
"       Patients undergoing a laparoscopic appendectomy for",
"       <strong>",
"        uncomplicated",
"       </strong>",
"       (eg, unperforated, no abscess) acute appendicitis were significantly more likely to have a shorter mean hospital stay (1.5 versus 1.8 days), higher rates of intraoperative complications (OR 2.61, CI 2.23-3.05), and higher costs (22 percent) compared with patients treated by an open appendectomy.",
"      </li>",
"      <li>",
"       For patients with",
"       <strong>",
"        complicated",
"       </strong>",
"       appendicitis, defined as an appendiceal perforation or abscess, laparoscopic approach was significantly associated with a shorter mean hospital stay (3.5 versus 4.2 days), higher rates of intraoperative complications (OR 1.61, CI 1.33-1.94), and higher hospital costs (9 percent) compared to patients undergoing an open appendectomy for complicated appendicitis.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Although laparoscopic appendectomy has gained widespread acceptance, these data show that there are benefits and limitations to the laparoscopic approach. As a result, the choice of laparoscopic or open appendectomy is best decided by the surgeon based on personal experience, institutional capabilities, severity of disease, body habitus, and other factors. There are clinical settings when laparoscopy may be the preferred approach. These include:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       An uncertain diagnosis &ndash; The laparoscopic approach provides an advantage in patients in whom the diagnosis is uncertain since it permits inspection of other abdominal organs. This benefit may be greater for women of childbearing age, who traditionally have had higher negative appendectomy rates, and in whom laparoscopy may reveal other causes of pelvic pathology [",
"       <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/11-14\">",
"        11-14",
"       </a>",
"       ]. In a study of 181 women who underwent laparoscopy for suspected acute appendicitis, 86 (48 percent) were diagnosed with a gynecologic disorder as the etiology of the symptoms [",
"       <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/14\">",
"        14",
"       </a>",
"       ].",
"      </li>",
"      <li>",
"       Obese patients &ndash; Laparoscopic appendectomy is useful in the overweight or obese patient, since exposure of the right lower quadrant during open appendectomy may require larger, morbidity-prone incisions [",
"       <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/15-17\">",
"        15-17",
"       </a>",
"       ]. In a retrospective review of 13,330 obese patients undergoing a primary appendectomy for confirmed appendicitis, the laparoscopic approach (n = 10,409 patients) was associated with a 57 percent reduction in overall morbidity compared with an open appendectomy (5.23 versus 13.49 percent, odds ratio [OR] 0.43, 95% CI 0.36-0.52) [",
"       <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/17\">",
"        17",
"       </a>",
"       ]. In addition, the mortality rate was also significantly lower for the patients undergoing a laparoscopic appendectomy (0.11 versus 0.58 percent, OR 0.47, 0.32-0.65).",
"      </li>",
"      <li>",
"       Elderly patients &ndash; Elderly patients may benefit significantly from a laparoscopic approach, as hospital stay is shorter and discharge rates to home are higher in this population than with an open appendectomy. In a retrospective review based upon outcome data from the North Carolina Hospital Association Patient Data System on 29,244 appendectomies performed in adults, 2,722 were performed in elderly patients (defined as age &gt;65 years) [",
"       <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/18\">",
"        18",
"       </a>",
"       ]. Among the elderly patients, laparoscopic appendectomy had the following benefits compared with elderly patients undergoing an open appendectomy:",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     <ul class=\"hyphen-block\">",
"      <li>",
"       For",
"       <strong>",
"        uncomplicated",
"       </strong>",
"       appendicitis, laparoscopic appendectomy was associated with the following significant benefits: shorter length of hospital stay (4.6 versus 7.3 days), higher rate of discharge to home rather than a step-down facility (91 versus 79 percent), fewer complications (13 versus 22 percent), and lower mortality rate (0.4 versus 2.1 percent).",
"      </li>",
"      <li>",
"       For a",
"       <strong>",
"        perforated",
"       </strong>",
"       appendix, laparoscopic appendectomy was associated with the following significant benefits: shorter length of hospital stay (6.8 versus 9.0 days), higher rate of discharge to home (87 versus 71 percent), and equivalent mortality rates (0.37 versus 0.15 percent).",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H6573388\">",
"     <span class=\"h2\">",
"      Disease severity score",
"     </span>",
"     &nbsp;&mdash;&nbsp;A scoring system has been proposed to assist in comparing outcomes and therapeutic modalities based upon the operative findings [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/19\">",
"      19",
"     </a>",
"     ]. This scoring system of acute appendicitis includes:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Grade 1 &ndash; Inflamed",
"      </li>",
"      <li>",
"       Grade 2 &ndash; Gangrenous",
"      </li>",
"      <li>",
"       Grade 3 &mdash; Perforated with localized free fluid",
"      </li>",
"      <li>",
"       Grade 4 &ndash; Perforated with regional abscess",
"      </li>",
"      <li>",
"       Grade 5 &ndash; Perforated with diffuse peritonitis",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      PREOPERATIVE PREPARATION",
"     </span>",
"     &nbsp;&mdash;&nbsp;Patients with acute appendicitis require adequate hydration with intravenous fluids, correction of electrolyte abnormalities, and perioperative antibiotics [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/20\">",
"      20",
"     </a>",
"     ]. The patient's vital signs and urine output should be closely monitored. A Foley catheter may be required in severely dehydrated patients. However, once the decision has been made to perform an operation for acute appendicitis, the patient should proceed to the operating room with as little delay as possible to minimize the chance of progression to perforation.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h2\">",
"      Antibiotics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Prophylactic antibiotics are important for preventing wound infection and intra-abdominal abscess following appendectomy [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/20\">",
"      20",
"     </a>",
"     ]. The flora of the appendix reflects that of the colon and includes gram-negative aerobes and anaerobes. Patients should receive prophylactic antibiotics within a 60-minute \"window\" before the initial incision [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/21,22\">",
"      21,22",
"     </a>",
"     ]. The selection of antibiotics is summarized here and discussed in more detail separately. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=see_link\">",
"      \"Overview of control measures to prevent surgical site infection\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H4\">",
"     <span class=\"h3\">",
"      Acute appendicitis",
"     </span>",
"     &nbsp;&mdash;&nbsp;In patients with acute",
"     <strong>",
"      non-perforated",
"     </strong>",
"     appendicitis, a single preoperative antibiotic dose for surgical wound prophylaxis is adequate. Guidelines established by the Medical Letter and the Surgical Care Improvement Project suggest the following options for colorectal procedures: a single dose of",
"     <a class=\"drug drug_general\" href=\"UTD.htm?10/53/11094?source=see_link\">",
"      cefoxitin",
"     </a>",
"     (1 to 2 g IV),",
"     <span class=\"nowrap\">",
"      <a class=\"drug drug_general\" href=\"UTD.htm?12/51/13112?source=see_link\">",
"       ampicillin",
"      </a>",
"      /sulbactam",
"     </span>",
"     (3 g IV), the combination of",
"     <a class=\"drug drug_general\" href=\"UTD.htm?4/2/4136?source=see_link\">",
"      cefazolin",
"     </a>",
"     (1 to 2 g IV) PLUS",
"     <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"      metronidazole",
"     </a>",
"     (500 mg IV), or, in patients allergic to penicillins and cephalosporins,",
"     <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"      clindamycin",
"     </a>",
"     PLUS one of the following:",
"     <a class=\"drug drug_general\" href=\"UTD.htm?34/45/35536?source=see_link\">",
"      ciprofloxacin",
"     </a>",
"     ,",
"     <a class=\"drug drug_general\" href=\"UTD.htm?32/46/33504?source=see_link\">",
"      levofloxacin",
"     </a>",
"     ,",
"     <a class=\"drug drug_general\" href=\"UTD.htm?35/10/36000?source=see_link\">",
"      gentamicin",
"     </a>",
"     , or",
"     <a class=\"drug drug_general\" href=\"UTD.htm?42/25/43414?source=see_link\">",
"      aztreonam",
"     </a>",
"     (",
"     <a class=\"graphic graphic_table graphicRef65369 \" href=\"UTD.htm?23/52/24397\">",
"      table 1",
"     </a>",
"     ) [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/23,24\">",
"      23,24",
"     </a>",
"     ]. Postoperative antibiotics are unnecessary [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/25\">",
"      25",
"     </a>",
"     ]. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=see_link\">",
"      \"Overview of control measures to prevent surgical site infection\"",
"     </a>",
"     .) &nbsp;",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H5\">",
"     <span class=\"h3\">",
"      Perforated appendicitis",
"     </span>",
"     &nbsp;&mdash;&nbsp;In patients with perforated appendicitis, the antibiotic regimen should consist of empiric broad-spectrum therapy with activity against gram-negative rods and anaerobic organisms pending culture results [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/26,27\">",
"      26,27",
"     </a>",
"     ]. As initial choice of an antibiotic, we suggest either monotherapy with a",
"     <span class=\"nowrap\">",
"      beta-lactam/beta-lactamase",
"     </span>",
"     inhibitor (",
"     <a class=\"drug drug_general\" href=\"UTD.htm?23/41/24216?source=see_link\">",
"      piperacillin-tazobactam",
"     </a>",
"     or",
"     <a class=\"drug drug_general\" href=\"UTD.htm?41/45/42710?source=see_link\">",
"      ticarcillin-clavulanate",
"     </a>",
"     )&nbsp;or the combination of a third-generation cephalosporin PLUS",
"     <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"      metronidazole",
"     </a>",
"     (eg,",
"     <a class=\"drug drug_general\" href=\"UTD.htm?10/17/10521?source=see_link\">",
"      ceftriaxone",
"     </a>",
"     plus metronidazole). Alternative regimens are shown in a table (",
"     <a class=\"graphic graphic_table graphicRef67894 \" href=\"UTD.htm?7/21/7517\">",
"      table 2",
"     </a>",
"     ).",
"    </p>",
"    <p>",
"     Regardless of the initial empiric regimen, the therapeutic regimen should be revisited once culture and susceptibility results are available. Recovery of more than one organism should suggest polymicrobial infection including anaerobes, even if no anaerobes are isolated in culture. In such circumstances, anaerobic coverage should be continued. Combination therapy with a second or third generation cephalosporin or a fluoroquinolone plus",
"     <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"      metronidazole",
"     </a>",
"     is adequate for most patients. Antibiotics should be continued until no clinical evidence of infection exists, typically 5 to 7 days [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/28-30\">",
"      28-30",
"     </a>",
"     ].",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H8\">",
"     <span class=\"h1\">",
"      LAPAROSCOPIC APPENDECTOMY",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H9\">",
"     <span class=\"h2\">",
"      Patient preparation",
"     </span>",
"     &nbsp;&mdash;&nbsp;In the laparoscopic approach, an orogastric tube is typically placed to decompress the stomach. The bladder can be decompressed either with a Foley catheter, or by having the patient void immediately prior to entering the operating room.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H10\">",
"     <span class=\"h2\">",
"      Patient positioning",
"     </span>",
"     &nbsp;&mdash;&nbsp;The patient is positioned supine on the operating room table with the left arm tucked. The video monitor is placed at the patient's right side, because once pneumoperitoneum is performed, the surgeon and assistant both stand on the patient's left.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H11\">",
"     <span class=\"h2\">",
"      Port placement",
"     </span>",
"     &nbsp;&mdash;&nbsp;Various port placements have been advocated for laparoscopic appendectomy. These methods share the principle of triangulation of instrument ports and the appendix to ensure adequate visualization and exposure. In one method, pneumoperitoneum is obtained through a 12 mm periumbilical port, through which the laparoscope is inserted and exploratory laparoscopy performed. The other two ports are placed under direct vision: a 5 mm port in the left lower quadrant and a 5 mm suprapubic port in the midline. If a 5 mm laparoscope is used, it can be placed through the left lower quadrant trocar, and the umbilical 12 mm trocar can be used for a stapler. Most staplers require a 12 mm port (",
"     <a class=\"graphic graphic_figure graphicRef78264 \" href=\"UTD.htm?41/26/42403\">",
"      figure 1",
"     </a>",
"     ).",
"    </p>",
"    <p>",
"     When the appendix is located in the retrocecal position, good triangulation of instruments can also be achieved with a 12 mm port placed in the upper midline. This port allows instruments or the laparoscope to be positioned for access to the gutter between the right colon and the abdominal wall. If the suspicion for open conversion is high, all midline incisions should be oriented vertically so they can easily be incorporated into a lower midline incision.",
"    </p>",
"    <p>",
"     An alternative abdominal access method to triangulation of instrument ports is the umbilical single-incision appendectomy [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/31\">",
"      31",
"     </a>",
"     ]. Large, prospective studies are needed to determine if any clinical advantage exists with this approach.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H12\">",
"     <span class=\"h2\">",
"      Mobilization and resection",
"     </span>",
"     &nbsp;&mdash;&nbsp;Once the diseased appendix is identified, any adhesions to surrounding structures can be lysed with a combination of blunt and sharp dissection. If a retrocecal appendix is encountered, division of the lateral peritoneal attachments of the cecum to the abdominal wall often improves visualization. Care must be taken to avoid underlying retroperitoneal structures, specifically the right ureter and iliac vessels.",
"    </p>",
"    <p>",
"     The appendix or mesoappendix can be gently grasped with a Babcock clamp and retracted anteriorly. The appendiceal artery is identified and divided between hemostatic clips, ultrasonic scalpel, a laparoscopic gastrointestinal anastomosis (GIA) stapler or other vessel ligation device. The appendix is cleared to its attachment with the cecum, and the appendiceal base is divided using a laparoscopic gastrointestinal anastomosis stapler (GIA) stapler, taking care not to leave a significant stump [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/32\">",
"      32",
"     </a>",
"     ]. It is sometimes necessary to include part of the cecum within the stapler to ensure that the staples are placed in healthy, uninfected tissue.",
"    </p>",
"    <p>",
"     The appendix is then removed through the umbilical port, using a specimen bag to avoid the risk of wound infection.",
"    </p>",
"    <p>",
"     The operative field is inspected for hemostasis and irrigated with saline if needed and then the fascial defect and skin incisions are closed.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H13\">",
"     <span class=\"h1\">",
"      OPEN APPENDECTOMY",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H14\">",
"     <span class=\"h2\">",
"      Incision",
"     </span>",
"     &nbsp;&mdash;&nbsp;The patient should be reexamined after the induction of general anesthesia, as this allows deep palpation of the abdomen. If a mass representing the inflamed appendix can be palpated, the incision can be located over the mass. If no appendiceal mass is detected, the incision should be centered over McBurney's point, one-third of the distance from the anterior superior iliac spine to the umbilicus [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/33\">",
"      33",
"     </a>",
"     ]. A curvilinear incision in a skin fold allows for an excellent cosmetic result.",
"    </p>",
"    <p>",
"     It is important not to make the incision too medial or too lateral. An incision placed too medial opens onto the anterior rectus sheath, rather than the desired oblique muscles, while an incision placed too lateral may be lateral to the abdominal cavity. Some surgeons prefer a transverse incision, however, because it is easily extended to increased exposure if needed (",
"     <a class=\"graphic graphic_figure graphicRef53185 \" href=\"UTD.htm?41/11/42166\">",
"      figure 2",
"     </a>",
"     ).",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H15\">",
"     <span class=\"h2\">",
"      Mobilization and resection",
"     </span>",
"     &nbsp;&mdash;&nbsp;The dissection begins through the subcutaneous tissue to the external oblique fascia, which is sharply incised lateral to the rectus sheath. Using a muscle-splitting technique, the external oblique is bluntly separated in the direction of the muscle fibers; the internal oblique and transversus abdominus muscles are bluntly separated in a similar fashion. The peritoneum is sharply entered, avoiding injury to the underlying intestine.",
"    </p>",
"    <p>",
"     The surgeon can often locate the appendix by sweeping a finger laterally to medially in the right paracolic gutter. Thin adhesions between the appendix and surrounding structures may generally be freed with blunt dissection; occasionally, sharp dissection is required for more dense adhesions. If the appendix cannot be identified through palpation, it can be located by following the teniae coli to its origin at the cecal base.",
"    </p>",
"    <p>",
"     Once identified and freed from adhesions, the appendix is delivered through the incision. The mesoappendix may be grasped with a Babcock clamp, taking care not to tear the appendiceal wall and cause spillage of enteric contents. The appendiceal artery, which runs in the mesoappendix, is divided between hemostats and tied with 3-0 absorbable suture.",
"    </p>",
"    <p>",
"     A non-absorbable purse-string suture is placed in the cecal wall around the appendix. After crushing the appendiceal base with a Kelly clamp, the appendix is doubly tied with 2-0 absorbable suture. The appendix is excised with a scalpel, and the remaining stump is cauterized to prevent a mucocele. The appendiceal stump is typically inverted into the cecum while the purse-string suture is tightened, although the usefulness of this is debatable [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/34-38\">",
"      34-38",
"     </a>",
"     ].The surgical bed is then irrigated with saline.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H16\">",
"     <span class=\"h2\">",
"      Closure",
"     </span>",
"     &nbsp;&mdash;&nbsp;The incision is closed in layers with running 2-0 absorbable suture, beginning with the peritoneum, followed by the transversus abdominus, internal oblique, and external oblique. Irrigation is performed at each layer. To improve analgesia and limit post-operative narcotic requirements, the external oblique fascia may be infused with local anesthetic. Scarpa's fascia is closed with interrupted 3-0 absorbable suture, followed by a subcuticular closure or staples for the skin. In nonperforated appendicitis, the skin may be closed primarily with a low likelihood of wound infection.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H17\">",
"     <span class=\"h2\">",
"      Postoperative management",
"     </span>",
"     &nbsp;&mdash;&nbsp;With both the open and laparoscopic approaches, most patients are discharged within 24 to 48 hours of surgery. Patients may be started on a clear liquid diet post-operatively and advanced to regular diet as tolerated. Antibiotics are not required postoperatively in nonperforated appendicitis.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H18\">",
"     <span class=\"h1\">",
"      PERFORATED APPENDICITIS",
"     </span>",
"     &nbsp;&mdash;&nbsp;The time course of progression of appendicitis to necrosis and perforation varies among patients. Approximately 20 percent of patients with perforated appendicitis present within 24 hours of the onset of symptoms [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/39\">",
"      39",
"     </a>",
"     ]. Although perforation is a major concern when evaluating a patient with more than 24 hours of symptoms, perforation can develop more rapidly and should always be considered.",
"    </p>",
"    <p>",
"     Patients with perforated appendicitis may appear acutely ill and have significant dehydration and electrolyte abnormalities, particularly if fever and vomiting have been present for a considerable time. The pain usually localizes to the right lower quadrant if the perforation has been walled off by surrounding intra-abdominal structures such as the omentum, or can be diffuse if generalized peritonitis ensues.",
"    </p>",
"    <p>",
"     Other unusual presentations of appendiceal perforation can occur, such as retroperitoneal abscess formation due to perforation of a retrocecal appendix or liver abscess formation due to hematogenous spread of infection through the portal venous system. An enterocutaneous fistula can result from an intraperitoneal abscess that fistulizes to the skin. Appendiceal perforation can result in a small bowel obstruction, manifested by bilious vomiting and obstipation. High fevers and jaundice can be seen with pylephlebitis (septic portal vein thrombosis) and can be confused with cholangitis.",
"    </p>",
"    <p>",
"     The management of appendiceal perforation will depend on the nature of the perforation. A free perforation can cause intraperitoneal dissemination of pus and fecal material. Urgent laparotomy is necessary for free perforation with appendectomy and irrigation and drainage of the peritoneal cavity. These patients are typically quite ill and may be septic. The diagnosis is not always appreciated before exploration and a midline incision is prudent. If the diagnosis of perforated appendicitis is certain, a right lower quadrant incision can be used.",
"    </p>",
"    <p>",
"     For management of a contained perforation, nonoperative treatment is an option. (See",
"     <a class=\"local\" href=\"#H23\">",
"      'Nonoperative approach'",
"     </a>",
"     below.) Treatment should be individualized for each patient, based on the clinical situation and the hospital's capabilities.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H19\">",
"     <span class=\"h2\">",
"      Incision",
"     </span>",
"     &nbsp;&mdash;&nbsp;Operative technique is similar in appendectomies for perforated or nonperforated appendicitis. In an open appendectomy for perforation, a larger incision may be needed to provide adequate exposure for drainage of abscesses, enteric contents, and purulent material. In some instances, a lower midline incision is preferable to a right lower quadrant incision. In both open and laparoscopic approaches, the goal is to remove any infected material and drain all abscess cavities. Copious irrigation is used to reduce the likelihood of post-operative abscess formation. Once the appendix and infected material have been removed, the muscle layers of the open incision are closed as previously described.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H20\">",
"     <span class=\"h2\">",
"      Drains",
"     </span>",
"     &nbsp;&mdash;&nbsp;Peritoneal drains are not necessary, as they do not reduce the incidence of wound infection or abscess after appendectomy for perforated appendicitis [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/40,41\">",
"      40,41",
"     </a>",
"     ]",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H21\">",
"     <span class=\"h2\">",
"      Closure",
"     </span>",
"     &nbsp;&mdash;&nbsp;Skin closure techniques include primary closure, loose partial closure, and closure with secondary intention. Because of wound infection rates ranging from 30-50 percent with primary closure of grossly contaminated wounds, many advocate delayed primary or secondary closure [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/42,43\">",
"      42,43",
"     </a>",
"     ]. However, a cost-utility analysis of contaminated appendectomy wounds showed primary closure to be the most cost-effective method of wound management [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/44\">",
"      44",
"     </a>",
"     ].",
"    </p>",
"    <p>",
"     Our technique of skin closure is interrupted permanent sutures or staples every 2 cm with loose wound packing in between. Removal of the packing in 48 hours often leaves an excellent cosmetic result with an acceptable incidence of wound infection. If heavy fecal contamination is present, the skin is often left open to close secondarily.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H22\">",
"     <span class=\"h2\">",
"      Postoperative management",
"     </span>",
"     &nbsp;&mdash;&nbsp;Post-operatively, these patients often have an ileus, and diet should only be advanced as the clinical situation warrants. Patients may be discharged once they tolerate a regular diet, usually in five to seven days. To reduce costs, a peripherally inserted central catheter (PICC line) enables intravenous antibiotics to be administered as an outpatient. (See",
"     <a class=\"local\" href=\"#H3\">",
"      'Antibiotics'",
"     </a>",
"     above.)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H23\">",
"     <span class=\"h2\">",
"      Nonoperative approach",
"     </span>",
"     &nbsp;&mdash;&nbsp;Patients who present 24 to 72 hours after the onset of symptoms usually undergo immediate appendectomy. In contrast, patients who present with a longer duration of symptoms (more than five days) and have findings localized to the right lower quadrant should be treated initially with antibiotics, intravenous fluids, and bowel rest. These patients will often have a palpable mass on physical examination; a computed tomography (CT) scan may reveal a phlegmon or abscess. Fortunately, many of these patients will respond to nonoperative management since the appendiceal process has already been \"walled-off\".",
"    </p>",
"    <p>",
"     Immediate surgery in patients with a long duration of symptoms and phlegmon formation is associated with increased morbidity, due to dense adhesions and inflammation. Under these circumstances, appendectomy often requires extensive dissection and may lead to injury of adjacent structures. Complications such as a postoperative abscess, or enterocutaneous fistula may ensue, necessitating an ileocolectomy or cecostomy. Because of these potential complications, a nonoperative approach can be considered if the patient is not ill-appearing [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/45-48\">",
"      45-48",
"     </a>",
"     ].",
"    </p>",
"    <p>",
"     If imaging studies demonstrate an abscess cavity, CT-or ultrasound-guided drainage can often be performed percutaneously or transrectally [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/48-50\">",
"      48-50",
"     </a>",
"     ]. Studies suggest that this approach to appendiceal abscesses results in fewer complications and shorter overall length of stay [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/47,51,52\">",
"      47,51,52",
"     </a>",
"     ]. Percutaneous drainage, generally with CT guidance, is a temporizing treatment option for perforated appendicitis. Patients who are clinically healthy but have a well-circumscribed abscess, or those who appear too sick to withstand an operation, are ideally suited to undergo percutaneous drainage. This allows inflammation to subside, sometimes negating the need for extended bowel resection, such as ileocecectomy.",
"    </p>",
"    <p>",
"     Nonoperative management includes intravenous antibiotics and fluids as well as bowel rest. Patients should be closely monitored in the hospital during this time. Treatment failure, as evidenced by bowel obstruction, sepsis, or persistent pain, fever, or leukocytosis, requires immediate appendectomy. If fever, tenderness, and leukocytosis improve, diet can be slowly advanced, usually within three to five days. Patients are discharged home when clinical parameters have normalized.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H24\">",
"     <span class=\"h2\">",
"      Interval appendectomy",
"     </span>",
"     &nbsp;&mdash;&nbsp;Using the initial nonoperative approach outlined above, more than 80 percent of patients who present with a \"walled-off\" appendiceal process can be spared an appendectomy at the time of initial presentation. Traditionally, an interval appendectomy has been recommended for these patients six to eight weeks after presentation for two primary reasons [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/53\">",
"      53",
"     </a>",
"     ]:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       To prevent recurrence of appendicitis [",
"       <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/54,55\">",
"        54,55",
"       </a>",
"       ].",
"      </li>",
"      <li>",
"       To exclude neoplasms (such as carcinoid, adenocarcinoma, mucinous cystadenoma, and cystadenocarcinomas) [",
"       <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/56,57\">",
"        56,57",
"       </a>",
"       ]. Older patients should have a colonoscopy or",
"       <a class=\"drug drug_general\" href=\"UTD.htm?12/17/12564?source=see_link\">",
"        barium",
"       </a>",
"       enema to rule out cecal pathology. (See",
"       <a class=\"medical medical_review\" href=\"UTD.htm?35/14/36074?source=see_link\">",
"        \"Cancer of the appendix and pseudomyxoma peritonei\"",
"       </a>",
"       .)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     The need for interval appendectomy is debated, with some studies suggesting that interval appendectomy is unnecessary [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/58,59\">",
"      58,59",
"     </a>",
"     ]. In a retrospective review of 1012 patients treated nonoperatively for acute appendicitis, 864 patients did not undergo an interval appendectomy [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/59\">",
"      59",
"     </a>",
"     ]. Of those 864 patients, 39 (4.5 percent) required an appendectomy at a median follow-up of four years. A meta-analysis of 61 observational studies in which an appendiceal abscess or phlegmon was present in 3.8 percent of patients with appendicitis found that immediate surgery was associated with higher morbidity than nonsurgical treatment [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/58\">",
"      58",
"     </a>",
"     ]. After successful nonsurgical treatment, a malignant disease was detected in 1.2 percent of cases and an important benign disease in 0.7 percent. Recurrent appendicitis developed in 7.4 percent of cases (95% CI 3.7-11.1).",
"    </p>",
"    <p>",
"     For these reasons, it is our practice is to recommend interval appendectomy for most adult patients. Colonoscopy should be considered prior to appendectomy in patients over 50 who have not had a recent colonoscopy.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H25\">",
"     <span class=\"h1\">",
"      COMPLICATIONS",
"     </span>",
"     &nbsp;&mdash;&nbsp;The most common complication following appendectomy is infection (either a simple wound infection or an intraabdominal abscess). Both occur typically in patients with perforated appendicitis; they are very rare in those with simple appendicitis. Thorough irrigation and broad spectrum antibiotics are used to minimize the incidence of post-operative infections. The practice of delayed primary closure has not been established to be beneficial [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/60\">",
"      60",
"     </a>",
"     ]. Thus, we recommend primary closure of the wound following open appendectomy.",
"    </p>",
"    <p>",
"     The rate of surgical site infections for a laparoscopic appendectomy compared with an open appendectomy was evaluated in a retrospective review of 39,950 patients identified from the American College of Surgeons National Surgical Quality Improvement Program database [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/61\">",
"      61",
"     </a>",
"     ].",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Incisional infections &ndash; Patients undergoing a laparoscopic appendectomy (n = 30,575) had significantly fewer incisional infections (1.7 versus 5.2 percent) compared with patients undergoing an open appendectomy (n = 9375). The protective effect of a laparoscopic appendectomy was greatest for patients with Class IV wounds (n = 8652, OR 3.03, 95% CI 2.44-3.85) but was also significant for patients with wound class II and II (n = 31,298, OR 2.44, 95% CI 2.04-2.94) (",
"       <a class=\"graphic graphic_table graphicRef51272 \" href=\"UTD.htm?0/55/892\">",
"        table 3",
"       </a>",
"       ).",
"      </li>",
"      <li>",
"       Organ space infections &ndash; In contrast, a multivariate analysis found that patients undergoing a laparoscopic appendectomy were significantly more likely to have an organ space infection (OR 1.44, 95% CI 1.21-1.73). The deleterious association was reported for wound class II or III (OR 1.67, 95% CI 1.18-2.46) and wound class IV (OR 1.36, 95% CI 1.11-1.68) (",
"       <a class=\"graphic graphic_table graphicRef51272 \" href=\"UTD.htm?0/55/892\">",
"        table 3",
"       </a>",
"       ).",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     An uncommon complication is pylephlebitis, which refers to thrombosis and infection within the portal venous system. It can occur following any intraabdominal infection. This complication has become exceedingly rare in the modern era of antibiotics, but should be considered in patients with fever and abnormal liver function tests. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/30/33254?source=see_link\">",
"      \"Pylephlebitis\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H26\">",
"     <span class=\"h1\">",
"      SPECIAL CONSIDERATIONS",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H27\">",
"     <span class=\"h2\">",
"      Normal appendix",
"     </span>",
"     &nbsp;&mdash;&nbsp;The diagnosis of appendicitis can be uncertain. In some historical studies, more than 15 percent of patients with suspected appendicitis have a normal appendix at laparotomy, with higher percentages in infants, the elderly and young women [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/62\">",
"      62",
"     </a>",
"     ]. However, the use of imaging studies appears to have reduced the negative appendectomy rate to less than 10 percent [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/2\">",
"      2",
"     </a>",
"     ].",
"    </p>",
"    <p>",
"     If an uninflamed appendix is encountered at appendectomy, it is important to search for other causes of the patient's symptoms, including terminal ileitis, cecal or sigmoid diverticulitis or a perforating colon carcinoma, Meckel's diverticulitis, mesenteric adenitis, or uterine, fallopian, or ovarian pathology in a female. If necessary, the right lower quadrant incision may be extended medially to afford exposure to left-sided pelvic organs.",
"    </p>",
"    <p>",
"     Even if the appendix appears normal, early intramural or serosal inflammatory changes can sometimes be found in subsequent microscopic evaluation [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/63,64\">",
"      63,64",
"     </a>",
"     ]. Accordingly, the normal appearing appendix should be removed. Moreover, if right lower quadrant pain recurs, appendicitis can be excluded from the differential diagnosis [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/65-67\">",
"      65-67",
"     </a>",
"     ].",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H28\">",
"     <span class=\"h2\">",
"      Elderly patients",
"     </span>",
"     &nbsp;&mdash;&nbsp;One in every 2000 adults over age 65 will develop appendicitis annually, making appendicitis an important cause of abdominal pain in this age group. The elderly tend to have a diminished inflammatory response, resulting in a less remarkable history and physical examination [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/68\">",
"      68",
"     </a>",
"     ]. For these reasons, older patients often delay seeking medical care and as a result, they have a considerably higher rate of perforation at the time of presentation [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/69,70\">",
"      69,70",
"     </a>",
"     ]. These patients may have cardiac, pulmonary, and renal conditions with resulting morbidity and mortality from perforation. In one series, the mortality from perforated appendicitis in patients over age 80 was 21 percent [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/71\">",
"      71",
"     </a>",
"     ]. In addition, diverticulitis and colonic neoplasms are more common in this age group and can mimic appendicitis. Elderly patients can also have a redundant sigmoid colon that can cause right-sided pain from sigmoid disease. Accordingly, prompt CT scanning can improve diagnostic accuracy in this population [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/72\">",
"      72",
"     </a>",
"     ].",
"    </p>",
"    <p>",
"     Laparoscopic appendectomy can be used successfully in the elderly population and results in shorter hospitalization for older patients with both perforated and nonperforated appendicitis [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/18,73\">",
"      18,73",
"     </a>",
"     ]. A study of 2722 appendectomies in patients over 65 years of age demonstrated a significantly shorter length of stay (4.6 versus 7.3 days) and a higher rate of discharge to home (91.4 versus 78.9 percent), fewer complications (13.0 versus 22.4 percent), and a lower mortality rate (0.4 versus 2.1 percent) than with open operation [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/18\">",
"      18",
"     </a>",
"     ]. It is notable that this study showed fewer complications with laparoscopic appendectomy than open operation, which differs from other large population based studies [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/6,7\">",
"      6,7",
"     </a>",
"     ].",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H29\">",
"     <span class=\"h2\">",
"      Immunocompromised patients",
"     </span>",
"     &nbsp;&mdash;&nbsp;Immunocompromised patients are increasingly common in surgical practice and include organ transplant patients and those receiving immunosuppressive therapy for autoimmune diseases, cancer and AIDS. Although certain causes of abdominal pain are specific to the immunocompromised state, appendicitis remains a concern [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/74,75\">",
"      74,75",
"     </a>",
"     ]. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/29/42456?source=see_link\">",
"      \"Surgical issues in HIV infection\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     The immunocompromised are susceptible to infection, and their immune response is blunted due to immunosuppressive medication or disease. As a result, they may not exhibit the typical signs and symptoms of appendicitis, and may have only mild tenderness on examination. In addition, laboratory and radiological tests may not show the expected level of inflammation. An expanded differential diagnosis includes but is not limited to opportunistic (mycobacterial) and viral (cytomegalovirus) infections, fungal infections, secondary malignancies (lymphoma and Kaposi's sarcoma), and typhlitis. Because of the broad differential diagnoses, there is often delay in reaching a diagnosis and presentation to surgical evaluation, which can increase the risk of perforation [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/74,76\">",
"      74,76",
"     </a>",
"     ].",
"    </p>",
"    <p>",
"     CT is particularly useful in this patient population, as it may not only diagnose appendicitis, but may eliminate or diagnose other potential causes for the patient's symptoms. If appendicitis is strongly suspected, operation should not be delayed, as there is no specific contraindication to operation in immunocompromised patients.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H30\">",
"     <span class=\"h2\">",
"      Children",
"     </span>",
"     &nbsp;&mdash;&nbsp;Appendicitis in children is discussed in detail separately. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/61/19416?source=see_link\">",
"      \"Acute appendicitis in children: Diagnostic imaging\"",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/3/32826?source=see_link\">",
"      \"Acute appendicitis in children: Clinical manifestations and diagnosis\"",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/2/31785?source=see_link\">",
"      \"Acute appendicitis in children: Management\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H31\">",
"     <span class=\"h2\">",
"      Pregnancy",
"     </span>",
"     &nbsp;&mdash;&nbsp;Pregnancy poses unique challenges in the diagnosis of appendicitis. Acute appendicitis in pregnancy is discussed in detail separately. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/34/42536?source=see_link\">",
"      \"Acute appendicitis in pregnancy\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H32\">",
"     <span class=\"h2\">",
"      Appendiceal neoplasms",
"     </span>",
"     &nbsp;&mdash;&nbsp;Neoplasms of the appendix are rare, occurring in less than one percent of appendectomies. Patients may present with symptoms of appendicitis, a palpable mass, intussusception, urologic symptoms, or an incidentally discovered mass on abdominal imaging or at laparotomy for another purpose. It is not uncommon for patients with an appendiceal neoplasm to have acute appendicitis as well [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/77\">",
"      77",
"     </a>",
"     ]. Typically, the diagnosis is not appreciated until laparotomy or pathologic evaluation of the appendectomy specimen. The most common appendiceal tumors include cystic neoplasms, carcinoid tumors, adenocarcinoma, and metastases. Other tumors have been reported but are extremely rare, such as lymphoma, stromal tumors (leiomyoma and leiomyosarcoma), and Kaposi's sarcoma [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/57\">",
"      57",
"     </a>",
"     ].",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H33\">",
"     <span class=\"h3\">",
"      Primary adenocarcinoma of the appendix",
"     </span>",
"     &nbsp;&mdash;&nbsp;Standard treatment is right hemicolectomy and reoperation is recommended if the diagnosis is made on pathologic evaluation of an appendectomy specimen. This is discussed in detail elsewhere. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/14/36074?source=see_link\">",
"      \"Cancer of the appendix and pseudomyxoma peritonei\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H34\">",
"     <span class=\"h3\">",
"      Cystic neoplasms and pseudomyxoma peritonei",
"     </span>",
"     &nbsp;&mdash;&nbsp;Sometimes referred to as mucoceles, mucinous neoplasms of the appendix include a spectrum of diseases including simple cyst, mucinous cystadenoma, mucinous cystadenocarcinoma, and pseudomyxoma peritonei. If there is any preoperative suspicion of an appendiceal tumor, care must be taken to avoid spillage of mucin-secreting cells throughout the abdomen. These tumors are discussed in detail elsewhere. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/14/36074?source=see_link\">",
"      \"Cancer of the appendix and pseudomyxoma peritonei\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H35\">",
"     <span class=\"h3\">",
"      Carcinoid tumor of the appendix",
"     </span>",
"     &nbsp;&mdash;&nbsp;As noted above, appendicitis can uncommonly be caused by a carcinoid that obstructs the appendiceal lumen. Simple appendectomy is sufficient in most cases of appendiceal carcinoid while right hemicolectomy is indicated if the tumor is &gt;2 cm in diameter or if the adjacent mesenteric nodes are involved. Management of carcinoid tumors is discussed elsewhere in detail. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/14/36074?source=see_link\">",
"      \"Cancer of the appendix and pseudomyxoma peritonei\"",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/60/969?source=see_link\">",
"      \"Clinical characteristics of carcinoid tumors\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H36\">",
"     <span class=\"h2\">",
"      Chronic appendicitis",
"     </span>",
"     &nbsp;&mdash;&nbsp;Chronic appendicitis refers to the pathologic finding of chronic inflammation or fibrosis of the appendix found in a subset of patients undergoing appendectomy [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/78,79\">",
"      78,79",
"     </a>",
"     ]. These patients are clinically characterized by prolonged (&gt;7 days) right lower quadrant pain that may be intermittent and a normal white blood cell count. Most patients have resolution of pain with appendectomy. Chronic appendicitis may be present in 14 to 30 percent of adults undergoing appendectomy [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/78,79\">",
"      78,79",
"     </a>",
"     ] but is much rarer in children.",
"    </p>",
"    <p>",
"     Recurrent appendicitis can occur but is also rare in children; such cases may be caused by a carcinoid tumor or a retained foreign body (eg, fecalith) in the lumen of the appendix [",
"     <a class=\"abstract\" href=\"UTD.htm?5/7/5242/abstract/80\">",
"      80",
"     </a>",
"     ]. Stump appendicitis is a form of recurrent appendicitis that is related to incomplete appendectomy that leaves an excessively long stump after open or laparoscopic surgery. (See",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/2/31785?source=see_link&amp;anchor=H29#H29\">",
"      \"Acute appendicitis in children: Management\", section on 'Late'",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"     <span class=\"h1\">",
"      INFORMATION FOR PATIENTS",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"     <sup>",
"      th",
"     </sup>",
"     to 6",
"     <sup>",
"      th",
"     </sup>",
"     grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"     <sup>",
"      th",
"     </sup>",
"     to 12",
"     <sup>",
"      th",
"     </sup>",
"     grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Basics topics (see",
"       <a class=\"medical medical_basics\" href=\"UTD.htm?35/18/36129?source=see_link\">",
"        \"Patient information: Appendicitis in adults (The Basics)\"",
"       </a>",
"       )",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H770943\">",
"     <span class=\"h1\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </span>",
"     &nbsp;&mdash;&nbsp;Surgery remains the gold standard for the treatment of appendicitis.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       The preoperative preparation for appendectomy includes intravenous hydration, correction of electrolyte abnormalities, and perioperative antibiotics. (See",
"       <a class=\"local\" href=\"#H2\">",
"        'Preoperative preparation'",
"       </a>",
"       above.)",
"      </li>",
"      <li>",
"       Both open and laparoscopic approaches to appendectomy are appropriate for all patients. Patients treated with a laparoscopic appendectomy have significantly fewer wound infections, less pain, and a shorter duration of hospital stay, but higher rates of readmission, intra-abdominal abscess formation, and higher hospital costs. (See",
"       <a class=\"local\" href=\"#H9259945\">",
"        'Surgical outcomes'",
"       </a>",
"       above.)",
"      </li>",
"      <li>",
"       An appendectomy rather than medical management with antibiotics alone is the gold standard for patients with a history and clinical findings, and radiographic images, consistent with appendicitis. Although some patients do well with antibiotic therapy alone, they are at risk of recurrent appendicitis. (See",
"       <a class=\"local\" href=\"#H26003216\">",
"        'Outcomes with medical therapy'",
"       </a>",
"       above.)",
"      </li>",
"      <li>",
"       A temporizing nonoperative approach with antibiotics, hydration, bowel rest, and percutaneous image guided abscess drainage is used as needed for patients with over five days of symptoms and an imaging study that reveals the formation of a phlegmon or an abscess. (See",
"       <a class=\"local\" href=\"#H23\">",
"        'Nonoperative approach'",
"       </a>",
"       above.)",
"      </li>",
"      <li>",
"       Following a temporizing, nonoperative management for appendiceal abscess or phlegmon, an elective appendectomy is performed for most patients, typically six to eight weeks following initial presentation. (See",
"       <a class=\"local\" href=\"#H24\">",
"        'Interval appendectomy'",
"       </a>",
"       above.)",
"      </li>",
"      <li>",
"       If a normal appearing appendix is identified during surgical exploration for right lower abdominal pain, an appendectomy should be performed. It is important to search for other causes of the patient's symptoms, including terminal ileitis, cecal or sigmoid diverticulitis or a perforating colon carcinoma, Meckel's diverticulitis, mesenteric adenitis, or uterine, fallopian, or ovarian pathology in a female. (See",
"       <a class=\"local\" href=\"#H27\">",
"        'Normal appendix'",
"       </a>",
"       above.)",
"      </li>",
"     </ul>",
"    </p>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/1\">",
"      Pittman-Waller VA, Myers JG, Stewart RM, et al. Appendicitis: why so complicated? Analysis of 5755 consecutive appendectomies. Am Surg 2000; 66:548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/2\">",
"      SCOAP Collaborative, Cuschieri J, Florence M, et al. Negative appendectomy and imaging accuracy in the Washington State Surgical Care and Outcomes Assessment Program. Ann Surg 2008; 248:557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/3\">",
"      Vons C, Barry C, Maitre S, et al. Amoxicillin plus clavulanic acid versus appendicectomy for treatment of acute uncomplicated appendicitis: an open-label, non-inferiority, randomised controlled trial. Lancet 2011; 377:1573.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/4\">",
"      Varadhan KK, Humes DJ, Neal KR, Lobo DN. Antibiotic therapy versus appendectomy for acute appendicitis: a meta-analysis. World J Surg 2010; 34:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/5\">",
"      Stengel JW, Webb EM, Poder L, et al. Acute appendicitis: clinical outcome in patients with an initial false-positive CT diagnosis. Radiology 2010; 256:119.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/6\">",
"      Faiz O, Clark J, Brown T, et al. Traditional and laparoscopic appendectomy in adults: outcomes in English NHS hospitals between 1996 and 2006. Ann Surg 2008; 248:800.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/7\">",
"      Sporn E, Petroski GF, Mancini GJ, et al. Laparoscopic appendectomy--is it worth the cost? Trend analysis in the US from 2000 to 2005. J Am Coll Surg 2009; 208:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/8\">",
"      Nguyen NT, Zainabadi K, Mavandadi S, et al. Trends in utilization and outcomes of laparoscopic versus open appendectomy. Am J Surg 2004; 188:813.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/9\">",
"      Br&uuml;gger L, Rosella L, Candinas D, G&uuml;ller U. Improving outcomes after laparoscopic appendectomy: a population-based, 12-year trend analysis of 7446 patients. Ann Surg 2011; 253:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/10\">",
"      Sauerland S, Jaschinski T, Neugebauer EA. Laparoscopic versus open surgery for suspected appendicitis. Cochrane Database Syst Rev 2010; :CD001546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/11\">",
"      McCahill LE, Pellegrini CA, Wiggins T, Helton WS. A clinical outcome and cost analysis of laparoscopic versus open appendectomy. Am J Surg 1996; 171:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/12\">",
"      Andersson RE, Hugander A, Thulin AJ. Diagnostic accuracy and perforation rate in appendicitis: association with age and sex of the patient and with appendicectomy rate. Eur J Surg 1992; 158:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/13\">",
"      K&ouml;rner H, S&ouml;ndenaa K, S&ouml;reide JA, et al. Incidence of acute nonperforated and perforated appendicitis: age-specific and sex-specific analysis. World J Surg 1997; 21:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/14\">",
"      Moberg AC, Ahlberg G, Leijonmarck CE, et al. Diagnostic laparoscopy in 1043 patients with suspected acute appendicitis. Eur J Surg 1998; 164:833.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/15\">",
"      Enochsson L, Hellberg A, Rudberg C, et al. Laparoscopic vs open appendectomy in overweight patients. Surg Endosc 2001; 15:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/16\">",
"      Golub R, Siddiqui F, Pohl D. Laparoscopic versus open appendectomy: a metaanalysis. J Am Coll Surg 1998; 186:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/17\">",
"      Mason RJ, Moazzez A, Moroney JR, Katkhouda N. Laparoscopic vs open appendectomy in obese patients: outcomes using the American College of Surgeons National Surgical Quality Improvement Program database. J Am Coll Surg 2012; 215:88.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/18\">",
"      Harrell AG, Lincourt AE, Novitsky YW, et al. Advantages of laparoscopic appendectomy in the elderly. Am Surg 2006; 72:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/19\">",
"      Garst GC, Moore EE, Banerjee MN, et al. Acute appendicitis: a disease severity score for the acute care surgeon. J Trauma Acute Care Surg 2013; 74:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/20\">",
"      Andersen BR, Kallehave FL, Andersen HK. Antibiotics versus placebo for prevention of postoperative infection after appendicectomy. Cochrane Database Syst Rev 2005; :CD001439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/21\">",
"      Fry DE. Surgical site infections and the surgical care improvement project (SCIP): evolution of national quality measures. Surg Infect (Larchmt) 2008; 9:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/22\">",
"      Bratzler DW, Houck PM, Surgical Infection Prevention Guidelines Writers Workgroup, et al. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 2004; 38:1706.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/23\">",
"      Bratzler DW, Hunt DR. The surgical infection prevention and surgical care improvement projects: national initiatives to improve outcomes for patients having surgery. Clin Infect Dis 2006; 43:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/24\">",
"      Antimicrobial prophylaxis for surgery. Treat Guidel Med Lett 2009; 7:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/25\">",
"      Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999; 20:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/26\">",
"      Ciftci AO, Tanyel FC, B&uuml;y&uuml;kpamuk&ccedil;u N, Hi&ccedil;sonmez A. Comparative trial of four antibiotic combinations for perforated appendicitis in children. Eur J Surg 1997; 163:591.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/27\">",
"      Schropp KP, Kaplan S, Golladay ES, et al. A randomized clinical trial of ampicillin, gentamicin and clindamycin versus cefotaxime and clindamycin in children with ruptured appendicitis. Surg Gynecol Obstet 1991; 172:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/28\">",
"      Nadler EP, Gaines BA, Therapeutic Agents Committee of the Surgical Infection Society. The Surgical Infection Society guidelines on antimicrobial therapy for children with appendicitis. Surg Infect (Larchmt) 2008; 9:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/29\">",
"      van Wijck K, de Jong JR, van Heurn LW, van der Zee DC. Prolonged antibiotic treatment does not prevent intra-abdominal abscesses in perforated appendicitis. World J Surg 2010; 34:3049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/30\">",
"      Spirt MJ. Complicated intra-abdominal infections: a focus on appendicitis and diverticulitis. Postgrad Med 2010; 122:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/31\">",
"      Frutos MD, Abrisqueta J, Lujan J, et al. Randomized prospective study to compare laparoscopic appendectomy versus umbilical single-incision appendectomy. Ann Surg 2013; 257:413.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/32\">",
"      Mangi AA, Berger DL. Stump appendicitis. Am Surg 2000; 66:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/33\">",
"      McBurney C. IV. The Incision Made in the Abdominal Wall in Cases of Appendicitis, with a Description of a New Method of Operating. Ann Surg 1894; 20:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/34\">",
"      Arnbj&ouml;rnsson E. Invagination of the appendiceal stump for the reduction of peritoneal bacterial contamination. Curr Surg 1985; 42:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/35\">",
"      Watters DA, Walker MA, Abernethy BC. The appendix stump: should it be invaginated? Ann R Coll Surg Engl 1984; 66:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/36\">",
"      Engstr&ouml;m L, Feny&ouml; G. Appendicectomy: assessment of stump invagination versus simple ligation: a prospective, randomized trial. Br J Surg 1985; 72:971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/37\">",
"      Street D, Bodai BI, Owens LJ, et al. Simple ligation vs stump inversion in appendectomy. Arch Surg 1988; 123:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/38\">",
"      Poole GV. Management of the difficult appendiceal stump: how I do it. Am Surg 1993; 59:624.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/39\">",
"      Temple CL, Huchcroft SA, Temple WJ. The natural history of appendicitis in adults. A prospective study. Ann Surg 1995; 221:278.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/40\">",
"      Greenall MJ, Evans M, Pollock AV. Should you drain a perforated appendix? Br J Surg 1978; 65:880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/41\">",
"      Petrowsky H, Demartines N, Rousson V, Clavien PA. Evidence-based value of prophylactic drainage in gastrointestinal surgery: a systematic review and meta-analyses. Ann Surg 2004; 240:1074.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/42\">",
"      Lemieur TP, Rodriguez JL, Jacobs DM, et al. Wound management in perforated appendicitis. Am Surg 1999; 65:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/43\">",
"      Cohn SM, Giannotti G, Ong AW, et al. Prospective randomized trial of two wound management strategies for dirty abdominal wounds. Ann Surg 2001; 233:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/44\">",
"      Brasel KJ, Borgstrom DC, Weigelt JA. Cost-utility analysis of contaminated appendectomy wounds. J Am Coll Surg 1997; 184:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/45\">",
"      Skoubo-Kristensen E, Hvid I. The appendiceal mass: results of conservative management. Ann Surg 1982; 196:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/46\">",
"      Nitecki S, Assalia A, Schein M. Contemporary management of the appendiceal mass. Br J Surg 1993; 80:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/47\">",
"      Oliak D, Yamini D, Udani VM, et al. Initial nonoperative management for periappendiceal abscess. Dis Colon Rectum 2001; 44:936.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/48\">",
"      Bagi P, Dueholm S. Nonoperative management of the ultrasonically evaluated appendiceal mass. Surgery 1987; 101:602.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/49\">",
"      Jeffrey RB Jr, Federle MP, Tolentino CS. Periappendiceal inflammatory masses: CT-directed management and clinical outcome in 70 patients. Radiology 1988; 167:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/50\">",
"      Gee D, Babineau TJ. The optimal management of adult patients presenting with appendiceal abscess: \"conservative\" vs immediate operative management. Curr Surg 2004; 61:524.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/51\">",
"      Siewert B, Raptopoulos V. CT of the acute abdomen: findings and impact on diagnosis and treatment. AJR Am J Roentgenol 1994; 163:1317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/52\">",
"      Brown CV, Abrishami M, Muller M, Velmahos GC. Appendiceal abscess: immediate operation or percutaneous drainage? Am Surg 2003; 69:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/53\">",
"      Nguyen DB, Silen W, Hodin RA. Interval appendectomy in the laparoscopic era. J Gastrointest Surg 1999; 3:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/54\">",
"      Eriksson S, Tisell A, Granstr&ouml;m L. Ultrasonographic findings after conservative treatment of acute appendicitis and open appendicectomy. Acta Radiol 1995; 36:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/55\">",
"      Hansson J, K&ouml;rner U, Khorram-Manesh A, et al. Randomized clinical trial of antibiotic therapy versus appendicectomy as primary treatment of acute appendicitis in unselected patients. Br J Surg 2009; 96:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/56\">",
"      Blair NP, Bugis SP, Turner LJ, MacLeod MM. Review of the pathologic diagnoses of 2,216 appendectomy specimens. Am J Surg 1993; 165:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/57\">",
"      Deans GT, Spence RA. Neoplastic lesions of the appendix. Br J Surg 1995; 82:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/58\">",
"      Andersson RE, Petzold MG. Nonsurgical treatment of appendiceal abscess or phlegmon: a systematic review and meta-analysis. Ann Surg 2007; 246:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/59\">",
"      Kaminski A, Liu IL, Applebaum H, et al. Routine interval appendectomy is not justified after initial nonoperative treatment of acute appendicitis. Arch Surg 2005; 140:897.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/60\">",
"      Rucinski J, Fabian T, Panagopoulos G, et al. Gangrenous and perforated appendicitis: a meta-analytic study of 2532 patients indicates that the incision should be closed primarily. Surgery 2000; 127:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/61\">",
"      Fleming FJ, Kim MJ, Messing S, et al. Balancing the risk of postoperative surgical infections: a multivariate analysis of factors associated with laparoscopic appendectomy from the NSQIP database. Ann Surg 2010; 252:895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/62\">",
"      Flum DR, Morris A, Koepsell T, Dellinger EP. Has misdiagnosis of appendicitis decreased over time? A population-based analysis. JAMA 2001; 286:1748.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/63\">",
"      Wang Y, Reen DJ, Puri P. Is a histologically normal appendix following emergency appendicectomy alway normal? Lancet 1996; 347:1076.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/64\">",
"      Grunewald B, Keating J. Should the 'normal' appendix be removed at operation for appendicitis? J R Coll Surg Edinb 1993; 38:158.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/65\">",
"      Chiarugi M, Buccianti P, Decanini L, et al. \"What you see is not what you get\". A plea to remove a 'normal' appendix during diagnostic laparoscopy. Acta Chir Belg 2001; 101:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/66\">",
"      Greason KL, Rappold JF, Liberman MA. Incidental laparoscopic appendectomy for acute right lower quadrant abdominal pain. Its time has come. Surg Endosc 1998; 12:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/67\">",
"      Teh SH, O'Ceallaigh S, Mckeon JG, et al. Should an appendix that looks 'normal' be removed at diagnostic laparoscopy for acute right iliac fossa pain? Eur J Surg 2000; 166:388.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/68\">",
"      Watters JM, Blakslee JM, March RJ, Redmond ML. The influence of age on the severity of peritonitis. Can J Surg 1996; 39:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/69\">",
"      Addiss DG, Shaffer N, Fowler BS, Tauxe RV. The epidemiology of appendicitis and appendectomy in the United States. Am J Epidemiol 1990; 132:910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/70\">",
"      Horattas MC, Guyton DP, Wu D. A reappraisal of appendicitis in the elderly. Am J Surg 1990; 160:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/71\">",
"      Paajanen H, Kettunen J, Kostiainen S. Emergency appendectomies in patients over 80 years. Am Surg 1994; 60:950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/72\">",
"      Hui TT, Major KM, Avital I, et al. Outcome of elderly patients with appendicitis: effect of computed tomography and laparoscopy. Arch Surg 2002; 137:995.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/73\">",
"      Guller U, Hervey S, Purves H, et al. Laparoscopic versus open appendectomy: outcomes comparison based on a large administrative database. Ann Surg 2004; 239:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/74\">",
"      Flum DR, Steinberg SD, Sarkis AY, Wallack MK. Appendicitis in patients with acquired immunodeficiency syndrome. J Am Coll Surg 1997; 184:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/75\">",
"      Bova R, Meagher A. Appendicitis in HIV-positive patients. Aust N Z J Surg 1998; 68:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/76\">",
"      Whitney TM, Macho JR, Russell TR, et al. Appendicitis in acquired immunodeficiency syndrome. Am J Surg 1992; 164:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/77\">",
"      Connor SJ, Hanna GB, Frizelle FA. Appendiceal tumors: retrospective clinicopathologic analysis of appendiceal tumors from 7,970 appendectomies. Dis Colon Rectum 1998; 41:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/78\">",
"      Mussack T, Schmidbauer S, Nerlich A, et al. [Chronic appendicitis as an independent clinical entity]. Chirurg 2002; 73:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/79\">",
"      Leardi S, Delmonaco S, Ventura T, et al. [Recurrent abdominal pain and \"chronic appendicitis\"]. Minerva Chir 2000; 55:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/7/5242/abstract/80\">",
"      Sar S, Mahawar KK, Marsh R, Small PK. Recurrent appendicitis following successful conservative management of an appendicular mass in association with a foreign body: a case report. Cases J 2009; 2:7776.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1383 Version 22.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-122.72.76.133-BCBD45DDC8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_7_5242=[""].join("\n");
var outline_f5_7_5242=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H770943\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26003216\">",
"      OUTCOMES WITH MEDICAL THERAPY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9259945\">",
"      SURGICAL OUTCOMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6573304\">",
"      Laparotomy versus laparoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6573388\">",
"      Disease severity score",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PREOPERATIVE PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Antibiotics",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Acute appendicitis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Perforated appendicitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      LAPAROSCOPIC APPENDECTOMY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Patient preparation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Patient positioning",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Port placement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Mobilization and resection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      OPEN APPENDECTOMY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Incision",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Mobilization and resection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Closure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Postoperative management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      PERFORATED APPENDICITIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Incision",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Drains",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Closure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Postoperative management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Nonoperative approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Interval appendectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SPECIAL CONSIDERATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Normal appendix",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Elderly patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Immunocompromised patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      Children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Pregnancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Appendiceal neoplasms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      - Primary adenocarcinoma of the appendix",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      - Cystic neoplasms and pseudomyxoma peritonei",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      - Carcinoid tumor of the appendix",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      Chronic appendicitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H770943\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/1383\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/1383|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?41/26/42403\" title=\"figure 1\">",
"      Laparoscopic appendectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?41/11/42166\" title=\"figure 2\">",
"      Appendectomy open",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/1383|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/52/24397\" title=\"table 1\">",
"      Antimicrobial prophylaxis for gastrointestinal surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?7/21/7517\" title=\"table 2\">",
"      Empiric therapy gram negatives and anaerobes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?0/55/892\" title=\"table 3\">",
"      Surgical wound classification",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/40/31370?source=related_link\">",
"      Acute appendicitis in adults: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/3/32826?source=related_link\">",
"      Acute appendicitis in children: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/61/19416?source=related_link\">",
"      Acute appendicitis in children: Diagnostic imaging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/2/31785?source=related_link\">",
"      Acute appendicitis in children: Management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/34/42536?source=related_link\">",
"      Acute appendicitis in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/14/36074?source=related_link\">",
"      Cancer of the appendix and pseudomyxoma peritonei",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/60/969?source=related_link\">",
"      Clinical characteristics of carcinoid tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/36/19018?source=related_link\">",
"      Diagnostic approach to abdominal pain in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/30/16874?source=related_link\">",
"      Differential diagnosis of abdominal pain in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=related_link\">",
"      Overview of control measures to prevent surgical site infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/18/36129?source=related_link\">",
"      Patient information: Appendicitis in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/30/33254?source=related_link\">",
"      Pylephlebitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/29/42456?source=related_link\">",
"      Surgical issues in HIV infection",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_7_5243="Criteria for adequate specimens";
var content_f5_7_5243=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F56119&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F56119&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Cytologic criteria for an \"adequate\" specimen during TBNA",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Bronchial epithelial cells should be absent or rare.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        A preponderance of lymphocytes should be found.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Strict criteria for cytologic diagnosis of malignancy should be established and adhered to, and all samples should be classified as negative, suspicious, or definitely malignant.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Only samples showing no evidence of pathology in the presence of lymphocytes should be considered true negatives.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Minai, OA, Dasgupta, A, Mehta, AC. Transbronchial needle aspiration of central and peripheral lesions. In: Bolliger, CT, Mathur, PN (Eds), Progress in Respiratory Research-Interventional Bronchoscopy. Karger, Basel, Switzerland, 1999.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_7_5243=[""].join("\n");
var outline_f5_7_5243=null;
var title_f5_7_5244="Symptoms of cystic fibrosis";
var content_f5_7_5244=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F76253&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F76253&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Clinical manifestations of cystic fibrosis",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Respiratory",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Bronchiolitis/asthma",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pseudomonas aeruginosa colonization of the respiratory tract",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Staphylococcal pneumonia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Nasal polyposis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Chronic productive cough",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Sinusitis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Digital clubbing",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Gastrointestinal",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Meconium ileus",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Rectal prolapse",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pancreatic insufficiency",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Distal intestinal obstruction syndrome (DIOS)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Hypoproteinemic edema",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Prolonged neonatal jaundice",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Biliary cirrhosis with portal hypertension",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Vitamin deficiency states (A, D, E, K)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Acrodermatitis enteropathica-like eruption with fatty acid and zinc deficiency",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Recurrent pancreatitis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Volvulus in fetal life",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Genitourinary",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Bilateral absence of vas deferens",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Male infertility",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Female infertility",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Other",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Hypochloremic, hyponatremic alkalosis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Pseudotumor cerebri",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_7_5244=[""].join("\n");
var outline_f5_7_5244=null;
var title_f5_7_5245="Opioid intoxication in adults - Rapid overview";
var content_f5_7_5245=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F55540&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F55540&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Opioid intoxication (adult): Rapid overview",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        <span style=\"color: #ff0000;\">",
"         To obtain emergent consultation with a medical toxicologist, call the United States Poison Control Network at 1-800-222-1222, or access the World Health Organization's list of international poison centers (",
"        </span>",
"        <a href=\"file://www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html\" target=\"_blank\">",
"         www.who.int/gho/phe/chemical_safety/poisons_centres/en/index.html",
"        </a>",
"        <span style=\"color: #ff0000;\">",
"         ).",
"        </span>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Clinical and laboratory features",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Altered mental status ranging from mild euphoria or lethargy to coma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Miotic pupils",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Decreased bowel sounds",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Low to normal heart rate and blood pressure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypoventilation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Diagnostic evaluation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Obtain rapid bedside serum glucose concentration, to exclude hypoglycemia as cause of coma.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Obtain creatine kinase (if history indicates prolonged immobilization).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Obtain chest radiograph (if physical examination suggests acute lung injury or aspiration).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Obtain serum acetaminophen concentration (if opioid was taken with intent of self-harm or in opioid/acetaminophen combination product).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Obtain electrocardiogram (if methadone or propoxyphene is suspected).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Treatment",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ensure adequate ventilation. If respiratory rate is &ge;12 breaths/minute and O2 saturation &gt;90 percent on room air, observe the patient in a monitored setting and reassess frequently. End-tidal CO2 monitoring using capnography is an excellent means to monitor ventilation.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        If the O2 saturation is &lt;90 percent on room air but the patient is breathing spontaneously, administer supplemental oxygen followed by intravenous naloxone, 0.05 mg. In absence of IV access, naloxone can be given intramuscularly. Repeat until ventilation is adequate. The goal of treatment is adequate ventilation,",
"        <strong>",
"         NOT",
"        </strong>",
"        normal mental status. If the response is inadequate after 5 to 10 mg, reconsider the diagnosis.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        If the patient is apneic, ventilate using a bag-valve mask attached to supplemental oxygen and administer naloxone in doses of 0.2 to 1 mg IV or IM. If no response occurs after a total of 5 to 10 mg of naloxone, reconsider the diagnosis and perform tracheal intubation.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        If hypoventilation recurs following the initial naloxone bolus, give additional bolus doses to restore adequate ventilation. When ventilation is adequate, a naloxone infusion can be instituted in lieu of frequent rebolusing. Begin the infusion rate at 2/3 of the total dose of naloxone needed to restore breathing, delivered every hour.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        If the patient develops respiratory depression despite a naloxone infusion, administer a naloxone bolus (using half the original bolus dose) and repeat if necessary until adequate ventilation returns, then increase the infusion rate.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        If the patient develops signs of opioid withdrawal, stop the infusion. If respiratory depression returns, start the infusion at half the original rate.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The patient is medically stable for transfer or discharge when their mental status and ventilation remain normal for more than one hour after cessation of naloxone.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Psychiatry consultation may be required to assess suicidality.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_7_5245=[""].join("\n");
var outline_f5_7_5245=null;
var title_f5_7_5246="Contents: Mental and medical disorders";
var content_f5_7_5246=[" <script type=\"text/javascript\">",
"  $$.inlineInitCustomer(",
"	false);",
"	var quirksmode = document.compatMode == \"CSS1Compat\";",
"	if (quirksmode) {",
"		$(\"html\").addClass(\"ie-standards\");",
"	}",
" </script>",
" <div id=\"message-wrap\">",
"  <div id=\"message-bg\">",
"  </div>",
"  <iframe id=\"message-bk\">",
"  </iframe>",
"  <dl id=\"message-container\">",
"   <dt id=\"message-title\">",
"   </dt>",
"   <dd id=\"message-body\">",
"   </dd>",
"   <dd id=\"message-controls\">",
"   </dd>",
"  </dl>",
" </div>",
" <div id=\"topPanel\">",
"  <div id=\"header\">",
"   <div id=\"header_container\">",
"    <h2 id=\"logo\">",
"     <a href=\"./toc\">",
"      Wolters Kluwer Health UpToDate",
"     </a>",
"    </h2>",
"    <div id=\"header_right\">",
"     <div id=\"searchpanel\">",
"      <a href=\"/login\" id=\"loginbutton\">",
"       Log in",
"      </a>",
"      <div id=\"cmsSearchBox\">",
"       <div class=\"header-search\">",
"        <form action=\"./search\" id=\"cmssearch\" method=\"get\" name=\"SearchForm\">",
"         <div class=\"header-search-left\">",
"          <input autocomplete=\"off\" class=\"searchfield\" id=\"cmsTxtBox\" name=\"search\" placeholder=\"Search UpToDate\" type=\"text\"/>",
"         </div>",
"         <div class=\"header-search-right\">",
"          <input alt=\"Search\" id=\"cmsSearchSubmit\" src=\"/sites/all/themes/uptodate/images/search_button.png\" type=\"image\"/>",
"         </div>",
"         <div class=\"clear\">",
"         </div>",
"        </form>",
"       </div>",
"      </div>",
"      <div id=\"cms_lang_dropdown\">",
"       <form accept-charset=\"UTF-8\" action=\"/\" id=\"lang-dropdown-form\" method=\"post\">",
"        <div class=\"form-item form-type-select form-item-lang-dropdown-select\">",
"         <select class=\"lang-dropdown-select-element form-select\" id=\"edit-lang-dropdown-select\" name=\"lang_dropdown_select\" style=\"width:100px\">",
"          <option selected=\"selected\" value=\"en\">",
"           English",
"          </option>",
"          <option value=\"ja\">",
"           ",
"          </option>",
"         </select>",
"        </div>",
"        <input name=\"lang_dropdown_type\" type=\"hidden\" value=\"language\">",
"         <input name=\"en\" type=\"hidden\" value=\"/\">",
"          <input name=\"ja\" type=\"hidden\" value=\"/ja\">",
"           <noscript>",
"            <div>",
"             <input class=\"form-submit\" id=\"edit-submit\" name=\"op\" type=\"submit\" value=\"Go\"/>",
"            </div>",
"           </noscript>",
"           <input name=\"form_build_id\" type=\"hidden\" value=\"form-on4lUWpxHun_wp6revUkjCG6rK2IBuCGME9Cw0HXeok\">",
"            <input name=\"form_id\" type=\"hidden\" value=\"lang_dropdown_form\">",
"            </input>",
"           </input>",
"          </input>",
"         </input>",
"        </input>",
"       </form>",
"      </div>",
"      <div class=\"clear\">",
"      </div>",
"     </div>",
"     <ul id=\"utility\">",
"      <li class=\"first\">",
"       <a href=\"/home/about-us\">",
"        About Us",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/news-events\">",
"        News &amp; Events",
"       </a>",
"      </li>",
"      <li>",
"       <a href=\"/home/contact-us\">",
"        Contact Us",
"       </a>",
"      </li>",
"      <li class=\"last\">",
"       <a href=\"/help\">",
"        Help",
"       </a>",
"      </li>",
"     </ul>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"nav\">",
"    <ul>",
"     <li id=\"productTab\">",
"      <a href=\"/home/product\">",
"       Product",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"editoralTab\">",
"      <a href=\"/home/editorial\">",
"       Editorial",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"whyUptodateTab\">",
"      <a href=\"/home/why-uptodate\">",
"       Why UpToDate",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"supscriptionOptionsTab\">",
"      <a href=\"/home/subscription-options\">",
"       Subscription Options",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"/store\">",
"       Subscribe",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"     <li id=\"wkhcsTab\">",
"      <a href=\"/home/wolters-kluwer-health-clinical-solutions\">",
"       Wolters Kluwer Health Clinical Solutions",
"       <span>",
"       </span>",
"      </a>",
"     </li>",
"    </ul>",
"    <div class=\"clear\">",
"    </div>",
"   </div>",
"   <div id=\"greyBar\">",
"    <div id=\"greyBarTitle\">",
"     <span class=\"emphasis\">",
"      <a href=\"UTD.htm?3/3/3134\">",
"       Contents",
"      </a>",
"     </span>",
"     <img src=\"./../images/space_arrows.myextg\">",
"      <a href=\"UTD.htm?41/24/42381\">",
"       Psychiatry",
"      </a>",
"      <img src=\"./../images/space_arrows.myextg\">",
"       Mental and medical disorders",
"      </img>",
"     </img>",
"    </div>",
"    <div id=\"greyBarButtons\">",
"     <div id=\"printGB\">",
"      <a class=\"icontxt\" href=\"?view=print\">",
"       <img align=\"middle\" alt=\"Print this page\" border=\"0\" height=\"20\" src=\"./../images/icn_print.myextg\" width=\"24\"/>",
"      </a>",
"      <a class=\"icontxt\" href=\"?view=print\" title=\"Print this page\">",
"       Print",
"      </a>",
"     </div>",
"    </div>",
"   </div>",
"   <!-- menuMessage.jsp -->",
"   <!-- /menuMessage.jsp -->",
"  </div>",
"  <!-- header -->",
" </div>",
" <!-- topPanel -->",
" <div id=\"leftPanel\">",
"  <ul>",
"   <li>",
"    <a href=\"UTD.htm?3/45/3806\">",
"     Specialties",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?18/22/18798\">",
"     Patient Information",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?3/13/3294\">",
"     What's New",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/37/606\">",
"     Calculators",
"    </a>",
"   </li>",
"   <li>",
"    <a href=\"UTD.htm?0/40/654\">",
"     Authors and Editors",
"    </a>",
"   </li>",
"  </ul>",
" </div>",
" <!-- leftPanel -->",
" <div id=\"rightPanel\">",
"  <noscript>",
"   <div id=\"javascriptDisabled\">",
"    It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"   </div>",
"  </noscript>",
"  <div id=\"printHeader\">",
"   <div id=\"printHeaderLogo\">",
"    <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"    </img>",
"   </div>",
"   <div id=\"printHeaderText\">",
"    Official reprint from UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"    <a href=\"file://www.uptodate.com\">",
"     www.uptodate.com",
"    </a>",
"    <br>",
"     &copy;2013 UpToDate",
"     <sup>",
"      &reg;",
"     </sup>",
"    </br>",
"   </div>",
"   <div id=\"printHeaderLinks\">",
"    <a href=\"#\" id=\"printHeaderPrint\" rel=\"\" title=\"Click here to print\">",
"     Print",
"    </a>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"     Back",
"    </a>",
"   </div>",
"  </div>",
"  <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" id=\"tocTable\" width=\"100%\">",
"   <trs>",
"    <tds>",
"     <h1>",
"      Contents:",
"			Mental and medical disorders",
"     </h1>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds valign=\"top\">",
"     <div class=\"toctable\" border=\"0\" cellpadding=\"0\" cellspacing=\"0\" width=\"100%\">",
"      <trs>",
"       <tds>",
"        <ul>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?12/13/12504\">",
"           Depression, mania, and schizophrenia in HIV-infected patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?30/22/31080\">",
"           Diagnosis of psychiatric and psychologic disorders in patients with cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/43/5816\">",
"           Diagnostic approach to the neuropsychiatric manifestations of systemic lupus erythematosus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?7/38/7781\">",
"           Eating disorders in pregnant women",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?27/1/27673\">",
"           Management of psychiatric and psychologic disorders in patients with cancer",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?37/46/38631\">",
"           Neuropsychiatric manifestations of systemic lupus erythematosus",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/62/24551\">",
"           Neuropsychiatric side effects associated with interferon-alfa plus ribavirin therapy: Recognition and risk factors",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?1/40/1674\">",
"           Neuropsychiatric side effects associated with interferon-alfa plus ribavirin therapy: Treatment and prevention",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?5/44/5831\">",
"           Overview of the neuropsychiatric aspects of HIV infection and AIDS",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?35/42/36517\">",
"           Psychiatric aspects of organ transplantation",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?11/3/11322\">",
"           Psychiatric illness in dialysis patients",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?21/52/22343\">",
"           Psychological stress and infertility",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?15/55/16250\">",
"           Psychosocial and other social factors in acute myocardial infarction",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?40/19/41273\">",
"           Psychosocial factors and rheumatic disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?24/59/25528\">",
"           Psychosocial factors in coronary and cerebral vascular disease",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?23/15/23800\">",
"           Psychosocial factors in sudden cardiac arrest",
"          </a>",
"         </li>",
"         <li>",
"          <a class=\"tocItem\" href=\"UTD.htm?2/31/2551\">",
"           Substance abuse and addiction in HIV-infected patients",
"          </a>",
"         </li>",
"        </ul>",
"       </tds>",
"      </trs>",
"     </div>",
"    </tds>",
"   </trs>",
"   <trs>",
"    <tds>",
"     <img height=\"10\" src=\"./../images/spacer.myextg\" width=\"1\"/>",
"    </tds>",
"   </trs>",
"  </div>",
"  <div id=\"footer\">",
"   <div id=\"footerNav\">",
"    <ul>",
"     <li>",
"      <a href=\"file://www.wolterskluwerhealth.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Wolters Kluwer Health",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.factsandcomparisons.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Facts &amp; Comparisons&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medispan.com\" rel=\"nofollow\" target=\"_blank\">",
"       Medi-Span&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationordersets.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Order Sets",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.provationmedical.com\" rel=\"nofollow\" target=\"_blank\">",
"       ProVation&reg; Medical",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://pharmacyonesource.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Pharmacy OneSource&reg;",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.medicom.com.cn/\" rel=\"nofollow\" target=\"_blank\">",
"       Medicom",
"      </a>",
"     </li>",
"     <li>",
"      <a href=\"file://www.lexi.com/\" rel=\"nofollow\" target=\"_blank\">",
"       Lexicomp",
"      </a>",
"     </li>",
"     <li class=\"last\">",
"      <a href=\"/home/privacy-policy\">",
"       Privacy Policy",
"      </a>",
"     </li>",
"    </ul>",
"   </div>",
"   <div id=\"footerLogo\">",
"    <a href=\"./toc\">",
"     Wolters Kluwer Health | UpToDate",
"    </a>",
"   </div>",
"   <div id=\"supportFooter\">",
"    <span class=\"sfInfo\">",
"     &copy; 2013 UpToDate, Inc. All rights reserved.",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Release: 21.3 - C21.34",
"    </span>",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    <span class=\"sfInfo\">",
"     <a href=\"/home/terms-use\">",
"      Terms of Use",
"     </a>",
"    </span>",
"    <br/>",
"    <span class=\"sfInfo\">",
"     Licensed to:",
"     <span class=\"emphasis\">",
"      UpToDate Marketing Professional",
"     </span>",
"    </span>",
"    <span class=\"sfInfo\">",
"     <span class=\"pipeSpace\">",
"      |",
"     </span>",
"     Support Tag: [0605-95.154.198.148-8760BFD0C6-14]",
"     <br/>",
"    </span>",
"   </div>",
"  </div>",
" </div>",
" <!-- rightPanel -->",
"</body>"].join("\n");
var script_f5_7_5246=[""].join("\n");
var outline_f5_7_5246=null;
var title_f5_7_5247="Folate and alcohol intake and CHD risk in women";
var content_f5_7_5247=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F51335&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F51335&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 569px\">",
"   <div class=\"ttl\">",
"    Women with the highest intake of folate and alcohol have the lowest risk for coronary heart disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 549px; height: 303px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The relative risk of coronary heart disease (nonfatal myocardial infarction and fatal coronary heart disease) by quintiles of folate intake across levels of alcohol consumption among 80,082 women in the Nurses' Health Study. Women in the lowest quintile of folate who did not drink alcohol were the reference category (relative risk 1.0). The benefits from increasing amounts of folate intake are seen primarily in women who consume alcohol and the benefit increases as alcohol consumption increases.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Rimm EB, Willeh WC, Hu FB, et al. JAMA 1998; 279:359.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_7_5247=[""].join("\n");
var outline_f5_7_5247=null;
